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ABSTRACT 
This thesis describes a new approach to the rational design of an artificial esterase, and 
is in three parts. 
The first part of the thesis is an introduction to the design and synthesis of artificial 
enzymes. This details both traditional "design', and more recent 'selection' approaches 
to artificial enzymes, and discusses the advantages and problems associated with the 
different strategies. 
The second part is a discussion of our investigations into the design and synthesis of 
polymeric artificial enzymes which are able to catalyse an ester hydrolysis. The research 
uses a novel strategy that combines the 'design' and 'selection' approaches: Using the 
concept of transition state theory, we aimed to design a unit that should bind and 
stabilise the transition state of a reaction. We then aimed to selectively incorporate this, 
and other catalytically active groups into a flexible, soluble polymer. The work starts 
with the synthesis of the ester substrate, and a phosphonate transition state analogue. 
The 'design' section of the project involved finding a low molecular weight 'binding 
unit' that could bind to the transition state analogue, and hence should bind and stabilise 
the transition state of our reaction. We decided to use dipeptides and studied binding 
using Pulsed Field Gradient NMR techniques to measure changes in diffusion 
coefficients. This is a technique which had previously only been used to study large 
molecule-small molecule binding. We successfully managed to apply this technique to 
studying small molecule-small molecule interactions, and thus it was found that the 
dipeptide arginine-arginine bound well to our transition state analogue, and the nature of 
the interactions were studied using molecular modelling. 
The 'selection' section involved incorporation of this unit into a polymer, along with the 
introduction of amino acids that could act as catalytically active groups. Both the 
dipeptide, and chosen amino acids were reacted with a polyallylamine backbone using 
standard peptide chemistry. The influences of the different polymers on the hydrolysis 
of the ester were investigated, and it was found that some of these polymers showed 
distinct catalytic 'enzyme like' properties. The results are reported within. 
The third section described the experimental work and procedure used throughout this 
thesis. 
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Chapter 1. Introduction. 
Introduction 
Progress in the Design and Synthesis of Artificial Enzymes. 
1. Introduction. 
Nature has developed enzymes as highly evolved catalysts which not only accelerate 
reactions, but which can also do so with near-perfect regio and stereo specificity. As 
well as providing an intellectual challenge, a proper understanding of the underlying 
principles of enzyme catalysis would enable us to develop 'artificial enzymes' which 
would act with the same efficiency as enzymes, and have some considerable advantages 
over the natural systems. These include the potential to design catalysts for systems for 
which either no natural enzymes are known, or are available for synthetic application. 
As enzymes are proteins, they generally operate in aqueous media in order to retain the 
3- dimensional structure required for catalysis. Artificial enzymes may not have this 
same requirement and therefore be better suited to use in organic solvents. Since the 
protein structure of enzymes is fragile, artificial enzymes can in principle be synthesised 
from macromolecular structures which are more chemically robust, and therefore could 
be utilised at higher temperatures and pressures. 
Nature has of course had billions of years to evolve enzymes into the complex 3-
dimensional structures with which we are familiar today. As synthetic chemists 
however, we need to concentrate this period into a feasible timescale for research. In 
order to be able to do this successfully, the first requirement is to have some 
understanding of the concepts that lie behind enzyme catalysis. 
1 1 
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2. Determinant Factors in Enzymic Catalysis. 
As early as 1894, Emil Fischer proposed that catalysis arose as a result of binding 
between the enzyme and substrate, a proposal he named the lock and key theory 1• 
Indeed, it is now known that a characteristic feature of an enzyme catalysed reaction is 
that it follows Michealis-Menton kinetics due to initial formation of an enzyme 
substrate complex2• 
Today, the most commonly accepted view is that proposed by Pauling in 1948, who 
suggested that catalysis occurs due to the enzyme's ability to stabilise the transition-
state structure of the substrate relative to that of the ground state3. The theory is 
illustrated below for a unimolecular reaction (Figure 1). 
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The activation energies for the reaction are denoted by ~Gcat and ~Guncat for the enzyme 
catalysed and free reactions respectively. For catalysis to occur, ~GETS the free energy 
of binding of the transition state must be greater than ~GES. This results in a lowering of 
12 
Introduction 
the activation energy, and thus acceleration of the reaction. For true catalysis to occur 
however, the system needs to exhibit turnover, i.e. the enzyme substrate complex must 
be lower in energy than the enzyme product complex. If the opposite is true, then 
product inhibition of the enzyme is observed. From this picture of enzyme action it can 
be seen that when designing the active site of an enzyme mimic, we must not only 
consider transition state stabilisation, but also the thermodynamically favourable release 
of the product. Clearly, in more complex models, application of the above model of 
transition state stabilisation is less straightforward. 
The design of many early artificial enzymes focused solely on the idea of transition state 
theory4. The above discussion is however a simplification of the real situation, since 
enzyme catalysis of a transformation often involves an alternative reaction pathway 
from the non-catalysed reaction, taking advantage of the enzymes ability to reduce the 
molecularity of multistep sequences. The lack of universal success in the attempt to 
synthesise an artificial system with the same capabilities as a natural enzyme has meant 
that we now need to look in more detail at what other factors are involved in enzyme 
catalysis, and how enzymes achieve their selective binding of the transition state. 
Simplistically, there are four mam factors involved in enzyme catalysis5. First, a 
chemical apparatus is required at the active site to deform or polarise bonds of the 
substrate, thus making it more reactive. This can be as simple as hydrogen bonding 
between the substrate and enzyme, or the binding of a metal. In more complex systems, 
amino acid residues are present in the active site that are capable of forming covalent 
bonds with the substrate, usually to form a more reactive intermediate. Secondly, the 
enzyme must contain a binding site that immobilizes the substrate in the correct 
geometry relative to the other groups that are participating in the chemical 
transformation. Thirdly, a correct and precise orientation of the substrate that permits 
each step of the reaction to proceed with minimal translational or rotational movement 
about the bonds of the substrate is also required. This is clearly important in controlling 
the stereochemistry of the reaction. Finally, immobilisation of the substrate must lower 
the energy of activation of the reaction. All these factors combine to enable the active 
site of an enzyme to function as a powerful catalyst. 
13 
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The serine - protease a-Chymotrypsin, provides a beautiful example which incorporates 
all of the above factors in its mode of action5,6,7. The role of this enzyme is to "cut up" 
proteins on the carboxyl side of aromatic amino acids. The mechanism of hydrolysis is 
shown in Scheme 1. 
tS-57 (50r-195 
AsP-102---{:' h 0 O-H~:YH.,~ LR1 R-N~ j 
o 
AsP-102---{ 
Q-H 
o 
ASP-102---{ 
Q-H 
~ (50r-195 eo 
N~N-H 
Scheme 1 
Hydrophobic binding pocket allowing 
productive binding of the substrate 
tetrahedral intermediate 
Acyl enzyme - easily hydrolysed 
by water 
Second tetrahedral intermediate 
Enzyme ready for another 
molecule of substrate 
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The enzyme contains a hydrophobic pocket, which binds the aromatic residue of the 
protein, in the correct geometry and orientation for the reaction to proceed. a-
Chymotrypsin contains a catalytic triad, consisting of the serine-195, aspartic acid-l 02. 
and histidine-57 residues, which interact via a charge-relay system. The function of the 
buried Asp-l02 group is to polarise the imidazole ring of His-57. since the buried 
negative charge induces a positive charge next to it. This allows proton transfer along 
hydrogen bonds, and the hydroxyl proton of Ser-195 is transferred to His-57. The acti\'e 
serine residue then becomes a reactive nuc1eophile capable of attacking the scissile 
peptide bond. An acyl-enzyme intennediate is fonned by a covalent bond between the 
Ser-195 and the substrate, which does not accumulate, but which is readily hydrolysed 
by water. 
This charge-relay system is not the sole factor in the catalytic efficiency of a-
chymotrypsin. Stabilisation of the transition state, and thus lowering of the activation 
energy is achieved by hydrogen bond fonnation between the carbonyl group on the 
substrate, and the amide hydrogen of Ser-195 and Gly-193. 
This example shows that whilst transition state stabilisation clearly plays an important 
role in enzyme catalysis, it is not the only factor involved. Therefore when looking to 
design a new artificial enzyme, we should try to create a mimic that imitates the entire 
mode of action, and does not just concentrate on one feature. 
In order to design an effective enzyme mImIC, we also need to have a better 
understanding of how enzymes achieve their selective binding of the transition state. A 
number of factors contribute to the difference in free energy of both substrate and 
enzyme in the unbound (E + S) and bound states (E.S), and between the ground-state 
(E.S) and transition-state (E.S#) forms of the enzyme substrate complex (Equation 1)8. 
.. E.S .. Equation 1 ... 
The first equilibrium is dependant on specific interactions between enzyme and 
substrate, comprising Van der Waals forces and hydrogen bonding in the active site, 
balanced by the enthalpic and entropic contributions from solvation of both 
15 
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components. In fact, the desolvation of substrate has been considered to be a vital 
factor. The formal equilibrium between ground state (E.S) and transition state (E.S#) 
also depends on substrate-enzyme interactions, but is less sensitive to solvation effects 
since there is little change in the solvent accessible surface at this stage. 
Whilst Van der Waals interactions are significant when calculating the total energy of 
an enzyme-substrate complex, they do not contribute much to the binding equilibrium, 
as Van der Waals interactions between elements in the first and second rows of the 
periodic table are relatively insensitive to the nature of the atoms involved. Therefore 
there is no significant change on replacing solvent-ligand contacts with solvent-solvent 
or enzyme-ligand contacts9• 
Electrostatic and hydrogen bonding contribute significantly to the total energy of an 
enzyme-substrate complex, but as enzymes operate in water, their effects are greatly 
moderated by solvation. It is often overlooked that formation of a hydrogen bond in a 
complex is an exchange process and that in order to form this bond similar bonds have 
to be broken between water and both substrate and enzyme. Likewise new hydrogen 
bonds are formed between the drug and receptor and between the previously hydrogen 
bonded water molecules and bulk water. The contribution to the binding equilibrium is 
the overall energy change involved in breaking and forming all these hydrogen bonds, 
and generally is found to be a modest value in the order of 1.5kcal mor l for a neutral-
neutral hydrogen bond 10,11,12. It has therefore been suggested that the role of hydrogen 
bonding is to determine ligand specificity by creating an energy penalty for binding the 
wrong ligand. 
The contribution of charged hydrogen bonds to binding enthalpy has been found to be 
more significant. Fersht studied the tyrosyl t-RNA synthase catalysed coupling of 
tyrosine to ATP to yield tyrosyl-AMpI 2• Site directed mutagensis was used to probe the 
energetics of the coupling. As the crystal structure of the complex was known, 
mutations could directly be interpreted as losses in specific hydrogen bonds, salt bridges 
and hydrophobic contacts. Through a series of point mutations they were able to 
determine that whilst the neutral-neutral hydrogen bond contributed only O.5-1.5kcal 
mor l , the presence of a charged hydrogen bond contributes up to 4.7kcal mor
l
, which is 
equivalent to a 3000-fold increase in affinity. 
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More recently the importance of the hydrophobic effect in selective binding has been 
highlighted. This stabilisation arises from the transfer of a hydrocarbon surface out of 
water and into a hydrophobic region of an enzyme. The interaction arises not from 
attraction of the hydrophobic surfaces for each other, but from the favourable change in 
free energy as ordered water molecules surrounding the hydrophobic surface are 
released to bulk water. As a result, the effect correlates with the area of the hydrophobic 
surface that is desolvated. A variety of approaches have been taken to determine the 
magnitude of this effect, which is worth a minimum of O.68kcal mor l or 28caiA mor l 
per methyl groupl3, 14. 
An example which demonstrates the hydrophobic effect is the binding of two series of 
HIV-2 protease inhibitors 1 and 2 (Figure 2)15. This example also introduces the 
concept of 'induced fit', in which the receptor undergoes a conformational change in 
order to optimise hydrophobic interactions with the ligand. 
(I , 
o 
~~ : N 
~ P2 H 
~ P3 0 
t;J~ 
OH ~ R 
1 2 
Figure 2 
Similar binding affinities are displayed by 1 and 2 despite the replacement of the P2 and 
P3 substituent in 1 with a phenoxy substituent in 2. Analysis of the protein-inhibitor 
complex of 1 by X-ray crystallography revealed hydrogen bonds between the quinoline 
amide and Asp-29 and Gly-48. The complex with 2 shows induced fit to the 
dimethylphenoxy group through a shift of lA for Asp-29 and a shift of 4A for the side 
chain at Asp-30. This elegantly demonstrates two major features of enzyme binding. 
First, that affinity can be enhanced through hydrophobic interactions, even at the cost of 
hydrogen bonds. Secondly, it demonstrates the inherent flexibility of enzymes, such that 
they can adopt different conformations in order to optimise binding. 
17 
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All of the above effects involve binding between discrete ligand and receptor moieties, 
and are influential in both of the equilibria shown in equation 1. The changes in active 
site interactions on going from ground state to transition state have seldom been 
addressed directly. This is because the system, and hence the bonding interactions, are 
dynamic in nature. This binding phenomenon, termed "dynamic binding", distinguishes 
between ground state and transition state recognition. Kirby has used the example of 
serine proteases to illustrate the concept of dynamic binding l6 . During the transition 
state for this reaction at least six bonds are being broken or formed (Figure 3). 
,H- - - -A--Enzyme 
, 
0' 
Enzyme--B.. R\lII";: Ii 
" " ~NR 
H----O I 
I H 
Enzyme 
Figure 3 
The exact nature of the transition state is unknown, but it is clear that the enzyme uses 
more than ordinary molecular recognition to "bind" this transition state. "Dynamic 
binding" interactions are represented by the partially formed covalent bonds at the 
reaction centre, which have no conveniently modelled ground state counterpart. These 
interactions playa significant role in the binding and stabilisation of the transition state, 
and represent one of the major differences between ground state and transition state 
recognition. 
All of the factors described above contribute to the overall binding of the transition 
state. Combining this information with other knowledge about enzymes mechanisms to 
create an effective enzyme mimic provides a true test of our understanding of the 
subject. It is to be hoped that investigations into the design and synthesis of artificial 
enzymes will not only be aided by this knowledge, but also that these investigations will 
in themselves lead to a better understanding of molecular recognition and catalysis 
itself. 
18 
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3. Previous Approaches to Artificial Enzymes. 
Traditional approaches to the synthesis of an artificial enzyme focused on the rational 
design and synthesis of a complex catalyst molecule. Whilst some impressive results 
have been achieved in this manner, this type of approach is time consuming, both in 
conception and practice, and the smallest flaw in design can lead to catastrophic results. 
More recent strategies have been based on the idea of selection, either by binding, or 
directly by catalytic activity, and, as we shall see, utilise fields as diverse as molecular 
biology and polymer chemistry. 
3.1 The Design Approach to Artificial Enzymes. 
The rational design of macromolecular receptors with appropriately positioned 
functional groups which try to recreate the binding, catalytic efficiency and 
microenvironment of enzyme active sites is, of course the most logical and cartisan 
approach. The functional groups have been chosen to mimic the amino acid residues 
known to be involved in the enzyme-catalysed reaction. The majority of attention has 
been focused on the design and synthesis of catalytic cyclodextrins 17-22, but recently 
some other techniques such as designed cyclophanes23 , and covalent conjugation24 have 
shown some impressive results, and proven to be more versatile in the reactions they 
can catalyse. From the initial concept through to catalytic studies has proven to be a 
long and arduous process, and although some impressive results have been observed, 
formation of a real "artificial enzyme", that not only causes a rate acceleration, but also 
does so in a selective fashion, and with turnover still seems some way off. 
3.1.1 Catalytic Cyclodextrins as Enzyme Mimics. 
Cyclodextrins are stable, water soluble, cyclic oligosaccharides consisting of 1,4 linked 
D-( + )-glucopyranose units. This cyclic array produces a hydrophobic cavity in the form 
of a truncated cone. Primary alcohols are located around the narrow rim, and secondary 
alcohols around the wide rim (Figure 4). 
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Hydrophobic Binding Cavity 
OH 
n 
n=8 a-CD 
OH 
n=7 ~-CD 
n=6 y-CD 
Figure 4 
Recognition that the cavity could bind hydrophobic organic molecules in water, and that 
functionalisation of the hydroxyl groups on the rims was possible, led to cyclodextrins 
being investigated as potential artificial enzymes. 
Unmodified cyclodextrins themselves have been shown to behave as good enzyme 
mimics, following Michaelis-Menton kinetics in reactions such as hydrolysis of 
nitrophenolate esters I7,18. Typically the phenyl group is bound within the hydrophobic 
binding cavity in such an orientation that nucleophilic attack on the ester by the 
secondary hydroxyl groups is possible. In the case of p-substituted phenyl derivatives 
however, when the ester group is bound near the central axis of the cavity, reacting 
groups cannot come into close proximity, and, in this case, general base catalysis 
competes (Scheme 2). 
Significant rate enhancements in the range between 4 and 2150-fold have been observed 
with unmodified cyclodextrins, but several problems are associated with this type of 
catalysis 17,18. First, the hydrophobic phenol product is usually bound tightly within the 
cavity of the cyclodextrin, and product inhibition is often observed. An excess of 
cyclodextrin is often used to avoid this problem, but with the unfortunate result that 
catalytic turnover is not achieved. Second, the nucleophilic mechanism goes via an 
acylated cyclodextrin as an intermediate. The rate determining step of the reaction is 
now hydrolysis of this intermediate, which in many cases has proven to be less reactive 
than the original substrate. 
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Nucleophilic Attack by the Secondary OH 
General Base Catalysis 
Scheme 2 
The close proximity of the hydroxyl groups in cyclodextrins means that functional 
groups attached at these points are often close enough that they can act in a co-operative 
manner, such as that observed in the active site of many enzymes. The electrostatic 
environment in the active site maintains the delicate balance of pKa's required for the 
various groups to participate catalytically. Histidine is often able to function as both an 
acid and base in simultaneous bi- or multifunctional catalysis. An example of this is in 
the enzyme Ribonuclease A, which utilises two histidine residues in the hydrolysis of 
RNA25 . 
Breslow was inspired by this system to design an artificial aldolase 19• Two different 
catalysts were synthesised by arranging two imidazole rings on the secondary rim of ~-
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cyc10dextrin (CD): on glucose units adjacent to each other (AB isomer) and glucose 
units 1540 apart (AD isomer). The intramolecular aldol cyc1isation of keto aldehyde 3 to 
anti ketoalcohol 4 was studied using these catalysts. In the presence of unmodified ~­
CD at neutral pH, no significant cyc1isation was observed. When the AB isomer was 
added, a 20-fold rate acceleration was observed relative to the uncatalysed reaction. 
However, this result was found to be the same as that observed with a monoimidazole 
functionalised ~-CD. With the AD catalyst however, a 50-fold rate acceleration 
occurred. This clearly indicated that the positioning of the imidazole rings was crucial, 
and when attached to sugars 1540 apart bifunctional catalysis could occur involving 
both the protonated and neutral imidazole species (Scheme 3). 
H H 
.. 
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1\ 
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In a more recent example, Breslow noted that the combination of a bound Zn(H) and a 
coordinated pyridyl-2-carboxaldoxime 5 can be effective in cleaving esters20. When the 
two nitrogens coordinate to the metal, the oxime hydroxyl is acidic, but the oxygen 
atom is not coordinated and can therefore attack a Zn(H) coordinated carbonyl group. 
An O-acyl oxime intermediate is formed which can be readily hydrolysed (Scheme 4). 
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Breslow constructed two catalysts based on cyclodextrin binding groups in which a 
similar oxime was an intrinsic part of the molecules20. In one catalyst 6, the oxime was 
attached to the primary face, and in the other 7, the secondary face (Figure 5). When 
tested as catalysts for the hydrolysis of p-nitrophenol acetate in the presence of Zn(II), 7 
showed a 22,600-fold rate acceleration over the uncatalysed system. In order to show 
that the catalysis was a result of the proposed mechanism (Scheme 4), two further 
cyclodextrin derivatives were synthesised, one with Zn(H) replaced by Cu(II), and the 
other containing an oxime methyl ether 8. The rate observed with the Cu(II) catalyst 
was 250 times slower than the Zn(II) catalyst, and when 8, containing the oxime methyl 
ether was used, the rate was only twice that of the uncatalysed reaction. The other 
catalyst 6 also showed a rate improvement, but only I500-fold. Breslow thought there 
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might be two reasons for the greater catalytic activity of the secondary face catalyst. 
First, there may be a preferential binding geometry, and second the primary face 
catalyst shows an undesired greater flexibility. 
/3-Cyc1odextrin 
6 
/3-Cyc1odextrin 
7 
Figure 5 
8 
The use of cyclodextrins as enzyme mimics has been extended to incorporate dimers 
and trimers of cyclodextrins21.26. This is a method of introducing more than one binding 
moiety into the catalyst. In addition, the linker can also contain catalytically active 
functional groups. The ~-cyclodextrin dimer 9 is linked via the primary face by tris(2-
aminoethyl)amine (tren)21. This linker was used as it was thought that at neutral pH, 
tren would exist primarily as a di-cation. Protonated and neutral amino groups would 
therefore co-exist, and would open the door to an effective general acidibase catalysis, 
such as that utilised by a number of enzymes, including ribonuclease A. 
The dimer 9 was used as a catalyst in the hydrolysis of bis-p-nitropheny1carbonate 10, 
the idea being that the two phenyl groups should sit inside the cavities of 9, and the 
carbonate moiety should be in close proximity to the tren amino groups, which could act 
as acid base catalysts (Figure 6). A 250-fold rate acceleration was observed when a 
2.5mM concentration of 9 was added to the reaction. If the pH was increased from 7.5 
to 8.5, the rate enhancement was significantly less, thus providing a clear indication that 
general acidibase, and not nucleophilic action was the catalytic mode of action. 
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Traditionally, the use of modified ~-cyclodextrins as artificial enzymes has been based 
on the design approach, and the incorporation of an aromatic ring in the substrate is of 
course mandatory. However, the subtleties of molecular recognition are difficult to 
predict a priori, and the chemistry for preparing regiospecific ~-CD isomers is only in 
its infancy. Several groups have therefore started to look at combinatorial chemistry, 
and to combine traditional design, with the more modem advances in selection 
approaches in their search for the perfect artificial enzyme. 
Yu et ai, have recently described their synthesis of thirteen ~-CD libraries, totalling 
approximately 28,000 compounds in their search for a host with phosphatase like 
activity22. The libraries were generated from reacting ~-CD with different combinations 
of eleven individual amines (11-21, Figure 7). The thirteen libraries were then evaluated 
against controls for their ability to hydrolyse p-nitrophenylphosphate (P-NPP) in the 
presence of Zn(II) at neutral pH. The best library, containing amines 1 L 13 and 20. 
showed a 66.7-fold increase in rate relative to the reaction carried out only in the 
presence of Zn(II) and buffer. Although this example does not show the rate 
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acceleration seen with the more complex designed systems, it is clear that the technique 
of combining combinatorial chemistry with the rational design of catalytic cyclodextrins 
holds considerable promise for the future. 
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3.1.2 Cyclic Metalloporphyrin Trimers as Artificial Diels-Alderases. 
14 
18 
21 
Whilst most effort in the rational design of artificial enzymes has been focused on 
looking at catalytic cyclodextrins, other synthetic hosts have also been investigated. One 
problem associated with cyclodextrins is that the size and geometry of the hydrophobic 
cavity in the host is fixed, and whilst functional groups on the rims can be readily 
exchanged, reactions that can be catalysed are limited to substrates that can be 
accommodated within the central cavity. It is therefore desirable to find a method where 
the cavity can be adjusted to fit to a certain reaction. 
With this in mind, Sanders et al. have studied the use of cyclic metalloporphyrin trimers 
as artificial enzymes27,28,29. They have been investigating the catalysis of a Diels-Alder 
reaction, which is an attractive target for a couple of reasons. First, although a natural 
Diels-Alderase has now been discovered, there is no catalyst available for synthetic 
use30. Second, there is a considerable challenge involved in controlling bimolecular 
reactions, since two substrates need to be recognised and correctly oriented at the same 
time. Their thinking was that porphyrin hosts 22 and 23 (Figure 8) could bind pyridine 
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base ligands within their cavity, in close proximity to each other, and hence catalyse the 
reaction simply by virtue of their binding properties (Figure 8)27,28. 
A Porphyrin Artificial Diels Alderase 
1,1,2-trimer 
22 
Figure 8 
I 
I 
2,2,2 Trimer 
23 
The hosts were designed to act as catalysts for the Diels-Alder reaction between the 
furan-derived diene 24 and the maleimide-derived dienophile 25 (Scheme 5). When the 
reaction was studied in the absence of hosts, the exo and endo adducts (26 and 27) were 
produced in an approximately 2: I ratio, with the exo adduct 26 being the 
thermodynamic product. At 30°C, in the presence of one equivalent of the 2,2,2 trimer 
23, the exo adduct 26 was the exclusive product, and a 1000-fold rate acceleration was 
observed. When the 1,1,2 trimer 22 was used however, the selectivity was reversed, 
with only the endo adduct 27 observed, with a 500-fold rate acceleration. The reversal 
of stereo selectivity between the two cyclic trimers was thought to be the result of the 
greater flexibility of the 2,2,2 trimer 23. Neither of the hosts contains the ideal geometry 
to bind the exo adduct's transition state, but the larger trimer is more flexible, and 
therefore able to adjust to meet the geometrical constraints of the exo pathway. This 
stereochemical reversal in its own right shows significant progress in the rational design 
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approach. It is worth noting however that the host always had to be used in a 
stoichiometric amount, since product inhibition prevented catalytic turnover, and this 
still poses one of the major challenges for the rational design of these systems. 
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3.1.3 Self-Assembled Molecular Capsules as Catalysts. 
26 
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Rebek has also investigated artificial enzymes which are capable of catalysing the 
Diels-Alder reaction31 . Previous work had focused on the synthesis of reversibly 
assembled self-dimers of the multi-ring structure 2832. The dimer is held together by 
sixteen hydrogen bonds, and has a pseudo-spherical shape, which has led to it being 
labelled as a "hydroxy-softball". As hydrogen bonds are dynamic, the "softball" forms 
and dissipates on the timescale of milliseconds, and provides a temporary receptacle for 
smaller complementary molecules. Observation that the cavity formed can 
accommodate two molecules of solvent benzene raised the possibility that the capsules 
could be used as chambers for bimolecular reactions. Studies focused on the specific 
Diels-Alder reaction between p-benzoquinone 29 with the thiophene dioxide derivative 
30 in p-xylene (scheme 6)31. 
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Previous efforts using a different substrate had found that whilst the reaction showed 
good rate acceleration in the presence of dimer 28, product inhibition proved to be 
problematic33,34. In this case however, it was hoped that extrusion of S02 from the 
adduct 31 would leave a product whose dimensions could no longer be accommodated 
by the dimer. In fact, the adduct 31 itself proved to be an unwelcome guest in the cavity 
of the dimer, and was driven out by the p-benzoquinone 29, thus allowing the system to 
show catalytic turnover. Rate increases with this system were more disappointing 
however, showing only a modest lO-fold acceleration when compared to the 
background system. 
3.1.4 Catalytic CvcIophanes. 
Diederich has pursued the mimicry of the mode of action of pyruvate oxidase, which 
utilises thiamine diphosphate 32 (ThDP) and flavin adenine dinucleotide 33 (FAD) as 
cofactors to catalyse the reaction from pyruvate to acetyl phosphate23 • In a similar 
system, aldehydes can be oxidised to carboxylic esters in an alcohol solvent by a 
thiazolium ion in the presence of flavin (Scheme 7). ThDP-mediated decarboxylation of 
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the aldehyde 34 generates an active aldehyde 35, which is oxidized by FAD 33 to form 
a 2-acetylthiazolium intermediate 36. This reacts with methanol to produce the ester 
product 37 and regenerate the thizolium ylide 38. 
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Initial work used the synthetic thiazolio-cyclophane 39 (Figure 9) as a catalyst, which 
was designed to contain a binding site for aromatic substrates35 . In methanolic solution, 
39 catalysed the oxidation of an aromatic aldehyde, but a flavin derivative had to be 
added in order for the reaction to proceed. A molecular modelling study showed that 
intermolecular oxidation by the flavin was hindered, as the active intermediate bound 
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within the cavity was not readily accessible. Diederich therefore proposed that 
cyc10phane 40 should be a better catalyst as the flavin moiety was now covalently 
incorporated into the catalyst23 • 
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The modified cyc10phane 40 was indeed found to catalyse the transformation of 
naphthalene-2-carbaldehyde 41 to methyl naphthalene-2-carboxylate 42 (Scheme 8) in 
basic methanol, with a kcat O.22s·l. This represented a 20-fold rate increase over the 
transformation using catalyst 39. In order for the system to show true catalysis, the 
flavin moiety needs to be reoxidised in situ. This was achieved by regeneration at a 
working electrode potential of -O.3V vs Ag/AgCI23 ,36. Under these conditions, this 
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system represents one of the most efficient enzyme mImICS yet produced, with a 
turnover of up to 100 catalytic cycles. 
o o 
40, MeOH 
H OMe 
41 42 
Scheme 8 
Diederich then tried to go one step further in his quest for the perfect artificial enzyme37. 
The transition states in the formation of the intermediate active aldehyde in the reaction 
is of a reduced polarity compared to the ground state substrate. The active site of the 
enzyme is in a microenvironment of reduced polarity, and this is beneficial in catalysing 
the reaction. He hoped to reproduce this microenvironment by inserting thiazolium-
cyclophanes into the core of globular dendrimers, to form catalytic dendrophanes 43 
and 44. 
43 R= Me 
Figure 10 
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When dendrophanes 43 and 44 were tested for catalysis on the naphthalene-2-
carbaldehyde system, an unexpected decrease of between 50 and 160-fold rate 
acceleration was observed when compared with the reaction catalysed by cyclophane 
40. This posed the question as to why the dendrophanes showed such reduced catalytic 
activity despite offering an active site with good binding, catalytic groups, and a 
favourable microenvironment of reduced polarity. Diederich reasoned that the 
intermolecular electron transfer from the active aldehyde intermediate to the flavin 
additive may have become rate determining due to the presence of the sterically 
shielding dendritic branches. These dendritic branches may also affect other transition 
states in the reaction, and mask any favourable contributions from the reduced polarity 
found within the active site. The concept behind this proposal was ingenious, but again 
shows the limitations of synthesising artificial enzymes by rational design. The protein 
shell around an enzyme site not only ensures the correct positioning of the catalytically 
active residues and provides the appropriate polarity, but also plays a vital role in 
keeping the site free of steric hindrance. 
3.1.5 Polymeric Enzyme Mimics Designed with a Catalytically Active Site. 
Polymers have been used as backbones for catalysts since the 1970's38. If a specific 
binding site is attached onto the backbone of the polymer, then an artificial enzyme can 
be created. The guanidinium group is utilised by many enzymes to help with 
recogmtIOn of specific substrates, e.g., the guanidinium ion of Arg-145 in 
carboxypeptidase A plays an essential role in recognising the carboxylate anion of the 
substrate. Suh attempted to mimic the action of this enzyme by randomly attaching 
guanidinium ions, and cyclen groups to poly(chloromethylstyrene-co-divinylbenzene) 
(PCD) (Figure 11 )39. The role of the cyclen was to complex a metal ion. It was thought 
that the guanidinium moiety should be able to bind the substrate in an orientation such 
that the metal ion could perform the catalysis. A Cu(II) ion was then complexed into the 
cyclen to form polymer 45. As a control, another derivative 46, of PCD was formed 
which contained only the cyclen complex. 
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The catalytic activity of the derivatives was tested on the hydrolysis of both the light 
(MW 25kDa) and heavy (MW 50kDa) chains of bovine serum y-globulin. Kinetic data 
showed that in the presence of derivative 45, containing both the guanidinium group, 
and Cu(n) cyclen complexes, the half-life of y-globulin was as short as 40mins. This is 
108 times shorter than that of the spontaneous hydrolysis of peptide bonds. The activity 
shown by derivative 45 is 104 times greater than that exhibited by the free Cu(n) cyclen 
complex. This enhancement is likely to be caused by the microenvironment surrounding 
the Cu(n) complex in the gel-like phase of the polymer, which in similar fashion to 
enzyme active sites contains both hydrophobic and regions. Derivative 46 also catalysed 
the reaction, but was 12-15 times less active than 45. 
Whilst the polymer 45 showed good catalytic activity towards the hydrolysis of large 
proteins, it is relatively inactive towards small amides. Suh reasoned that this was 
probably due to the random attachment of the functional groups creating a large active 
site within which the catalytic groups are not in sufficiently close proximity to each 
other40. Accordingly, in order to create a more efficient mimic of metallopeptidases, the 
guanidinium ion was covalently attached to a Cu(n) tetra-aza complex and then 
incorporated into a partially chloromethylated cross-linked polystyrene (PCPS), with 
the result of providing a more well defined active site 47 (Figure 12)40. 
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The hydrolysis of amides 48-51 was studied in the presence of polymer 47. The 
hydrolysis of amide 48 was not affected by the addition of 47. On the other hand, 
hydrolysis of amides 49-51 showed a rate increase in the presence of 47. For example 
kcat for 49 was greater than 0.06 h- I , which can be compared with ko of 2 x 10-6h-1 for 
the spontaneous hydrolysis of unactivated small amides. All of the amides hydrolysed 
contain carboxyl groups, which led Suh to propose the mechanism shown in Scheme 9. 
Thus, the carboxylate group is bound by the guandinium ion in the correct orientation 
and geometry for the bound hydroxide ion to make a nucleophilic attack on the carbonyl 
centre. A similar approach has been used to create cobalt complexed polymers capable 
of hydrolysing DNA 41. 
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3.1.6 Artificial Enzvmes built by Transfer of Catalytic Elements Combined in a 
Prebuilt Cage. 
Enzymes such as methionine aminopeptidase, metallo-~-lactamase, and proline 
dipeptidase catalyse the hydrolysis of acyl derivatives by collaboration between two or 
more metal ions in the active site. If a receptor site could be designed with two or more 
metal ions in close proximity, then it seems reasonable to suggest that the receptor 
should be able to function as an artificial enzyme. Suh prepared a trinuclear artificial 
metalloenzyme 52 through transfer of three moieties of tris(2-aminoethyl)amine (tren) 
from the trinuclear macroyclic Cu(II) complex 53 to PCD (Figure 13)42. Active sites 
containing varying quantities of the tren moieties were also prepared. 
[(Cu(II)trenhluPCDMeO 52 
o 
Figure 13 
The catalytic activity of 52 was tested on the hydrolysis of unactivated amides 48-51. 
When the neutral amide 48 was used as the substrate, no hydrolysis was observed after 
54 hours at pH8 and 50°C. All three of the carboxyl containing amides 49-51 were 
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however effectively hydrolysed by 52 under the same conditions. The catalyst 52 
containing three tren moieties was found to be the most effective catalyst, although all 
of the catalysts showed much higher catalytic activity than other previously reported 
synthetic peptidases. The mechanism of action was proposed to be that shown in 
Scheme 10, with the carboxyl group coordinated to one of the eu(n) ions, and a second 
eu(n) ion coordinating the amide oxygen. The third eu(n) ion possessing a hydroxyl 
group is then considered to be in the ideal geometry for nucleophilic attack on the 
amide. 
Scheme 10 
3.1. 7 Chemogenetic Design of Artificial Enzymes. 
Semisynthetic enzymes such as thiazol-papain43 , and seleno-subtilisin44 have been 
designed and synthesised by the covalent conjugation of a catalytically active group to a 
protein scaffold. The protein mimics the active site of an enzyme by enhancing binding, 
and providing a chiral environment. Until recently however, the interaction of 
functional groups from the protein scaffold with the cofactor or substrate had not been 
investigated. 
Pyridoxamine phosphate is utilised as a cofactor by enzymes that catalyse 
transamination reactions45 . The mechanism of action is shown in Scheme 11. The 
aldehyde form of the cofactor is covalently bound via a Schiff base linkage to the £-
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amino group of a lysine residue 54. Nucleophilic attack on this imine 54 by the amino 
group of an incoming substrate 55 releases the lysine, and an aldimine complex 56 is 
formed between the substrate and aldehyde. The same lysine residue then acts as a 
general base in the subsequent conversion of the aldimine 56 to an internal ketimine 57. 
Hydrolysis yields the pyridoxamine 58 and products. 
Pyridoxal 54 
(Schiff base) 
oe De ~ De 
~ ~ ~ Ne Ne Ne H H H 
Aldimine 56 Ketimine 57 
Simplified Transamination Half Reaction 
Scheme 11 
~ De 
~ 
Ne 
H 
Pyridoxamine 58 
Haring and Diestefano combined the covalent conjugation approach with site-directed 
mutagenasis to construct a transaminase active site containing a lysine residue capable 
of Schiff base formation and general acid/base catalysis24 . Intestinal fatty acid binding 
protein from rats (IF ABP) was used as the protein scaffold as its spherical shape was 
thought to be beneficial in correctly positioning functional groups in a 3-dimensional 
fashion. A cysteine residue was introduced into the protein at residue 60 via 
mutagenasis, and pyridoxamine was tethered to this residue through a sulfide bond. 
Modelling was used to identify appropriate sites to position the active lysine residue. 
The ideal positions were found to be residues 38 and 51, and site-directed mutagenesis 
was used once again to introduce the lysine residues to IF ABP at these positions. The 
two conjugates were then tested for their ability to catalyse the transamination of u-
ketoglutarate 59 and phenylalanine 60 to glutamate 61 and 3-phenylpyruvate 62 
(Scheme 12). 
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Results showed that the overall catalytic efficiency of the conjugate with the lysine 
residue at position 51 was 4200-fold increased compared to unconjugated pyridoxamine 
phosphate. It also accelerated the reaction 12-fold when compared to the IFABP 
containing conjugated pyridoxamine, but without lysine mutations. The reactions with 
both conjugates were also shown to be stereoselective. To show that the increased 
catalytic activity occurred due to the introduction of the lysine residues, the two 
conjugates were incubated with an excess of a-ketoglutarate 59. In the absence of an 
amino acid substrate, only half the catalytic cycle can be accomplished, resulting in the 
conversion of the pyridoxamine cofactor to the corresponding pyridoxal. In the presence 
of lysine, this should be able to form a Schiff base complex such as 54. In both cases the 
UV absorbance spectra showed a band at 422-428nm, characteristic of a pyridoxal-
Schiff base complex. In control experiments with conjugates without the lysine 
mutation, no such absorbance was observed, indicating that in the case of the lysine 
mutated conjugates the mechanism is via Schiff base formation as shown in Scheme 11. 
3.2 The Selection Approach. 
As described above, the traditional approach to artificial enzymes has been the rational 
design of active sites. This strategy has provided us with much information on the 
criteria required for successful catalysis, such as binding processes, positioning of 
functional groups, and the importance of the correct polarity within the 
microenvironment of the active site. The unfortunate reality is however, that from 
concept to catalysis is a very time-consuming process, and as shown by Deiderich's 
dendrophanes, the concept does not always work in practice as well as theory. To return 
to the drawing board, and adjust even small fragments of the design can take years. In 
an attempt to move away from this linear approach, several groups have started to use a 
selection strategy, which allows for the simultaneous screening of a wide range of 
possible catalysts thus significantly reducing the time required to detect the best hosts. 
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Traditionally, this has been the domain of biological chemistry as in the cases of 
catalytic antibodies and ribozymes, but the introduction of combinatorial chemistry. and 
improvements in screening techniques have opened up this strategy to the synthetic 
chemist. 
The selection approaches can loosely be divided into two catagories: those which use 
binding of a transition state analogue as their selection criteria, and those which base 
their selection directly on catalytic activity. However, experimental practice has shown 
that whilst the initial concept is based on either one of these, the combination of both 
produces the most effective results. 
3.2.1 Approaches Utilising Binding Capabilities as their Selection Criteria. 
The earliest pioneers of selection approaches based their screening criteria on the ability 
of a host to bind the transition state analogue (TSA) of a given reaction. The logic 
behind this was that if a macromolecule showed an affinity for a molecule that 
resembled the transition state of a reaction both geometrically and electronically, then 
the host should act as an enzyme mimic for that reaction by preferentially binding, and 
stabilising the transition state of a reaction over the ground state. 
3.2.1.1 Catalytic Antibodies. 
Antibodies are proteins produced by the body in response to an antigen (alien species) 
which bind selectively to that molecule alone. As early as 1948, Pauling recognised that 
the fundamental processes that determine binding in enzymes and antibodies is the 
same46 . In 1969, Jencks went one step further and surmised that an artificial enzyme 
could be prepared by raising antibodies against a molecule that is a stable representation 
of the transition state for the reaction of interest47 . Raso and Stollar used a TSA to 
generate polyclonal antibodies that would exhibit catalytic activity for Schiff-base 
formation as part of a reaction analogous to pyridoxal-assisted amino acid 
metabolism48 . Antibodies were formed that showed binding to the substrate, but no 
catalysis was observed. It was not until after the introduction of technology that allowed 
for the isolation of monoclonal antibodies49 that Lemer50 and Shultz51 simultaneously 
reported the preparation and use of the first truly catalytic antibodies in 1986. 
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Early studies were purely based on a TSA approach. The TSA of a given reaction was 
designed and synthesised. As small molecules are not recognised by the immune 
system, the TSA had to be attached to a carrier protein, generally keyhole limpet 
hemocyanin (KLH) after which it is termed the hapten. The hapten was introduced into 
the bloodstream and immunisation allowed to occur. The desired monoclonal antibody 
was then selected from the polyclonal population based on its ability to bind the TSA. 
Schultz exemplified this approach through his early work on the hydrolysis of 
carbonates (Scheme 13)51. The charge distribution and tetrahedral geometry of the 
intermediate formed in the hydrolysis of carbonate 63 was mimicked using the 
phosphonate ester 64 as a TSA. Antibodies raised against 64 exhibited both good 
substrate selectivity, and excellent rate accelerations of factors of up to 104 • As a result 
of the lesser size of the p-nitrophenol product compared with the carbonate substrate, 
and due to the expulsion of carbon dioxide, catalytic turnover was also achieved. 
--O- ~/~'02N < > OH 02N ~ ;) 0 0 \\ II + 
63 
64 
Scheme 13 
Using this primitive approach, catalytic antibodies have been generated for reactions 
including ester hydrolysis50, transesterification52, hydride reduction of carbonyl 
53· . . 54 55· . d I . t' 56 compounds , Dlels-Alder cychsatlOns ' , rIng-openmg an c osmg reac IOns , 
sulfoxidations57, carbohydrate deprotections58, oxy-Cope rearrangements59 and cationic 
cyclisations6o• Although rate accelerations were observed in all cases, these did not 
come close to rivalling those observed in the case of natural enzymes. These 
disappointing results are the product of two flaws in the concept: inaccurate design of 
the TSA, and the selection event being based on TSA binding only. Significant 
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improvements have been made on both these fronts in recent years leading to some 
impressive results. 
Thus, design of a TSA is problematic, since the transition state for a given reaction is 
not a real discrete entity, and in many cases there are a multiplicity of transition states to 
consider. Furthermore, any TSA can only be considered as an approximation to the true 
charge distribution required. To compensate for this, recent developments have been to 
design a hapten that not only mimics the transition state, but also has the role of placing 
functional groups at decisive positions within the antibody-binding site. There are three 
main strategies here: reactive immunisation61 ,62, bait-and-switch haptens63 , and 
heterologous immunisation64 • 
In reactive immunisation a reactive antigen is designed so that a chemical reaction or 
reactions, such as the formation of a covalent bond, occurs in the binding pocket of the 
antibody during immunisation. The chemical reactivity programmed into the antibody is 
designed to be an integral part of the reaction when the corresponding substrates are 
used. Lerner et al. have utilised this approach in the design of aldolase catalytic 
antibodies65 . 
A lysine residue in the active site of natural aldolases is crucial to the mode of catalytic 
action (Scheme 14)66. Attack of this lysine on the substrate 65 forms a complex 66 in 
which the enzyme is covalently bound to the substrate via a Schiff base linkage. 
Tautomerisation of this imine 66 forms an enamine 67 that reacts with the second 
carbonyl substrate 68 to form another Schiff base 69. Hydrolysis with water affords the 
aldol product 70 and releases the active lysine group. 
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Lerner used the p-diketo sulfone hapten 71 to generate antibodies capable of catalysing 
an aldol reaction (Figure 14)65. The tetrahedral geometry found in the transition state of 
the C-C bond forming step is mimicked using the sulfone moiety. The role of the p-
diketone moiety is to introduce a lysine residue into the active site of the antibody. 
Lerner reasoned that if an antibody had an appropriately placed lysine residue it would 
attack one of the hapten carbonyl groups to form a carbinolamine that should collapse to 
a Schiff base. By virtue of the acidity of the central proton of the p-dicarbonyl unit, this 
can tautomerise to form an enamine, which due to a second carbonyl functionality in the 
P-position is a stable vinylogous amide. This has a strong UV absorption outside the 
range of the protein (316nm), and thus instead of screening for binding, catalysts were 
selected by screening for the new absorption. 
H 
HO~N 
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Seventeen monoclonal antibodies were isolated in this way. Before testing for catalysis, 
the antibodies were first screened for their ability to covalently react with 2.4-
pentanedione to form a stable enaminone. Nine of the seventeen antibodies showed the 
enaminone UV absorption at 316nm after incubation with 2,4-pentanedione. All nine 
were then found to catalyse the aldol reactions between acetone 72 and 3-(4-
acetamidophenyl) propanal 73 and 4-isobutyramidobenzyaldehyde 74 with rate 
accelerations greater than 105 fold (Scheme 15). The same antibodies also showed 
activity in catalysing retro-aldol reactions. All the reactions followed Michaelis-Menton 
kinetics, and were inhibited by 2,4-pentanedione, which confirmed that catalysis was 
occurring via the proposed covalent mechanism. 
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The kinetic capabilities of these antibodies for a variety of substrates were compared 
with the commercially available aldolase antibody 38C2. In all cases the catalytic 
proficiency was found to be superior to the commercially available antibody, and in the 
particular case of the antibody named 84G3, activity was found to be 1000-fold higher 
than for any other reported catalytic antibody67. Using reactive immunisation clearly 
shows great potential, and this example represents the most efficient antibody catalysts 
prepared to date. 
In the "bait-and-switch" approach, haptens are designed which contain strongly charged 
or polarised functional groups aimed to act as a "bait" to the immune system63 . Counter-
charged or polarised residues are thus obtained in the binding site. When we "switch" 
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from the inducing antigen to the substrate, these amino-acid residues are expected to 
play an important role in catalysis. 
Terpenoid cyclase catalysed carbocation cyclisation cascades are some of the most 
important and complex carbon-carbon bond forming reactions in chemistry and 
biology68. For example, in the biosynthesis of cholesterol, the cyclisation of the open-
chain polyene squalene oxide 75 to yield the tetracyclic product lanosterol 76 is 
perfomed in a single chemical reaction catalysed by lanosterol synthase (Scheme 16). 
Seven stereocentres are formed during the cascade reaction, and remarkably out of a 
possible 128 stereoisomers, only one is formed. 
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76 
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The active site of terpene cyclases is nested deep within an a-helical superstructure, 
where numerous hydrophobic residues have two roles: to sequester the linear polyene 
substrate from solvent, and to form a template that forces the substrate into the correct 
conformation and stereochemistry required for cyclisation. Aromatic residues within the 
active site are positioned to stabilise any carbocation cyclisation intermediates through 
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cation n-interactions. Polar residues in the active site participate In electrostatic 
stabilisation and govern the regiochemistry of deprotonation and protonation steps. 
Lerner recognised that development of a catalytic antibody which could imitate terpene 
cyc1ases was a desirable target, since it would be possible to engineer the catalyst to 
maximise the diversity of cyc1isation products, and also enable the use of unnaturally 
occurring polyene substrates69 • He designed hapten 77 to mimic the productive chair-
chair conformation required for the cyc1isation of polyene 78 to the trans-decalin 79 
(Scheme 17). 
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The "bait and switch" strategy was incorporated into the design by the introduction of 
the N-oxide moiety, which was expected to elicit polar functional groups in the antibody 
active site that would initiate the cyclisation reaction by facilitating the departure of the 
leaving group. The epoxide moiety was introduced into the hapten in the hope that it 
would encourage termination either by fixing the B ring of the hapten in the half-chair 
conformation that could favour proton elimination, or by eliciting a polar residue that 
could interact with a water molecule that could in tum act as a nuc1eophile for attack on 
the final carbocation. 
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Use of this hapten generated an antibody HA5-19A4 that, when reacted with 78, 
produced the desired trans-decalin 79. X-ray crystallography revealed that, as designed, 
the N-oxide moiety had elicited an aspargine residue in a position to stabilise the 
developing negative charge on the aryl sulfonate leaving group. The rest of the active 
site was lined with hydrophobic aromatic side chains. The epoxide was found not to 
have elicited any polar residue that could encourage nucleophilic formation of a tertiary 
alcohol, and instead elimination occurred to form three regioisomeric "decalenes" 
(Scheme 17). Recently the "bait-and-switch" strategy has also been successful in 
developing antibodies that trigger and control multi-ring cyclisations starting from an 
epoxide moiety as seen in sterol biosynthesis70 . 
Heterologous immunisation consecutively uses two related hapten structures in the 
immunisation of a single animal64• By carrying different functional groups, the two 
haptens can stimulate stereoelectronic features of the transition state that cannot be 
readily incorporated into a single hapten. Ersoy et al. used this approach to investigate 
the generation of antibodies capable of amide hydrolysis64. 
Ersoy envisaged that hapten 80 should be a good TSA for the amide hydrolysis of 
substrate 81 64 . He recognised that the acyl transfer step in serine protease catalysed 
reactions was crucial, and had made several futile attempts to incorporate a nucleophilic 
residue in the active site of the antibody. As a different approach, he incorporated a 
phenolic nucleophile into the substrate 81. The functional groups on hapten 80 were 
separated and two haptens, 82 and 83 synthesised (Scheme 18). The pyridinium salt on 
83 was intended to induce a basic residue in the antibody to accept the proton from the 
attacking phenolic hydroxyl group. This protonated residue could then deliver its proton 
to the amine functionality of the tetrahedral intermediate formed in the reaction, and 
thus facilitate its departure. The tertiary alcohol was to serve as an isosteric replacement 
for the tetrahedral intermediate. The phosphonamidate hapten 82 was designed to 
induce an acidic residue in the active site to stabilise the developing oxyanion of the 
transition state. The six-membered ring containing the phenol and phosphonamidate 
was intended to ensure the correct orientation of the hydroxyl group such that 
nucleophilic attack on the amide could occur. Antibodies were then generated against 
each of the haptens, and heterologously by sequential immunisation of both haptens. 
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Hydrolysis of substrate 81 in the absence of any antibodies was found to be very slow, 
with a rate of k=4. 7 x 1 0-7min- l , and almost identical to that of substrate 84 without the 
phenol group. In the presence of antibodies generated using only one of the two 
haptens, catalysis was observed, with a kcat of 1.8 x 10-3min- l • The antibodies generated 
using the heterologous immunisation method were however over 10 times more 
effective than those antibodies generated homologously, and catalysed with kcat of 1.5 x 
10-2min- l • Interestingly, none of the antibodies catalysed the hydrolysis of amide 84, 
which was a clear indication that the phenolic moiety was essential for catalysis to 
occur. 
Perhaps even more importantly the other problem of selection has also been addressed. 
Selection techniques have been shifted in the direction of catalysis over affinity. As 
antibody library sizes increase, more sensitivity is required in screening techniques. 
Advances in technology have meant that this can be achieved through the use of 
chromogenic or fluorogenic assays, ESI mass spectrometry, or through the selective 
amplification of catalytic events62 • 
48 
Introduction 
As shown in the examples above, the field of catalytic antibodies has made significant 
advances since Schultz and Lerner first reported their achievements in 1986. There are 
still many problems associated with this technique, despite these impressive successes. 
The antibody is generated by the immune system only for hapten affinity, and thus only 
develops the tools of molecular recognition necessary to obtain the required dissociation 
constant (l0-4 to 10- loM). It may therefore be unnecessary for the immune system to 
recognise all the features of hapten design. The sacrifice of mice for the generation of 
antibodies is not desirable, although introduction of in vitro immunisation techniques 
has made this less of an issue. The major drawback however, is that the biological 
techniques involved in generating and isolating catalytic antibodies are both complex 
and time consuming, such that the whole process from design of the hapten, to 
structural characterisation of the active site can take years. 
3.2.1.2 Molecularly Imprinted Polymers. 
Whilst antibodies have shown promising results, they share many problems with 
enzymes such as lack of thermal stability and chemical robustness which make them 
inappropriate for use on a large scale. A synthetic analogue would therefore be of much 
interest. With this in mind, molecular sized cavities have been generated in the solid 
state by polymerisation in the presence of a template molecule. If the template is a TSA 
then the polymer formed should behave as an artificial enzyme towards the reaction 
chosen. This technique, first introduced by Wulff, is known as molecular imprinting?l. 
The polymerisation process is shown in Scheme 19. The first step is the pre-
organisation of functional monomers around the template molecule 85. The functional 
groups are chosen such that they should interact with specific binding sites on the 
template. Radical polymerisation of a monomer 86/cross-linker 87 mixture around the 
pre-organised complex 88 forms a macroporous polymer 89 in which the template 
molecule is bound at specific binding sites. Removal of the template molecule from the 
polymer leaves cavities of the correct size and shape of the template, and bearing 
appropriately placed functional groups for binding and catalysis. 
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Two methods are used to appropriately position the functional monomer groups 72. The 
first of these is the self-assembly approach, in which electrostatic interactions are used 
to bind together the template and the functional group. In this instance the pre-
organisation step is actually a dynamic equilibrium, with the free and complexed forms 
in constant exchange. As a result, the molecular recognition sites formed within the 
polymer are heterogeneous, which can lead to problems in the catalytic applications of 
these polymers. The second method is the controlled distance approach, in which the 
functional monomer is actually a conjugate of the template. 
The self-assembly approach has proved to be the more popular, since the potential for a 
"better fit" is greater if the intermolecular bonds are strong enough. It is thought that as 
hydrogen bonds and Van der Waals forces are strongly dependant on bond lengths, the 
controlled method will not necessarily place interacting groups the correct distances 
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apart. Molecular imprinting has been used with great success to produce chiral 
stationary phases for chromatography and for selective extractions, and the goal now is 
to apply this methodology to finding efficient enzyme like catalysts. 
Molecularly imprinted polymers formed using a TSA have shown modest success in 
being applied as enzyme catalysts. Rate enhancements have been observed, most 
notably in ester hydrolysis73 , aldol reactions74 and Diels-Alder cyc1oadditions75 , but 
these are generally in the value of between 1.6 and 100-fold, and do not approach the 
activity of enzymes. However, as with catalytic antibodies, researchers have realised 
that recognition of a TSA alone is not enough to confer catalytic activity. 
Arginine residues play a crucial role in many natural enzymes, as the guanidinium 
group is excellently suited to binding oxyanions such as carboxylates and phosphates. In 
recognition of this fact Wulff designed a molecularly imprinted polymer 91 containing 
an appropriately positioned amidine group, to catalyse the hydrolysis of ester 9273 . The 
thinking was not only that this should stabilise the transition state of the reaction, but 
also polarise the carbonyl moiety of the ester group to make it more receptive to attack 
from incoming nuc1eophiles. The polymer was imprinted with TSA 93, a phosphonate 
chosen for its tetrahedral geometry mimicking that found in the intermediate formed 
during ester hydrolysis (Scheme 20). 
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The molecularly imprinted polymers formed after imprinting with 93 were found to 
cause a 100-fold acceleration of the hydrolysis of ester 92, and also to follow Michaelis-
Menton kinetics. 
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Wulff used a similar amidine-phosphate complex to form molecularly imprinted 
polymers capable of catalysing the hydrolysis of diaryl carbonate 94 and aryl carbamate 
95 (Figure 15) using supension polymerisation techniques76 . Carbonates were chosen 
since they do not form stable anionic products which in ester hydrolysis are thought to 
act as reaction inhibitors. The polymers formed catalysed hydrolysis of 94 and 95 by a 
factor of 588 and 1435 respectively. Interestingly, the polymer which was randomly 
functionalised with the ami dine monomer, was also found to be a significantly active 
catalyst. The rate enhancements shown by the molecularly imprinted polymer were only 
6-24 fold when compared to this reference polymer. In contrast the amidine functional 
monomer in solution showed negligible catalysis at the reaction pH. This is by far the 
largest rate accleration for ester hydrolysis achieved thus far with molecular imprinting 
techniques, but the results clearly show that non-specific catalysis at the surface of the 
polymers also has a role to play in rate enhancements. 0yO H ~ ~ ~ NyO 
~ 0 ~ ~ 0 
94 95 
Figure 15 
By combining both noncovalent and covalent binding forces between the template and 
functionalised monomers Shea has synthesised molecularly imprinted polymers that 
incorporate the elements believed to be responsible for the catalytic action of 
chymotrypsin77 . The polymer 96 imprinted with template 97 should have, after removal 
of the template molecule, an active site complementary to the D enantiomer of 
BocPheOEt 98. A phenol imidazole catalytic group should be positioned in close 
proximity to the carbonyl group of the bound substrate. Hydrogen bonds between 
carboxylic acid groups in the polymer, and complementary hydrogen bonding groups on 
the substrate should enable selective binding, and the tetrahedral geometry provided by 
the phosphonate group should create a site complementary to a transition state structure. 
It was hoped that an extra carboxylic acid group should also be hydrogen bonded to the 
imidazole group, and thus complete a "catalytic triad" similar to that observed in 
chymotrypsin (Scheme 21). 
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To investigate which functional groups were key elements to the catalysis, a variety of 
polymers were also designed without the imidazole group, with random placement of 
the carboxylate groups, without the tetrahedral complementarity, and with achiral 
templates such that no stereospecificity should be observed. When BocPheOEt was 
hydrolysed in the presence of polymer 96, complete stereoselectivity for the D-isomer 
was observed, and catalysis occurred with 10-fold rate acceleration. The catalyst also 
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exhibited turnover, performing 5 catalytic cycles. Use of the control polymers showed 
less significant catalysis, and revealed that all the catalytic elements incorporated were 
required. Although the rate accelerations obtained were relatively modest, the 100% 
enantioselectivity observed must be considered a significant achievement. 
The synthesis of artificial metalloenzymes is a highly desirable target. The activity and 
selectivity of metalloenzymes is determined decisively by the ligands of the second 
coordination sphere, i.e. by the microenvironment of the catalytically active centre. 
Molecular imprinting provides a method to control the microenvironment of synthetic 
transition metal catalysts. In this approach, a catalytically active metal substrate with a 
spectator ligand containing one or more polymerisable side chains is coordinated to a 
pseudo substrate. The complex should represent the transition state of the catalytic 
transformation. Polymerisation in the usual manner, and decomplexation of the psuedo 
substrate should yield an immobilised catalyst with a specific cavity in close proximity 
to the catalytically active metal centre. Mosbach prepared an aldolase-mimicking 
synthetic polymer in this manner, but the metal complexes were prepared in situ prior to 
the polymerisation, and not characterised74 . 
More recently Severin has reported the synthesis of imprinted ruthenium catalysts that 
accelerate the transfer hydrogenation reaction of benzophenone 9978,79. Half sandwich 
complexes of ruthenium containing amine-based ligands are known to catalyse this 
reaction with high rate accelerations and enantioselectivity. The reaction proceeds via a 
six-membered transition structure 100. Severin prepared a polymer using the fully 
characterised phosphinato ruthenium complex 101 as a TSA (Scheme 22)79. The role of 
the diphenylphosphinato ligand was to act as a pseudo substrate for benzophenone 99. 
A control polymer was also synthesised, using the ruthenium complex 102. This 
polymer should contain the same amount of active ruthenium, but without the specific 
microenvironment surrounding it as a result of the diphenylphosphinato ligand. 
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The transfer hydrogenation of benzophenone 99 was catalysed by both polymers, but 
the one that was imprinted with the TSA 101 was more active than the control polymer 
by a factor greater than five. Both polymers also exhibited turnover. This is quite a 
remarkable rate acceleration when we consider that both the imprinted and control 
polymers contain the same percentage of ruthenium complex. The substrate specificity 
of the two polymers was also examined using substrates 103-109 (Figure 16). 
Competition experiments using equal amounts ofbenzophenone 99 and a second ketone 
in the presence of the imprinted polymer always showed a preference for benzophenone 
as the substrate. In the control polymer, no significant preference for either substrate 
was observed. Severin has therefore successfully prepared a highly active, substrate 
specific artificial metalloenzyme using the molecular imprinting technique. 
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Although the concept of using molecularly imprinted polymers as artificial enzymes is 
very elegant, the results obtained so far using this technique have been relatively 
modest. One of the major problems of imprinted polymers is lack of homogeneity 
provided by the active sites, since polymerisation itself is a kinetic process. Another 
significant feature of enzyme catalysis is the ability of the enzyme to change it's 
conformation to welcome the substrate, and expel the product. Molecularly imprinted 
polymers are, by comparison, very rigid structures, and as such, product inhibition is 
often a major problem. 
3.2.1.3 Imprinting an artificial proteinase. 
1. Suh proposed that if a scaffold is used to assemble functional groups, and the pre-
assembled functional groups are then cross-linked with a synthetic macromolecular 
spacer, then the removal of the scaffold would produce an active site with functional 
groups in close proximity to each other80. This idea is very similar to that of molecular 
imprinting, but utilises a pre-formed polymer backbone as the cross-linker. Using this 
method Suh inti ally developed a soluble polymeric artificial proteinase whose active 
site contained three hydroxyl groups80. 
More recently, Suh has developed this methodology to generate an insoluble aspartic 
protease analogue8l . He used an Fe(III) ion as his scaffold, and preorganised three 
molecules of 5-(bromoacetyl)salicylic acid 110 around it. The complex was attached to 
a poly(aminomethylstyrene-co-divinylbenzene) (PAD) backbone, and the Fe(III) ion 
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removed to yield the polymer 111 with three salicate groups in close proximity (Scheme 
23). 
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The trisalicylate units in 111 contain three carboxyl groups and three phenol groups as 
well as the amino groups of the PAD backbone. The carboxylate groups might be 
expected to mimic the side chain of aspartic acid, and the phenol groups are similar to 
the tyrosine side chain. The polymer acted as an aspartic protease analogue in the 
cleavage of bovine serum albumin (Mr 66,000) at a variety of pH values, but found it's 
optimum value (ko=3.1 x 10-3min- 1) at pH3, the same optimum value as for natural 
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aspartic proteases. The activity of 111 was much higher than for a randomly 
functionalised PAD, in which the salicylate residues are positioned some distance apart 
from each other. This indicated that the catalysis was occurring through participation of 
two or more salicylate residues. Catalysis could in theory either be due to colloboration 
between two carboxylate groups, or between a phenol and carboxylate group. That the 
optimum pH value for catalysis is 3, indicates that it is the former, as in natural aspartic 
proteases, since pH6-8 would be the optimum value for a phenol-carboxylate 
collaboration. 
3.2.1.4 Bioimprinting. 
It has recently been shown that the specificity and activity of enzymes and proteins can 
be modified when used in anhydrous or nearly anhydrous media82,83. New binding sites 
can be introduced into proteins using the bioimprinting technique, in which ligands are 
used to alter protein conformations in organic solvents84 . This technique has now been 
adapted to generate artificial enzymes. 
Slade and Vulfson induced catalytic activity III proteins by lyophilisation in the 
presence of a TSA85 • The p-elimination of 112 (Scheme 24) has been studied 
extensively using catalytic antibodies and molecular imprinting. p-Lactoglobulin was 
imprinted by freeze-drying in the presence of TSA 113. The sample produced was 
dried, and its ability to catalyse the p-elimination of 112 in anhydrous acetonitrile at 
50°C investigated, and then compared to that of a non-imprinted control prepared under 
the same conditions. The imprinted protein showed catalytic activity more than three 
times that of the non-imprinted control, and 4 orders of magnitude higher than 
spontaneous p-elimination. This result seems relatively modest when compared to some 
of the rate accelerations obtained using catalytic antibodies, but was actually found to be 
an almost identical rate acceleration to that observed using molecularly imprinted 
polymers. 
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A major drawback of this method of imprinting is that the enhanced properties of these 
proteins are only available in nearly anhydrous environments, since an aqueous 
environment causes renaturation of the protein and consequential loss of any imprinting 
effect. Peifl3ker and Fischer reported a novel way to avoid this problem, by combining 
imprinting with a two step immobilisation method, with the result that the imprinted 
enzymes permanently retain their new structure in aqueous media (Scheme 25)86. 
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Two enzymes, a-chymotrypsin, and subtilisin Carlsberg were derivitised using itaconic 
anhydride, to introduce polymerisable vinyl groups onto the protein. The itaconic 
anhydride functionalised the amino groups of lysine, hydroxyl groups of tyrosine, and 
thiol groups of cysteine. The derivatised proteins, and also non-derivatised proteins 
were imprinted with N-Ac-D-trp 114 (Figure 17) in buffer solution, precipitated using 
propanol, and dried. They were then either tested directly for their ability to hydrolyse 
the ester N-Ac-D-trp ethyl ester 115 in buffer solution, or crosslinked with ethylene 
glycol dimethacrylate using radical polymerisation, and then tested for catalysis. 
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Neither of the native enzymes, nor those that had solely been imprinted with 114, nor 
those imprinted and derivatised enhanced the slow hydrolysis of ester 115. However, 
when the crosslinked imprinted proteins were used, very impressive relative rate 
accelerations of 5.4 x 104 mM-1 and 1.1 x 105 mM-1 were observed for chymotrypsin 
and subtilisin respectively. This represents the first example where the imprinted 
property of an enzyme has been stabilised by covalent crosslinking, and therefore been 
made available for use in aqueous media. Clearly, although still in its infancy, this 
technique is a very significant advance and holds much promise for the future. 
3.2.1.5 Dynamic Combinatorial Libraries. 
A dynamic combinatorial library consists of compounds formed by the reversible 
interactions between a set of building blocks87. The proportion of each compound in the 
library is controlled by thermodynamic equilibria. If a template molecule that binds to 
one of the library members is introduced, then a selective amplification of the amount of 
that member could be expected. It therefore follows that molecules identified in a 
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templated mixture should contain appropriate recognition properties to be able to act as 
a good host for the template molecule. As with MIP's, if the template is a TSA for a 
given reaction, then the chances that the host will catalyse the reaction in question 
should be greater than for an independently designed molecule. 
Templating of dynamic combinatorial libraries (DCLs) can be in two forms: casting or 
moulding (Scheme 26)87. In the moulding process, macrocyclic, or macromolecular 
structures assemble around a template molecule, whilst in the casting process the cavity 
of an enzyme, protein or other macromolecule induces the assembly of a substrate that 
fits the cavity. As the system is dynamic, the strong binding of a good receptor/substrate 
will not only lead to an increase its concentration, but also a decrease in the 
concentration of the other library members. 
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Clearly the advantage of this method of library formation is that of all the possible 
permutations of products, only the formation of those with the desired binding 
properties is thermodynamically favoured. There are some disadvantages however. One 
of the key issues in designing DCLs is the choice of reversible chemical reaction. Thus 
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far a number of reactions have been tested, including imine exchange87 , isomerisation 88, 
hydrazone formation89 and ligand exchange in coordination complexes9o, but few 
examples of thermodynamic control have been reported. In addition, the termination of 
the reversible reaction is usually achieved by a change in temperature91 , pH92, or by 
chemical methods87 , anyone of which can change the structure of the formed ligand or 
receptor. 
This approach has not yet been used successfully in the synthesis of artificial enzymes, 
but since the concept was only reported in 1996 studies are still in their infancy. This 
technique has however been used to design enzyme inhibitors, and macromolecules 
capable of binding templates, and a discussion of these applications makes it easy to see 
how this approach could be applied in the future to the design and synthesis of artificial 
enzymes. 
By way of illustration, Lehn and Huc reported the use of DCLs to design ligands for 
the enzyme carbonic anhydrase 1187 . They utilised the imine-aldehyde exchange 
reaction, and chose the amine and aldehyde library precursors based on the knowledge 
that para-sulfonamides such as 116 are known inhibitors of the enzymes (Figure 18). 
After equilibration in the presence of carbonic anhydrase II, the library was chemically 
frozen by reduction with NaBH3CN. Analysis of the library showed that the proportion 
of para-sulfonamide 117 was amplified relative to the library formed in the absence of 
the receptor. 
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Miller and Karan have recently reported the use of DCLs to identify complexes that 
selectively bind to RNA93. This is a particularly important biological issue, since small 
molecules capable of binding selectively to RNA over DNA have potential as new 
therapeutic agents. 
Salicylamides 118-123 (Figure 19) were chosen as the components of the DCL, since 
they would be capable of binding to metal ions. The variable functionality consisted of 
different amino acid groups as it was predicted these should bind to RNA, since 
regulation of RNAs by proteins is well documented. Cu(II) was chosen as the metal, 
since it shouldn't react with the RNA at a typical DCL concentration, and it should be 
capable of forming spectroscopically detectable structurally well-defined complexes 
with compounds 118-123. A library of at least 27 distinct metal complexes should be 
able to form, assuming the formation of square-planar mono- and bis(salicylamide) 
complexes. 
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The salicylamides 118-123 were equilibrated in a buffer solution, both in the presence 
and absence of Cu(n) ions. These solutions were then equilibrated either in the presence 
of the RNA hairpin 124, the DNA hairpin 125, or in the absence of any template. As 
expected it was observed that none of the compounds 118-123 bound to either the DNA 
or RNA hairpin in the absence of Cu(n). However, analysis of solutions containing 
Cu(n) equilibrated in the presence of the RNA hairpin 124 showed a significant amount 
of the complex containing 121 and Cu(n) bound to the RNA. Interestingly, there was a 
significant difference in the amount of 121 selected by the RNA sequence and the DNA 
sequence. Further binding studies showed that 121 binds the RNA hairpin with greater 
than 300-fold selectivity over the homologous DNA sequence. 
Other recent examples have used DCLs to design receptors for transition metal ions, 
and have combined the use of different reversible reactions to form double-level 
DCLs94 . However, whilst this technique has the potential to be used in the synthesis of 
artificial enzymes, the first application of this type of approach has yet to be reported. 
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3.2.2 Catalytic Activity Based Selection Approaches. 
The other selection approach uses catalytic activity as the selection event, and utilises 
combinatorial chemistry and molecular biology to simultaneously synthesise vast 
libraries of different molecules. The use of combinatorial chemistry in the synthesis of 
artificial enzymes creates diversity which can be exploited in the search for catalysis by 
an appropriate choice of screening methods. 
3.2.2.1 Combinatorially Generated Polymers As Enzyme Mimics. 
In 1995 Menger used combinatorial chemistry to generate polymer-bound polyamides 
that acted as catalysts for the hydrolysis of a phosphodiester95 . A range of different 
acids 126-133, in varying amounts were condensed with polyallylamine 134 (Scheme 
27). The solutions of the combinatorially generated polymers were then screened for 
catalytic activity in the hydrolysis reaction with and without Zn(II) ions present. The 
most active polymer was found to increase the rate of hydrolysis by a factor of 3 x 104 . 
This is over five times more than the best rate enhancement achieved by a catalytic 
antibody for the same reaction. 
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The composition of each polymer is combinatorial, and each individual polymer 
contains a range of metal ion sites. Thus as well as each polymer differing from each 
other in composition, each polymer in itself represents a combinatorial range of sites. It 
is to be expected that there will be regions of local organisation, since one residue 
attached to the backbone will influence subsequent neighbouring substitutions. Thus, 
the major drawback of these polymers is that we will never be able to fully characterise 
the active site. However, these polymers have successfully been utilised not only in the 
aforementioned reaction, but also in the reduction of benzoylformic acid to mandelic 
acid96. 
More recently Menger has formed derivatives of poly(acrylic anhydride) usmg 
functional amines97 • The combinatorial polymer formed was capable of catalysing the 
dehydration of ~-hydroxy ketone 135 to a,~-unsaturated ketone 136 with a kcat of 920 
over the background reaction (Scheme 28). 
OH 0 
135 136 
Scheme 28 
3.2.2.2 Combinatoriallv Generated Peptide Catalysts. 
Combinatorial chemistry has been used to generate polypeptides for many years. 
Berkessel recently reported use of a combinatorially developed undecapeptide-
zirconium complex as a catalyst for phosphate hydrolysis98 . A library of 625 solid-phase 
bound undecapeptides was generated based on the general structure shown in Figure 20. 
The polymer bound peptides produced contained four variable positions denoted by the 
letter X, separated by three spacers Gly-Gly and occupied by either L-Arg, L-His, L-
Tyr, L-Trp or L-Ser in a combinatorial fashion. Arginine was chosen since in enzymes 
such as Staphylococcal nuclease which catalyses phosphoryl transfer, the activation of 
the anioinic phosphate towards nucleophilic attack is by ion-pair formation with the 
guanidinium moiety of arginine. Both histidine and tyrosine are known to act as ligands 
for transition metal ions in many enzymes. The aromatic indole system of tryptophan 
was introduced to display 1t-1t stacking interactions with aromatic substrates, and the 
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hydroxyl of serine had the potential to serve as the acceptor for a phosphoryl group in a 
transesterification reaction. 
o-PEG-Phe-X-GIYGIY-X-GIYGIY-X-GIYGIY-X 
PEG = polyethylene glycol. 
Figure 20 
The polymer beads were complexed with ImM solutions of Cu(II), Zn(II), Fe(III), 
Co(III), Eu(III), Ce(IV) or Zr(IV). The library was screened for hydrolase activity 
against the 2-hydroxyindole derivatives 137 and 138. When the ester function is 
hydrolysed, the resulting indoxyl derivative 139 is oxidised to afford the turquoise and 
insoluble indigo dye 140 (Scheme 29). Thus any bead which acts as a catalyst will be 
dyed indigo during the course of the reaction. Activity was found with 20 of the beads 
in the presence of Zr(IV). Quantitative rate analysis was not possible due to the 
insolubility of 140. The three most active, and two of the least active peptides were 
isolated, and characterised in order to identify any particular residues essential for 
catalysis. All three peptides that catalysed the reaction contained a serine residue at 
position Xl, and a histidine at X4, suggesting that histidine is essential to bind the 
Zr(IV) ion, and the serine acts as a phosphate acceptor. 
CI 0 sr&R sr& Br hydrolysis air oxidation I ~ , • I~ • 
#' N #' N Br 
H H 0 CI 
137 R= COCH3 139 140 
138 R=PO/ 
Scheme 29 
Whilst the employment of peptides as artificial enzymes seems logical, since they 
contain the catalytic residues found in enzyme active sites, and have the ability to fonn 
3-dimensional helical structures capable of mimicking those found in enzymes, the 
future of this approach seems limited. Only small peptides can realistically be employed 
here since the number of combinations of amino acids in larger peptides is , 
prohibitively large. Combinatorial chemistry has been utilised widely in the search for 
catalysts, but these are not discussed here, since not many of them come under the 
I f . fi . I ,,99 umbrel a 0 "artl ICla enzymes . 
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3.2.2.3 Directed Evolution of Enzymes. 
Biochemists have investigated the directed evolution of enzymes in order to find 
biocatalysts with new or modified activity. Directed evolution strategies generally 
utilise some method of introducing random mutations into a gene followed by screening 
or selection for a given property, such as catalysis101 . The cycle is repeated several times 
until the selection criteria is achieved, or further cycling produces no further 
optimisation in the desired property (Scheme 30). Successes have been reported using 
point mutations generated by a number of techniques such as error prone polymerase 
chain reaction (PCR) or in more recent examples, DNA shufflingl02. 
o 
gene (DNA) wild-type enzyme t random mutagenesis 
~C>~~C> etc. 
library of mutated genes 
repeat ~ expression 
00 00 etc. 
library of mutated enzymes 
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c>/0 
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Scheme 30 
The enzyme cycloartenol synthase converts oxidosqualene 75 to cycloartenol 141 and 
parkeol 142 in a 99: 1 ratio via an intermediate lanosteryl cation 143. Hart et at. 
reasoned that mutant enzymes might be obtained that could abstract the C8 proton of 
31) 103 L I' l' the lanosteryl cation 143 to produce lanosterol 76 (Scheme . anostero IS a cyc IC 
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intermediate in the biosynthesis of ergosterol. Arabidopsis thaliana cycloartenol 
synthase was subcloned and expressed into SMY8, a yeast lanosterol synthase deletion 
mutant that requires ergosterol supplementation. The resultant strain biosynthesises 
oxidosqualene 75, which it converts to cycloartenol 141 using the foreign enzyme. The 
mutant is unable to convert cycloartenol 141 to ergosterol, and therefore remains 
dependant on exogeneous sterol. The strain was shaken at 30°C in an inducing medium, 
supplemented with trace amounts of ergosterol. The low ergosterol level limits growth 
so that after 24 hours the culture was only slightly turbid. After 24 hours, a small aliquot 
of this culture was used to inoculate more of the same medium, and this process was 
iterated daily so that rapidly growing mutants that evolved lanosterol biosynthetic 
ability were able to dominate the culture. After 17 days, the culture reached a high 
density, indicating the presence of a spontaneous mutant with low ergosterol 
requirements. When this mutant (Ile481 Val) was isolated and used in the cyclisation of 
oxidosqualene 75, as well as observing the usual products 141 and 142, lanesterol 76 
was also produced in a 26% yield. 
H 
H 
oxidosqualene 75 lanosteryl cation 143 
H-19 proton loss H-8 proton loss H-ll proton loss 
H H H 
H 
cyc1oartenol141 lanosterol 76 parkeol142 
Scheme 31 
Aspartate aminotransferase (AspA T) is a homodimeric enzyme that catalyzes amino 
group transfer between acidic amino acids, aspartate and glutamate, and their 
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corresponding 2-oxoacids. Que et al. utilised DNA shuffling to change the substrate 
specificity of AspAT so that it showed activity for ~-branched amino acids such as 
valine l04• The selection system involved an auxotrophic strain of E.coli that is deficient 
in the gene for branched-chain amino acid aminotransferase. The higher the activity of a 
plasmid-encoded mutant AspAT for 2-oxavaline, the faster the auxotrophic E.coli 
carrying the plasmid grows on the selection plate. Using this technique Que isolated a 
mutant enzyme with 17 amino acid substitutions that showed a 2.1 x 106 fold increase in 
the catalytic efficiency for valine. Interestingly, X-ray crystallography showed that only 
one of the seventeen mutations appears to be able to contact the substrate, and the role 
of most of the mutations is in altering the microenvironment, and tertiary structure of 
the active site. This approach has also been successfully applied by Reetz to synthesise 
an artificial enzyme which hydrolysed the racemic ester 144 to the (S)-isomer with an 
excellent ee of 81 % 105 (Scheme 32). 
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4. Conclusions. 
As we have shown above, the techniques used in the design and synthesis of artificial 
enzymes are continually evolving. The more traditional approach has been the rational 
design of a molecule utilising our knowledge of enzyme mechanisms. The design tends 
to be focused on one aspect of enzyme mechanisms, such as designing co-operative 
catalytic groups, providing a suitable microenvironment for the reaction to occur, and 
selective binding of a transition state. However, while there have been some 
considerable successes using rational design, it is recognised that the time and effort 
involved in affording just one possible host is considerable, and that the smallest flaw in 
the design can lead to the greatest change in possible activity. Effort is now therefore 
biased towards selection approaches, where many hosts can be generated at one time. 
These design studies are worth persevering with however, since even the failures are 
able to teach us more about the requirements for molecular recognition, and this 
information is invaluable in the further design of enzyme like systems. 
There are two options for selection in the combinatorial approaches to artificial 
enzymes: binding and catalysis. Selection using binding has been utilised to a greater 
extent, largely due to it being easier to monitor binding using a TSA than catalysis. 
However, TSA design is rarely entirely accurate, since the transition state of reaction is 
a transient species which cannot be isolated. That in designing a stable analogue we can 
mimic all of the geometric and electronic features of this species is unlikely. It has also 
been recognised that binding of a transition state is not the only requirement for a 
molecule to act as an artificial enzyme. Many other factors are involved in enzyme 
catalysis and, in recognition of this, groups have started to incorporate catalytically 
active groups into the active site of artificial enzymes. In the introduction of methods 
such as reactive immunisation in catalytic antibodies, research has started to focus on 
the design of the library using TSA binding, but selection of hosts based on catalytic 
activity - a combination which thus far has achieved significant results. 
Since the ultimate goal is to design a molecule with catalytic capabilities, then clearly 
selection by catalytic activity should provide us with the most efficient artificial 
enzymes. However screening for catalytic activity is not trivial, and it is only due to the 
73 
Introduction 
development of new techniques using UVNis spectroscopy, fluorescence spectroscopy, 
IR thermography, and improvements in automated mass spectrometry that this avenue 
has been opened for exploration. These techniques were initially developed for used in 
the directed evolution of enzymes, but are now being applied to synthetic combinatorial 
chemistry. Whilst most success observed in screening for catalytic activity has been in 
biochemical techniques, synthetic applications have started to appear. as demonstrated 
with the work by Menger using combinatorial polymers. 
Problems that are associated with all selection approaches are the huge number of 
possible permutations of products possible. This has led to problems in molecular 
imprinting, when the lack of homogeneity observed in active sites probably leads to a 
decrease in catalytic activity. In the case of combinatorial polymers, it means that whilst 
catalysis is observed, we have no way of knowing the actual 3-dimensional structure of 
the catalyst, which would be essential in trying to improve the efficiency of the catalyst. 
Combinatorial chemistry is generally performed on very small scales, and isolation and 
characterisation of the selected hosts can be difficult. In biological techniques this is 
less problematic, since gene expression leads to amplification of the desired compound. 
The introduction of DCLs perhaps gives a solution to the synthetic chemist, since the 
selected host is amplified within the system. 
Despite all of these significant advances, there are few examples yet of artificial 
enzymes that rival the efficiency of natural enzymes. Those that do show significant rate 
enhancements such as catalytic antibodies, and directed evolution of enzymes still share 
many of the problems associated with the natural systems, since they too are proteins 
and share the same lack of thermal stability. Clearly, we still have much to learn from 
nature itself, and the future of the subject must surely lie in the ability to combine our 
knowledge with the advances in selection techniques to develop a synthetic receptor that 
catalyses with efficiency, stereoselectivity and turnover, and can truly be called an 
"artificial enzyme". 
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Results and Discussion 
1. A Novel Semi-Rational Approach to the Design and Synthesis of 
Artificial Enzymes. 
The foregoing introduction has hopefully highlighted that several successful and highly 
innovative advances have been made in recent years towards the synthesis of effective 
artificial enzymes. Nevertheless, it is also clear that, whether by the design approach, or 
through selection, we have still much to learn in terms of formulating an efficient 
strategy for the creation of these catalysts. All too often, the slightest miscalculation in 
engineering a tailored 3-dimensional pocket by design can lead to disastrous results, and 
frustratingly, selection approaches such as those involved in catalytic antibodies62 , or 
the in vitro evolution protocol pioneered by Reetz105, whilst leading to active catalysts 
require retrospective structural analysis to determine the molecule which has been 
provided. 
In the light of the above situation, we therefore set out to devise a novel strategy for the 
modular assembly of artificial enzymes which would not only allow us greater freedom 
in altering key features such as the receptor site and the catalytically active groups, but 
also, through systematic investigation, permit us to assess the relative merits of the 
many and varied factors which are often argued to be essential for enzymatic activity. 
Within this framework, we were inspired by consideration of the possible 3-dimensional 
structure of the inherently flexible polymers produced by Menger in his combinatorial 
approach (See Chapter 1, p67)95. The beautiful and beguiling 3-dimensional structures 
which are revealed by X-ray crystal structure determination often belie the fact that 
many enzyme systems can be substantially altered by conformational changes induced 
on binding. We therefore decided that the greatest chances of success lay in preparing 
much less rigid systems, and that the capacity for rapid structural alteration through a 
combination of both design and selection approaches would be the key feature in this 
novel strategy. 
In total contrast to any previous system which has been devised, we decided from the 
outset that our artificial enzymes would be "physically" divided into a binding "region" 
for the substrate molecule and a second "region" wherein a catalytically active group 
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could be located. Whilst the disassembly of a catalytic triad in this manner may be 
regarded as heresy, our intention was to consider an enzyme at its most simplistic level 
as a molecule which can both "hold" a substrate (recognition and binding) and also 
"bite" (carry out a catalytic reaction by virtue of proximal functional groups). 
This approach is simplistically shown in Figure 21. In essence, each polymer strand can 
be regarded as the leg of a millipede which randomly possess either a designed receptor 
site based on binding a transition state analogue, or a catalytically active group. The 
exact tertiary structures that evolve will of course be unknown, but the overall 
flexibility maximises the possibility of developing an effective region for catalysis. 
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The reaction chosen for study was the hydrolysis of ester 145. The mechanism of ester 
hydrolysis is well documented, and proceeds via nucleophilic attack on the carbonyl 
group, resulting in addition, and a change in hybridisation from Sp2~Sp3 to give a 
tetrahedral intermediate which then collapses in the rate determining step to afford the 
product106. The transition state of the reaction is thought to closely resemble the 
tetrahedral intermediate. Hydrolysis can be catalysed by either acid or base (Scheme 
33). 
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As the transition state is thought to resemble the tetrahedral intermediate, any stable 
analogue that mimics the geometry and charge distribution of this tetrahedral 
intermediate should in theory be a good TSA. Phosphonates have been used as 
inhibitors of natural esterases, since they are believed to exhibit properties similar to 
those of the transition state107 . Phosphonate 146 was therefore a logical choice for our 
TSA (Figure 22). 
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This specific ester was chosen for a number of reasons. Firstly the TSA 146, and hence 
the transition state of the reaction contains three possible binding sites. Both the 
carboxylic acid and phosphonate moieties should be able to bind to bases, and hydroxyl 
groups, and the amide linkage has the potential to form hydrogen bonds with other polar 
groups. Secondly, all three of the binding sites are on the acid side of the ester bond, 
and therefore the catalyst formed may act on a range of esters, as the alcohol could be 
varied. Finally, an unactivated ester was chosen so that any rate enhancement could be 
seen as a significant result. 
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2. Synthesis of the Transition State Analogue. 
A nine-step synthesis of the TSA 146 starting from benzyl bromide 147 and trimethyl 
phosphite 148, both cheap commercially available products was selected (Scheme 34). 
Thus, a Michaelis-Arbuzov reaction between 147 and 148 should yield the dimethyl 
benzyl phosphonate ester 149. Nitration and reduction then lead to the p-amino 
compound 150, and subsequent protection using the trifluoroacetyl group should give 
compound 15l. Monochlorination forms a reactive species 152 that, under basic 
conditions should react with alcohol 153 to form the mixed phosphonate 154. 
Chemoselective deprotection of the amide and reaction with glutaric anhydride then 
furnishes the amide 155. Finally selective demethylation of the phosphonate with either 
tertiary butylamine or trimethylsilyl bromide yields the required TSA 146. 
The initial step of the synthesis was the Michaelis-Arbuzov reaction between benzyl 
bromide 147 and trimethyl phosphite 148. The para-nitrated benzyl bromide could not 
be used due to possible interference of the nitro group, and attempts by other groups to 
perform Arbuzov reactions with nitrated compounds have resulted in failure 108. 
Following a literature procedure, benzyl bromide 147 was treated with 10 equivalents of 
trimethyl phosphite 148 in refluxing benzene. Removal of excess reagents, and 
distillation afforded dimethyl benzylphosphonate 149 in a 93% yield. 
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At this stage we wished to achieve selective para-nitration of the benzene ring. 
Although treatment of phosphonate 149 with a nitric acid-sulphuric acid mixture at ooe 
yielded a nitrated product in a 70% yield, NMR analysis revealed that the product 
contained both the ortho 156 and para 157 isomers in a 1:9 ratio (Scheme 35) 
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Unfortunately, these could not be separated. It is presumed that the para isomer 
favoured due to the steric bulk of the phosphonate group hindering nitration in the ortho 
position. 
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Fortunately catalytic hydrogenation of 156 in the presence of 100/0 palladium on 
charcoal led to selective reduction of the para- Isomer to afford p-
aminobenzylphosphonate 150 in 57% yield. Initially this figure seemed poor, but in fact 
compared well with the 55% yield reported in the literature lo9. 
Protection of the amino group was then required to prevent possible reaction of the 
amine with the phosphonochloridate formed in the next step. The protecting group 
chosen had to be stable under the acidic conditions required to form the chloride 
species, and also under the basic conditions required to form the mixed phosphonate 
ester. The trifluoroacetyl group fulfilled these requirements, with the added bonus of 
being easily reduced using sodium borohydride llO. Treatment of the amino compound 
150 in anhydrous THF with trifluoroacetic anhydride and N-methylmorpholine as 
described by Moree et al. yielded the required protected amine 151 in an 80% yield 
after chromatography (Scheme 36) III . 
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The dimethyl phosphonate 151 had to be converted into a reactive species for coupling 
with phenethyl alcohol 153. The most common reactive intermediate utilised is the 
phosphonochloridate species, which is thought to behave in an analogous manner to an 
acyl chloride 1 12. The tried and tested method for conversion of a dialkyl phosphonate to 
the mono phosphonochloridate has been by treatment of the ester with phosphorus 
pentachloride112• Following this procedure, 151 was treated with phosphorus 
pentachloride in chloroform and heated to 40°C for 5 hours. The product can be 
observed using 31 P NMR as a peak at 41 ppm, with the starting material at 30 ppm. 
After 5 hours 31 P NMR showed no remaining starting material, and good conversion to 
the required product 152, however several unknown by-products with peaks between 30 
and 35 ppm also seemed to have formed (Scheme 37). 
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Methyl phosphonate esters are susceptible to methylation by an SN2 mechanism, and it 
was a concern that the phosphonochloridate formed may be sensitive to any residual 
PCls, and other by-products formed during the course of the reaction. Separation of the 
product from the phosphorus waste also proved to be problematic. It was therefore 
decided to try a milder approach as described by Coward 113. In this approach, the 
dimethyl phosphonate is first converted to the monomethyl phosphonic acid by 
treatment with tert-butylamine and then treated with oxalyl chloride to form the 
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phosphonochloridate species (Scheme 38). The mechanism of the demethylation step 
h t b d' d' h l' 113114 as no een lscusse III t e lterature ' . The overall yield of the reaction has been 
reported to be slightly lower than that obtained with PCls, but this method was preferred 
because of the volatile nature of oxalyl chloride, and thus its easy removal after the 
reaction had gone to completion. 
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Dimethyl phosphonate 151 was treated with an excess of tert-butylamine and heated to 
reflux. After 7 days TLC showed the reaction to have gone to completion, and removal 
of the excess amine yielded the tert-butylamine salt 158 in a 92% yield. The free 
phosphonic acid 159 was obtained in 680/0 yield by stirring with a cation resin in 
methanol for four hours. Finally the phosphonochloridate 152 was obtained after 
treatment of 159 with oxalyl chloride and a catalytic amount of DMF in dry DCM. 31 p 
NMR showed clean conversion to the product in 80% yield. 
The phosphonochloridate had now to be coupled with phenethyl alcohol 153 to form the 
mixed phosphonate 154. In the synthesis of a similar TSA, Lerner had obtained the 
mixed phosphonate by treatment of a phosphonochloridate with sodium hydride and an 
alcohol I IS • When the same conditions were tried with our phosphonochloridate 
however, none of the desired product 154 was formed (Scheme 39). 
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The use of different bases has been reported in the coupling of phosphonochloridates 
and alcohols. Coward reported the use of 2 equivalents of triethylamine in THF to 
successfully form mixed phosphonates 114. THF is used as the solvent here as it 
precipitates the triethylamine hydrochloride formed during the course of the reaction, 
and thus pushes the reaction towards formation of product. When this approach was 
tried using 152 and phenethyl alcohol 153, the required product 154 was obtained in a 
79% yield after chromatography (Scheme 40). 
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Deprotection of the trifluoroacetyl group can be effected either by treatment with 
aqueous sodium carbonate solution, or by reduction with sodium borohydride 11O. Since 
no other functionality within the molecule was likely to be affected by the presence of 
sodium borohydride the decision was made to use the latter. When 154 was treated with 
10 equivalents of sodium borohydride the deprotected amine 160 was obtained in 96% 
yield (Scheme 41). 
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A method described by Lerner was then used to incorporate the amide side chain of 
146 115, and involved the addition of glutaric anhydride to a solution of triethylamine and 
the p-aminophosphonate 160 in dry DCM The solution was then refluxed for 12 hours 
to afford the product 155 in an 84% yield (Scheme 41). 
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Two methods were considered for the selective demethylation of the mixed 
phosphonate 155. Trimethylsilyl bromide selectively reacts with methyl phosphonate 
esters to form an intermediate TMS ester, which can be hydrolysed under mild 
conditions to afford phosphonic acids (Scheme 42)116. The other method was the one 
utilised earlier, in which tert-butylamine selectively deprotects methyl phosphonate 
esters. 
tert-butylamine 
reflux 
TMS-Br 
+ H ,MeOH 
Scheme 42 
The tert-butylamine method was preferred, since purification of the final product occurs 
when the product is stirred with the acid exchange resin. The tert-butylamine salt 161 
was obtained after stirring in the refluxing amine for 7 days. Unfortunately however, 
stirring 161 in methanol with a cation exchange resin did not yield the required TSA 
molecule 146. Instead, 1H NMR showed that formation of the methyl ester 162 had 
occurred. Hydrolysis of this methyl ester proved facile by treatment with 5N Hel to 
afford the required TSA 146 in 62% yield over the two steps (Scheme 41). 
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3. Synthesis of the Ester Substrate. 
A five-step synthesis of ester 145 was devised starting from commercially available p-
aminophenylacetic acid 163 (Scheme 43). Initial protection of the amine as its 
trifluoroacetamide gives 164. Formation of the acid chloride 165 followed by 
esterification with phenethyl alcohol should afford ester 166. Subsequent deprotection 
of the amine would give 167 which followed by coupling with glutaric anhydride then 
provides the desired ester substrate 145. 
___ T_F_AA ____ • 0 ~OH 
Na2C03 F C)lNA/ 8 
163 
166 
INaBtI~ MeOH 
167 
I Glutaric anhydride Et3N DCM reflux 
MeCN 3 H 
H20 
f)!°u o 0 ~ ~ ~ I~ ° I~ HO N 
H 
145 
Scheme 43 
164 
SOCI) 
CHCl3 
reflux 
165 
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As in the synthesis of the TSA 146 the trifluoroacetyl group was used to protect the 
amine. Treatment of p-aminophenylacetic acid 163 with trifluoroacetic anhydride and 
sodium carbonate in a mixture of acetonitrile and water afforded the protected amine 
164 in 58% yield (Scheme 44). 
OH 
163 
TFAA 
Na2C03 
MeCN 
H20 
OoC - r.t 
Scheme 44 
OH 
o 
58% 
164 
The acid was activated for the esterification step by forming the acid chloride. Protected 
amine 164 was suspended in anhydrous DCM and stirred with oxalyl chloride, and a 
catalytic amount ofDMF. When all the acid had been converted to the chloride 165, the 
solution became homogeneous. The acid chloride 165 was immediately reacted with 
phenethyl alcohol 153 and triethylamine in anhydrous THF to afford, after 
chromatography, the required ester 166 in 63% yield (Scheme 45) 
o 
F CAN 
3 H 
o 
164 
~OH 
V 
153 
OH CI 
(COC1h 
DMF,DCM 
Et3N 
------------1 THF, 
12hours 
o 
O~ V 
166 
Scheme 45 
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Esterification of amino acids is generally effected by treatment with an excess of 
alcohol and HCI gas. This approach was attractive as it would by-pass the need for an 
amine protecting group. Therefore, p-aminophenylacetic acid 163 was dissolved in an 
excess of phenethyl alcohol 153 and treated with HCI gas (Scheme 46). The product 
167 was formed, however separation proved troublesome and so this approach was 
abandoned. 
OH 
163 o 
OH 167 
153 
Scheme 46 
Deprotection of trifluoroacetyl groups is usually effected either by hydrolysis with 
sodium carbonate, or by reduction with sodium borohydride llO• Initially sodium 
carbonate was utilised, since the activated trifluoroacetamide group should be more 
prone to hydrolysis than the stable ester. However, when 166 was treated with sodium 
carbonate, hydrolysis of the ester occurred in preference to the amide group. Sodium 
borohydride is known to preferentially reduce amides over esters, unless in the presence 
of a Lewis acid. When 166 was treated with 5 equivalents of sodium borohydride and 
stirred for up to 12 hours, the required deprotected amine 167 was obtained albeit in a 
40% yield. If the reaction was left to stir longer, or if more equivalents of sodium 
borohydride were added then further reduction of the product 167 started to occur 
preferentially over the starting amide 166 (Scheme 47). 
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The final step in the synthesis was to couple the amme with glutaric anhydride. 
Gratifyingly, treatment of the amine 167 with glutaric anhydride and triethylamine in 
DCM afforded the required ester 145 in 99% yield (Scheme 48). 
O~ 
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Scheme 48 
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4. Design of the Receptor Site. 
4.0 Possible Receptors. 
With the TSA 146 in hand, we were ready to design our "receptor site" which would be 
incorporated into the polymer with the role of stabilising the developing tetrahedral 
transition state of the reaction. The receptor site would be designed and selected based 
on its ability to bind to the TSA. The TSA 146 had been chosen such that there were 
three possible points for recognition (Figure 23). The receptor site was envisaged as 
consisting of one molecule with the potential to bind the TSA both at the carboxylate, 
and the phosphonic acid moieties, and also to form a hydrogen bond with the amide 
linkage. 
X2=O or N, capable of forming an 
H bond with the amide in the TSA. 
____________ ~2 
x~ \ 
-o o 
Xl =functional group interacting with 
carboxylic acid 146 
Figure 23 
Q.3 
o 
I 
~o 
o 
X3=functional group 
interacting with the 
phosphonic acid moiety 
In theory, the receptor site could have been constituted from a number of discrete 
entities, with each one binding to one of the aforementioned points on the TSA. 
However, if more than one functional monomer is used to achieve these multiple 
binding interactions, the complex becomes less entropically favourable 1 18. An additional 
advantage of the single molecule receptor site was that it would then be possible to 
study the binding between the receptor and the TSA prior to its incorporation into the 
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polymer. If three distinct binding entities were used, then they would need to be 
correctly positioned on the polymer before the binding interactions could be understood. 
The Cambridge Structural Database166 was used to highlight different functional groups 
that show favourable interactions with the different moieties of the TSA. As expected, 
carboxylic acids form complexes with basic groups. Phosphonic acids also form 
energetically favourable complexes with bases, but also several complexes have been 
crystallised in which the phosphonic acid interacts with hydroxyl groups. Finally, as 
expected, aromatic aliphatic amides, such as the one in our TSA, form hydrogen bonds 
with other amide groups. 
Natural amino acids contain functionality that should bind to the TSA. In addition, we 
reasoned that if a dipeptide were chosen with suitable functionality to bind to the 
carboxylic acid and phosphonic acids moieties, the peptide bond should also be 
appropriately placed to form a hydrogen bond with the amide in our TSA. It was 
therefore decided to choose the receptor unit from a series of dipeptides (Figure 24). 
Nine commercially available dipeptides were chosen for use in binding studies with the 
TSA (Figure 24). Four, Arg-Arg 168, Ala-Arg 169, ~-Ala-Lys 170 and L-Camosine (~­
Ala-His) 171 contained one or more basic groups. Two dipeptides, Ala-Tyr 172, and 
Ala-Thr 173 contained hydroxyl residues, and one dipeptide, Ser-His 174 contained 
both basic and hydroxyl residues. For comparison in the binding studies, two peptides, 
Ala-Gly 175 and ~-Ala-Leu 176 which contained neither basic, nor hydroxyl groups 
were included in the set. 
A variety of techniques have been reported in the literature for studying binding 
interactions between a ligand and host. The majority use NMR methods, but mass 
spectrometry techniques such as MALDI-MS and ESI-MS, as well as affinity 
chromatography have also been utilised. A recent review highlights the advances and 
relevant applications in all of these areas ll9 . However, NMR methods seemed most 
appropriate to look at the binding between the TSA and peptides, since all the studies 
could be performed first hand in house. 
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4.1 Measurement of Translational Diffusion Coefficients Using PFG 
NMR Studies. 
When two molecules fonn a complex together in solution, many NMR sensitive 
parameters change, such as chemical shift of the protons involved, T I and T 2 relaxation 
rates, and diffusion rates. Many examples have been reported in the literature, but most 
involve binding between a small ligand and a large receptor such as a protein l20. 
Monitoring of small molecule-small molecule binding such as we were hoping to see is 
more complex since the changes observed are not as large. 
Perhaps the most common method of detennining binding has been to examine the 
change in chemical shift with varying concentrations of the two components. The 
signals most commonly used are amide NH peaks121 (although other signals have been 
used37) since these peaks are downfield and usually distinct from the rest of the 
spectrum, and any change can be clearly observed. However, these changes are usually 
monitored in organic solvents such as chlorofonn. In our situation we wished to monitor 
binding in water, since the reaction to be catalysed is ester hydrolysis, and the binding 
between receptor and transition state has to occur in aqueous solution. This posed a 
problem for observing chemical shift change. Firstly, if deuterium oxide is used as the 
solvent, then the amide NH peak is no longer observed in the spectrum due to deuterium 
exchange. Water could be used as the solvent, but some of the amide resonances 
overlapped with the intense water peak at 4.6ppm, and if water suppression was applied 
then the overlapping peaks were also suppressed. In view of this, it was decided instead 
to observe changes in translational diffusion rates upon complexation. This is a 
technique which has largely been used to look at large-molecule, small-molecule 
binding l22,123, and we were therefore very interested to see if it could be successfully 
applied to our system in order to study binding between two small molecules. 
The translational diffusion coefficient of a molecule III solution is molecular mass 
dependent: small molecules diffuse faster than large molecules. Therefore, when a 
ligand fonns a complex with a host, the apparent molecular mass changes, and this can 
be observed as a slowing, or decrease in the translational diffusion coefficient. This 
change can be monitored using Pulsed Field Gradient (PFG) NMR techniquesI24.I25. 
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In NMR experiments, nuclear spins precess about the magnetic field at a frequency that 
is defined by their chemical identity and local electronic environment. Ignoring field 
inhomogeniety, all spins experience an identical magnetic field. The application of a 
field gradient has the effect of making the magnetic field strength linearly dependent on 
position. 
When a gradient pulse is applied to the system the spins no longer have a coherent 
phase, and instead the phase of the individual spins becomes dependent on their 
transverse position. If no translational diffusion has occurred the spins can return to 
their coherent phase by application of a second gradient pulse of inverse polarity, and 
no loss of NMR signal will occur. However, if the spin has undergone translational 
diffusion, the second gradient pulse cannot realign the phases of the spins, and the 
resulting NMR signal will appear attenuated. The smaller the molecule, the further it 
will have diffused from its starting position, and the greater the attenuation of the signal. 
The intensity of the NMR signal can described by Equation 2126: 
Equation 2 
Where 10 is the intensity of the resonance in the NMR spectrum in the absence of 
gradient pulses, y is the gyromagnetic ratio, ~ is the diffusion delay time, g and 0 are the 
amplitude and duration of the bipolar gradient pulse pair, D is the diffusion coefficient, 
and l' is the delay between the bipolar gradient pulse pair. 
If the field gradient is varied, and all other NMR parameters kept constant, this can be 
simplified to Equation 3. A plot of Lnl against the field gradient squared affords a 
straight line with the gradient of the slope proportional to the diffusion coefficient D. 
2 InI = InIo - CDg Equation 3 
The formation of the complex is an equilibrium process, and usually the exchange 
between free molecules and complex occurs faster than the NMR timescale. In this case, 
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the measured diffusion coefficient of, for instance the ligand, will be the mole fraction 
weighted average of the diffusion coefficient of bound and free molecules (Equation 4). 
In cases where the host is considerably larger than the ligand, it can be assumed that the 
diffusion coefficient of the complex (DHd is the same as that for the free host, and thus 
the percentage of bound ligand can be calculated from Equation 4. In our case however 
this assumption cannot be made, since the difference in molecular weights between the 
TSA and peptides was relatively small. 
Equation 4 
Where Dobs is the observed diffusion coefficient, DL is the diffusion coefficient of free 
ligand, DHL the diffusion coefficient of the complex, and X is the mole fraction. 
Using this technique the translational diffusion coefficients of the peptides and TSA 
were measured both in free solution and in a mixture containing one peptide, and TSA 
in D20 at pD7. Neutral pD was used, since the aim of the project was to synthesise a 
polymer that would catalyse ester hydrolysis under neutral conditions. Binding studies 
therefore had to be performed under similar conditions. The ratio of concentrations of 
TSA:peptide used was 30:3. The formation of the complex is an equilibrium process. 
Initially measurements used a 1: 1 ratio, but very small changes in diffusion coefficient 
were observed. By Le Chatelier's Principle, use of an excess of the TSA would push the 
position of the equilibrium to the right, and encourage formation of any complex. 
The diffusion coefficient of the TSA was measured to be 4.05 x 10-10 m2/s in free 
solution. In the presence of any of the peptides, it was expected that this value would 
not significantly change, since even if a very stable complex formed only 10% of the 
TSA molecules could be involved in binding at anyone time. We were therefore most 
interested in observing the change in diffusion coefficients of the peptides. Peptides 
showing the strongest binding should show the greatest decrease in diffusion 
coefficient. The results are summarised in Table 1. The first two columns show the 
measured diffusion coefficients. The third column is the change in diffusion coefficient 
as percentage value. The values are accurate to ± 0.1 x 10-lOm2/S. 
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Peptide Dpep Dobs ADlDpep x 100 
( x 10-lOm2/s) ( x 10-lOm2/s) (%) 
H-Arg-Arg-OH 5.01 4.06 18 
H-Ala-Arg-OH 5.62 5.01 11 
H-~Ala-Lys-OH 5.82 5.30 9 
L-Camosine 6.20 5.69 8 
H-Ala-C1ly-OH 7.22 6.79 6 
H-C1ly-Tyr-OH 5.90 5.56 5 
H-~-Ala-Leu-OH 6.07 5.81 5 
H-Ser-His-OH 5.91 5.70 3.5 
H-C1ly-Thr-OH 6.67 6.51 3 
Table 1 
All of the dipeptides are unprotected, and therefore contain at least one free amino 
group at their N-terminus. Therefore all should be capable of forming a complex, 
however weak, between the amine and the carboxylic acid group on the TSA. It was 
expected in all cases to observe a slight change in the diffusion coefficient upon mixing 
with the TSA. As can be seen from Table 1, this was indeed the case. 
Using the information obtained from the Cambridge Structural Database, it was 
expected that the dipeptides containing basic, or hydroxyl residues should form the 
strongest complexes with the TSA, since the terminal amino group could interact with 
the carboxylic acid group, and the hydroxyl or basic residue interact with the 
phosphonic acid. As shown in Table 1, the four peptides containing one or more basic 
residues show the largest change in diffusion coefficient upon mixing. Surprisingly the 
three peptides containing hydroxyl residues did not appear to show good affinity for our 
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TSA. This may have been due to confonnational restrictions in the case of the tyrosine 
residue, or steric hindrance caused by branching in the dipeptides containing serine and 
threonine. 
Of the four peptides containing basic residues, L-Camosine 171 showed the weakest 
complexation to the TSA. Two possible explanations can be put forward. Firstly, at 
pD7, we would expect the imidazole ring to be neutral, since the pKa of the imidazole 
ring in histidine is 6.0. Secondly, the rigidity of the 5-membered ring may prevent the 
molecule achieving an energetically favourable confonnation for binding. Of the other 
three basic dipeptides, the two that showed the greatest change were Ala-Arg 169, and 
Arg-Arg 168. This comes as no real surprise, since the side chain of arginine contains a 
guanidine group, which is known to fonn stable complexes with carboxylate groups, as 
shown in Figure 25 127. It is highly possible that a phosphonic acid might be able to 
interact in similar manner. 
I 
c O~""'O 
~ ~ 
r -
N N 
H/ ""'C~ "H 
I 
NH 
Figure 25 
Of the two dipeptides that contained neither a basic nor a hydroxyl residue, one, ~-Ala­
Leu 176 showed only a very small change in diffusion coefficient as expected. 
However, the other peptide, Ala-Gly 175, although not showing a change as large as 
that observed with the basic dipeptides, still showed a significant decrease in the value 
of Dpep. Possibly due to the simple structure of the molecule, it can find a favourable 
confonnation in which the tenninal carboxylate is able to interact with the phosphonic 
acid on the TSA. 
It is worth noting at this point that the changes observed in the diffusion coefficient of 
these dipeptides are only an indication of binding. As mentioned above, due to the small 
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size of our two molecules, it is not possible to determine a binding constant from the 
data collected. However, the results are enough to clearly indicate which peptides show 
complexation to the TSA. As the results seemed to show that Arg-Arg 168 was the best 
binder, and showed the most potential to be incorporated into our polymer catalyst, we 
decided to measure the binding constant Ka for the complex between 168 and the TSA 
146. 
4.2 Measurement of the Binding Constant for the Complex between 
Arg-Arg and TSA. 
The binding constant for a bimolecular host-ligand complex (Equation 5) can be given 
by Equation 6128• 
TSA + Pep 
-
K = [Complex] 
a [TSAIPep] 
-
Complex Equation 5 
Equation 6 
Equation 6 can be used to relate the binding constant to the measured diffusion 
coefficient. In a situation where the equilibrium process is occurring faster than the 
NMR timescale, the observed diffusion coefficient is the mole fraction weighted 
average of the diffusion coefficients observed in the free and complexed molecule 
(Equation 4). 
Equation 4 
In systems where the host is considerably larger than the ligand, the diffusion 
coefficient of the host should not be affected upon complexation, and hence DHL is 
assumed to be equal to the diffusion coefficient of the free host. The mole fractions can 
therefore be found from Equation 4, and the binding constant Ka calculated. In cases 
such as our system, where the two molecules are similar in size, no such assumption can 
be made, and there are therefore two unknown parameters: Ka and DHL. These two 
parameters can be calculated by measuring the diffusion coefficients with a series of 
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differing concentrations of ligand and host, and usmg a non-linear curve fitting 
procedure 128. 
The principle of curve fitting methods is that if the binding stoichiometry is known, a 
binding isotherm may be calculated and compared to the experimental data. DHL and Ka 
are separate variables and the correct values of these two variables are those that 
produce the best fit of calculated to observed data. 
The concentration of Arg-Arg 168 was kept constant (lmM), and the concentration of 
the TSA 146 was varied from 0-52mM. The diffusion coefficient was measured at all 
concentrations using the method described above. The results are shown in Table 2. 
Ratio Peptide: TSA Dpep 
1 : 0 5.17 
1 : 1 4.82 
1 : 1.8 4.74 
1 : 3.9 4.57 
1 : 6.8 4.46 
1 : 8.7 4.40 
1 : 15.8 4.35 
1 : 18.6 4.25 
1 : 27.4 4.20 
1 : 37 4.15 
1 : 52 4.11 
Table 2 
The diffusion coefficient of the peptide in the complex was plotted against the 
concentration of the TSA, and the binding constant Ka was calculated using the non-
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linear least squares curve-fitting programme Associate VlS#129,130. The calculated value 
was found to be 393LM-1±10%. 
Weak binding generally has a value ofKa less thanlOLM-1, and strong binding a value 
of Ka greater than 105LM-1 128. Our complex has a binding constant in the middle of 
these two values, and therefore it can be deduced that the peptide has a reasonably 
strong affinity for the TSA. It would not have been expected to see strong binding in a 
system such as this, since the use of water as a solvent interferes with much of the 
hydrogen bonding between, for instance, the guanidine group and the carboxylate. 
Should the studies have been performed in a non-polar aprotic solvent such as 
chloroform, we would have expected to observe a much higher value for Ka. 
Although these data told us that the Arg-Arg 168 was binding to the TSA, it was only 
possible to estimate how, and whether it was acting as a bidentate ligand as envisaged 
(Figure 23). Molecular modelling studies were therefore performed to learn more about 
the possible structure and conformation of the actual complex. 
4.3 Molecular Modelling Studies. 
The aim of the molecular modelling studies was to look at possible interactions between 
the TSA 146 and dipeptide Arg-Arg 168 in aqueous solution. The intended method was 
to do this by performing conformational analysis on the TSA and dipeptide to find low 
energy conformers that matched known geometrical constraints. These conformers 
could then be docked together and the energy minimised to find low energy complexes. 
Both the TSA 146 and dipeptide 168 were built in Syby1131. The calculations were 
performed as if at pH?, in which case both guanidine groups, and the terminal amino 
group of the dipeptide would be protonated, and the carboxylate and phosphonic acid 
groups of TSA 146 deprotonated. All the energy calculations were performed using the 
Tripos force field. A distance dependant dielectric constant of 80 was used in order to 
take account of any solvent interactions l32 . Water plays an important role in determining 
conformational preferences of polar molecules, and in modulating the forces between 
# Programme generously donated by Dr. B. R. Peterson (See Ref 130.) 
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ligand and host. Accounting for solvation effects IS essential for a qualitative 
understanding of the interactions between molecules. Four main methods have been 
developed to model the effects of solvents133. Due to time limitations, and the software 
available to us, we decided to use the distance dependent dielectric approach. 
The force felt between two charges is generally accounted for by force fields using 
Coulomb's Law (Equation 7). 
Tr' qzq; 
y lj -
4I1&rij Equation 7 
Where Vij is the force felt between two charges, qi and ~, rij is the distance separating 
the two charges and E is the dielectric constant of the medium. If the dielectric constant 
in the molecular mechanics simulation is increased from the value for vacuum (E= 1) to 
that of water (E=80) then the electrostatic screening effect of the solvent may be 
simulated. This treatment, as used by some force fields can however overestimate the 
forces felt between molecules at long distance, as the charges are interacting through 
bulk solvent and are more heavily screened. The Tripos force field employs a distance 
dependent dielectric, where the dielectric constant in Coulomb's Law is replaced by drij 
(d= a proportionality constant) and the force now decays as lIri{ This method reduces 
the large forces experienced at long distances, but does not completely eliminate them. 
Both molecules were energy minimised using the Tripos force field and a distance 
dependant dielectric function of 80. The TSA was then subjected to a conformational 
analysis. Conformational analysis can be performed in a number of ways134. The 
simplest method is energy minimisation, in which the atoms of a molecule are moved in 
such a way is to reduce the total energy of the system based on an empirical 
representation for the interaction energy of the atoms of a molecule. However, when 
this procedure is carried out from the same starting point it always produces one single 
conformation, and therefore cannot guarantee to find the conformation with the global 
minimum energy. At the other extreme is systematic conformational analysis, in which 
a set of rotatable bonds is identified. All possible rotamers of each of these bonds are 
examined as a function of each other. This method identifies a full set of conformations, 
but if the molecule contains a very large number of rotatable bonds, is a very time 
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consuming method producing vast numbers of conformations. We therefore elected to 
use the Random Search method 135. 
Random Search is a conformational analysis method in the Sybyl package that 
combines random torsional perturbations with energy calculations, minimisation and 
conformer comparison in an iterative process in order to output sets of unique 
conformations. The measure of completeness is based on recording how often each 
conformer is found, and the random search will find the same conformations many 
times. If every conformation has been found at least n times there is a (l-(lI2)n 
probability that all possible conformations have been found. Thus if each conformation 
has been found five times there is a 96.9% chance that all possible conformations have 
been found. 
When a Random Search was performed on the TSA using the Tripos force field, a 
database of over 1500 possible conformations was generated. The database was sorted 
in order of increasing energy, and the lowest energy conformer subjected to 
minimisation. This gave a global minimum energy conformation of the TSA of 34.373 
kcal/mol. This was a huge number of possible conformations. The possible 
conformations were reduced in number by measuring some geometrical constraints, and 
then applying them to the library of possible conformers. 
Internuclear distances of the TSA molecule were measured using 2D-NOESY NMR 
spectroscopy. The internuclear distance between two spins Crab) can be calculated by 
comparing the volume integral intensity of the cross peak (intenSityab) in the NOESY 
experiment with that (intensityrej) for a pair of protons of known internuclear separation 
rrejCEquation 8)136. 
I 
[ 
intensity ab ] 6 
fab = f ref . • 
mtenSIty ref 
Equation 8 
In OUf system the TSA contains a para-substituted phenyl ring. The distance between 
A136 .c·f h' . ortho protons in a system such as this is known to be 2.8 . Therelore, I t e mtensIty 
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of all the cross peaks were measured and Equation 8 applied, we should have some idea 
of internuclear distances in the TSA. 
2D-NOESY NMR spectra of TSA 146 were obtained in D20 at pD7 at a variety of 
mixing times ranging from 100-600ms. The maximum cross-peak intensities were 
found at 300ms. Using the knowledge that the distance between two ortho protons in a 
para-substituted phenyl ring is approximately 2.8A, the volume integral intensities of 
all the cross peaks in the spectra were measured, and inserted into Equation 8 to 
calculate internuclear distances. The results are shown in Table 3. 
o o 
HO 
Geometrical Feature 
Distance 8H-9H 
Distance 9H-14H 
Distance 14H-17H 
Torsion Angle 1, 2, 3, 4 
Torsion Angle 2, 3, 4, 5 
Torsion Angle 13, 14, 15, 16 
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N 
H 
8 
I 
7 
11 o II 14 
12
P
\--O 
\ 13 
OH 
146 
Constraint 
2.8A 
3.62-3.75 A 
3.26-3.62 A 
1800 
1800 
1800 
Table 3 
15 
18 
17~ I 19 
As can be seen from Table 3 some torsion angles in the TSA were also measured. This 
was done simply using the IH NMR spectra of 146. The CH2 at positions 2,4, 14 and 15 
all appear as triplets. Interpretation of this data means that the two protons of the CH2 
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are chemically equivalent, but magnetically inequivalent. The only conformation that 
can fit this scenario is when the torsion angle is 1800 as shown by 177 in Figure 25. If 
the torsion angle is as that shown in 178, then the two protons are now in different 
chemical environments, and a multiplet would be observed. Although there is free 
rotation around all the bonds, there is almost 100% population of this "trans" 
conformation. 
H H 
H H 
177 
Torsion angle 1800 
Figure 26 
H 
178 
Protons no longer chemically 
equivalent 
The constraints in Table 3 were then applied to the library of conformations for 146 
calculated during the Random Search. Four conformations were found to match the 
geometric constraints. Two of these conformations however showed distinct distortion 
of one of the phenyl rings, and were therefore discarded from use in further studies. 
This left two conformers which we could use to dock with Arg-Arg. 
A similar Random Search was performed on the dipeptide, Arg-Arg 168. Again the 
conformers were sorted by energy in order to find the global minimum of 
13.253Kcallmol. In order to find conformers suitable for docking with the TSA 146, the 
distance between the carboxylate and phosphonic acid groups of the two TSA 
conformers was measured and found to be 12-14 A. Only conformers of 168 in which 
the distance between either the two guanidine groups, or the terminal amino group and 
one of the guanidine groups, was similar to this value were considered for docking 
against the TSA. This left a set of 10 possible conformers. 
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Different conformations of the dipeptide 168 and TSA 146 were docked together by 
eye. Out of the all the possible combinations, four complexes, Temp 137 Arg618, 
Templ37Argl93, Temp137Arg894, Temp137Arg1760, were studied further, as they 
showed the potential for hydrogen bonding between both a guanidine group and the 
phosphonic acid, and a guanidine group and the carboxylate. All four of these involved 
the same TSA conformation. Using the DOCK command, the dipeptide was fitted 
interactively to the TSA in such a way as to maximise the electrostatic interactions, and 
minimise the steric energy. 
The first attempt to minimise the energy of the complex used the MINIMISE_DOCK 
command. However, this tool concentrates only on minimising the electrostatic energy, 
and consequently significantly altered the conformations of both TSA and peptide such 
that the energies of the individual components were now very unfavourable. Instead the 
entire complex was minimised under three different sets of conditions: I) Tripos 
forcefield, distance dependent dielectric of 80; 2) Tripos force field, distance dependent 
dielectric of 1; MMFF94s force field, dielectric constant of 1. The minimised energies 
of the complex, and of the two components were measured, and used to calculate the 
interaction energy of the complex using Equation 9: 
E j = Etotal - (Epep + E tsa ) Equation 9 
Where Ei is the interaction energy, Etotal the energy of the complex, and Epep and Etsa the 
energies of the individual components. The results are summarised in Tables 4-6. 
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1) Tripos force field, distance dependent dielectric 80 
Complex Energy of Energy of Energy of Interaction 
Complex TSA Peptide Energy 
Temp137Arg618 8.231 3.137 16.098 
-11.004 
Temp137Arg193 8.000 3.324 17.554 -12.878 
Temp 137Arg894 11.053 2.992 18.253 -10.193 
Temp137Arg1760 9.913 3.593 17.610 -11.29 
Table 4 
2) Tripos force field, distance dependent dielectric 1 
Complex Energy of Energy of Energy of Interaction 
Complex TSA Peptide Energy 
Temp137Arg618 -162.398 -8.838 5.928 -160.108 
Temp137Arg193 -132.286 -13.741 -17.623 -100.922 
Temp 137Arg894 -128.668 -14.610 -31.405 -82.653 
Temp137Arg1760 -139.555 -10.720 -28.667 -100.168 
Table 5 
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3) MMFF94s force field, dielectric constant 1 
Complex Energy of Energy of Energy of Interaction 
Complex TSA Peptide Energy 
Temp137Arg618 -641.665 84.525 -325.537 -400.653 
Temp 137 Arg193 -610.686 73.343 -356.559 -327.47 
Temp137Arg894 -528.367 65.130 -332.247 -26l.25 
Templ37Argl760 -634.320 74.188 -342.666 -365.842 
Table 6 
As can be seen from Tables 4-6 all of the complexes formed had favourable interaction 
energies. Although the minimisations with Tripos (distance dependent dielectric 1) and 
the MMFF94s force fields gave complexes with favourable interaction energies, when 
the complexes were studied in further detail, it was clear that the conformations of 146 
and 168 had been distorted in order to maximise the electrostatic interactions. Therefore 
the complexes obtained using the Tripos field, distance dependent dielectric 80 were 
used for further study. The complexes were then compared to known small molecule 
close contacts. 
Isostar is a computerised library containing information about the non-bonded contacts 
formed by some 250 chemical groupings 137,138,139. This database was used to study the 
geometrical preferences of interactions between guanidine groups and both carboxylate 
and phosphonate groups. The results are shown in Figure 27. 
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Guanidine-carboxylate interactions 
Guanidine-phosphonate interactions 
This information was compared with the geometries observed in our complexes. We 
were pleased to note that in two of the complexes, Temp137Arg618, and 
Temp 137Arg193, the geometries observed closely matched those in the database, 
although the guanidine-carboxylate interaction is usually more planar than that observed 
in our complex. Three different diagrammatic representations of the complex 
Temp137Arg618 are shown in Figures 28-30. 
The combination of NOE NMR spectroscopy and molecular modelling has given us a 
clear diagrammatic representation of how the TSA molecule 146 and dipeptide Arg-Arg 
168 could complex together. As envisaged, it does indeed seem possible for the two 
guanidine moieties to interact with the carboxylate and phosphonate on 146 as a 
bidentate ligand. In the modelled complex, it is also pleasing to note that the carboxylic 
acid group of the dipeptide is not involved in any binding, and can therefore be utilised 
to attach the group to a polymer backbone. The only slight disappointment, as can be 
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seen in Figure 28, is that the hydrogen bond which we had envisaged between the two 
amide groups is not observed. In addition, when the complex is compared with known 
small molecule complexes, it can be seen the geometries of the interactions in our 
complex are very similar to that observed in actual crystallographic data. The 
information obtained from the modelling studies, and the diffusion rate measurements 
indicated that Arg-Arg should be able to act as a receptor site capable of binding the 
transition state of our reaction. It was therefore decided to incorporate this moiety into 
our potential catalytic polymer. 
Figure 28 
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5. Development of the Polymer Catalyst. 
With the dipeptide Arg-Arg 168 chosen as the "receptor site" the next step was to 
decide on which functional groups to incorporate into the polymer to act as "catalytic 
groups". As the receptor site was comprised of a dipeptide, it seemed both logical and 
"natural" to use amino acid residues as our active functional groups as well. The 
carboxylic acid moiety of the amino acid could of course be utilised to attach the group 
onto the polymer backbone. 
With this in mind, data on the active site of the proteases, was examined. Proteases can 
be split into four classes, according to their activities and functional groups 140. The 
serine proteases have a reactive serine residue and operate at neutral pH. The thiol 
proteases are similar to serine proteases, but with an active cysteine residue replacing 
the serine residue. Their optimum pH is also around 7. The carboxyl proteases contain 
catalytically important carboxyl (e.g. aspartic acid) residues, and tend to operate at low 
pH. Finally, the zinc proteases are metalloenzymes which also operate at neutral pH. 
Since the objective of the project was to create an artificial enzyme which could 
catalyse ester hydrolysis at neutral pH, the carboxyl proteases were therefore 
disregarded, and attention focused on the other three classes. The mechanism of the 
serine proteases has been discussed in detail in Part 1, with the conclusion that catalysis 
is a result of a triad of residues, His-57, Ser-195 and Asp-l02, as shown in Figure 
31 5,6,7. The key step of the reaction relies on hydrogen transfer from the hydroxy I group 
of the serine residue to the imidazole ring of the histidine. Thus the hydroxyl can then 
act as a nucleophile and attack the carbonyl group of the substrate to form a tetrahedral 
intermediate. It was therefore logical to investigate the use of both serine, and histidine 
as catalytic functional groups in an artificial enzyme. 
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Thiol proteases such as papain, ficin and bromelain are widely distributed in nature 140. 
In a similar manner to serine proteases, a cysteine and histidine residue act in concert. 
Initially it was believed that the mechanism was virtually identical to that of the serine 
proteases, i.e. histidine general base-catalysed attack of the cysteine on the substrate to 
form an acyl enzyme followed by deacylation. However, there was no evidence from 
model systems that thiol nucleophiles can be activated by general base catalysis. Instead 
it is believed that the active form is [RS-.ImH+], where 1m represents the histidine. The 
currently accepted mechanism is shown in Scheme 49. Using this information, cysteine 
was also chosen for incorporation into the polymer. 
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The third class of protease, zinc proteases, were also disregarded at this stage since none 
of the modelling or binding studies had been performed in the presence of a metal ion, 
and it was uncertain how it would affect the mode of binding of the substrate to the 
"receptor unit". If required, the mode of action could be re-examined at a later date. 
With histidine chosen as one of the functional groups, it is also worth discussing the 
action of Ribonucleases, since they demonstrate how two histidine residues can function 
together as a general acid/base pair140. Bovine pancreatic ribonuclease catalyses 
phosphate hydrolysis by a two-step process in which a cyclic phosphate intermediate is 
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formed (Scheme 50). The reaction is catalysed by concerted general-acid-general base 
catalysis by the His-12 and His-119 residues. In the initial cyclisation step, His-119 acts 
as a general acid to protonate the leaving group. In the second hydrolysis step, His-119 
activates the attack of water by general-base catalysis, and His-12 protonates the leaving 
group. It was envisaged that in the microenvironment created by a polymer, it may be 
possible for two histidine residues to act in a similar manner to hydrolyse an ester 
substrate. 
riHiS-119 
N~NH o 
- \I O-P-OH 
I 
P. 
Scheme 50 
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We now had three potential catalytic residues for incorporation into our polymer. The 
next step was to choose the polymer backbone. The requirements were that it had to be 
commercially available, have functionality available to attach the peptide and amino 
acid residues onto the backbone, and preferably be soluble in a variety of solvents. With 
this in mind, polyallylamine 134 (Figure 32) was chosen. The primary amino groups are 
suitable for attachment of the amino acid residues by standard peptide coupling 
techniques. Although the commercially available form of polyallylamine is as its 
hydrochloride salt, it can be readily converted to the free base by stirring with ion-
exchange resin, and the free base is soluble in a range of solvents, including water, 
chloroform, methanol and ethanol. 
n 
134 
Figure 32 
If standard peptide coupling techniques were to be used to attach the amino acids and 
peptide to the polymer backbone, then the side chains and a-amino groups had to be 
protected. It was decided to protect the a-amino groups of all the amino acids as their 
base labile Fmoc derivatives. The imidazole ring of histidine, and thiol group of 
cysteine were to be protected as trityl derivatives, the guanidine group of arginine as the 
Pbf derivative, and the hydroxyl group of serine as the tertiary butyl derivative. All of 
the side chain protecting groups chosen were acid labile. 
It was important that the Arg-Arg dipeptide should be conformationally mobile, such 
that even when attached to the polymer backbone it could achieve the energetically 
favourable conformation required to bind to the transition state of the reaction. It 
therefore seemed logical to place a spacer between the polymer backbone and the 
peptide. Lysine initially seemed a suitable choice for the spacer, since it could be 
117 
Results and Discussion 
coupled onto the polymer via the a-carboxyl group. The side chain amino group, which 
would be five carbons away from the polymer, could be coupled to the dipeptide. 
However, not wishing there to be complications arising from the peptide accidentally 
being coupled to the a-amino group, an analogue of lysine, 6-aminocaproic acid 179 
(Figure 33) was used as the spacer molecule instead. To ensure that the arginine 
dipeptide was coupled to this linker, the pseudo "tripeptide" would be synthesised and 
attached to the polymer as a single unit. 
o 
HO 
179 
Figure 33 
At the same time it was decided to functionalise any unreacted amino groups from the 
polymer backbone with a lysine residue. The thought was that the amino groups of the 
lysine may be suitably positioned to aid with the catalysis, either as functional groups, 
or they may aid in the binding of the substrate. Although not often present in the active 
site of proteases, lysine residues do playa crucial role in the catalytic action of some 
enzymes (e.g. aldolases, see page 43). In the neutral environment of the polymer, the 
lysine residues should be protonated, and therefore could behave as a general acid 
catalyst. 
The final part of the strategy was to decide upon the ratio of receptor: functional group 
incorporated into the polymer. Initial studies would involve the use of only one of the 
potential catalytic groups in each polymer. After the polymer had been tested for its 
catalytic capabilities, data could then be compared and combined such that the most 
effective groups could be incorporated together to form a "second generation" more 
efficient catalyst. AI: 1 ratio of arginine dipeptide: functional group was initially used, 
each occupying a third of the amino groups on the polymer backbone. The final third 
would be functionalised with lysine, to form a polymer such as that shown in Figure 34. 
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The catalytic residue and receptor dipeptide would be incorporated into the polymer at 
the same time such that they could influence the positioning of the other on the polymer 
backbone. As explained in section 1, each binding site will be surrounded by a number 
of catalytic groups, and only one needs to be in the right position and orientation 
relative to the substrate for the hydrolysis reaction to occur. 
Figure 34 
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6. Synthesis of the Receptor Unit. 
The receptor unit, consisting of the protected dipeptide attached to a 6-aminocaproic 
acid linker, 179, was synthesised manually on the solid phase using standard Fmoc 
methodology. The acid labile 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl (Pbf) 
group was used to protect the guanidine side chain of the arginine residues 141 . Although 
at the end of the synthesis we required all protecting groups still to be in place, some 
level of orthogonality was preferred, so that when the peptide was attached to the 
polymer backbone side chains could be selectively deprotected if required. 
o 
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As it was a requirement of the synthesis that the peptide had to be fully protected after 
cleavage from the solid support, the choice of resin was crucial. Cleavage of the peptide 
from the chosen resin had to take place under mild conditions. The most commonly 
used resin is the Wang resin 180142 (Figure 35), but cleavage from this resin requires the 
use of TFA which would also cleave the Pbf protecting groups. Instead it was decided 
to use the 2-chlorotrityl resin 181 143 , since cleavage requires use of dilute acetic acid 
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which should leave all the protecting groups in place. The procedure for the synthesis is 
outlined in Scheme 51. 
Fmoc-CA-OH + 2-CI-Trt--C:> 
DIPEA, DCM 
Fmoc-CA-~ 
20% Piperidine/DMF 
FmocArg(Pbf)-OH, PyBOP, 
HOBt, DIPEA, DMF 
Fmoc-Arg(Pbf)-CA -o--C:::> 
200/0 Piperidine/DMF 
H2N-Arg(Pbf)-CA-0--C:::> 
FmocArg(Pbf)-OH, PyBOP, 
HOBt, DIPEA, DMF 
FmocArg(Pbf)-Arg(Pbf)-CA-O-<:::::) 
2:2:6 
AcOH:MeOH:DCM 
F mocArg(Pbf)-Arg(Pbf)-CA -0 H 
Scheme 51 
c:> = 2-ChloroTrityl Resin 
CA = -HN(CH2)sC02H 
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Fmoc protected 6-aminocaproic acid (CA) 182 was prepared according to literature 
procedure by adding 9-fluorenylmethyl chloroformate (Fmoc-CI) 183 in dioxane to a 
solution of 179 in aqueous sodium carbonate (Scheme 52)144. The product 182 (Fmoc-
CA) was obtained in an 86% yield following chromatography. 
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Scheme 52 
Fmoc-CA 182 was attached to 2-chlorotrityl resin 181 (substitution 1.08mmol/g) under 
standard conditions 143. A solution of diisopropylethylamine (DIPEA) and 182 in dry 
DCM was added to the resin under nitrogen. Filtration and washing with solvent 
afforded the resin bound Fmoc-CA. After this, and every subsequent coupling step, a 
test of Fmoc-substitution was performed to see if the coupling reaction was complete, 
i.e. that there were no unreacted groups which could react in future coupling reactions to 
form truncated peptides. The theoretical substitution can be calculated using Equation 
10 145 • 
A _ B x 1000 
- [1000 + (B x (M - X))] Equation 10 
Where A is the theoretical substitution in mmol/g, B is the substitution of the starting 
resin, M is the molecular weight of the peptide and protecting groups, and X has a value 
of 36 for a chlorotrityl resin. The actual substitution can be measured by reacting the 
Fmoc protected resin with a solution of 200/0 piperidine in DMF. Piperidine cleaves the 
Fmoc protecting group via a ~-elimination process to form a dibenzofulvene product 
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184 (Scheme 53). Excess piperidine adds to this product to form a fulvene-piperidine 
by-product 185 which has a characteristic UV absorbance at 290nm. If a known amount 
of the substituted resin (~1 mg) is reacted with a known volume of 20% piperidine in 
DMF (3ml), and the absorbance at 290nm measured, then using Equation 11 145, which 
has been derived from the Beer-Lambert Law (€ for the piperidine fulvene adduct is 
5252M-1cm-I), the substitution of the resin in mmol/g can be calculated . 
• 
o .. 
Scheme 53 
. ( absorbance J SubstitutIOn = 
mass of sample x 1.75 
Equation 11 
The results of the tests for this, and the subsequent coupling steps are summarised in 
Table 7. 
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Coupling Step Theoretical Result of Fmoc Analysis 
Substitution 
Attachment of FmocCA to 0.81mmol/g 0.88mol/g 
reSIn 
1 st Arginine coupling 0.59mmol/g 0.6mmol/g 
2nd Arginine coupling 0.38mmol/g 0.3mmol/g 
Table 7 
The Fmoc protecting group was removed by sonicating the resin in 20%) piperidine in 
DMF. The first FmocArg(Pbt) residue was coupled to the resin by mixing with DIPEA, 
PyBOP and HOBt in DMF. Fmoc deprotection as before, followed by the coupling of 
the second FmocArg(Pbt) residue afforded the protected peptide attached to the 2-
chlorotrityl resin. The peptide was cleaved from the resin using a very mild cleavage 
cocktail of 2:2:6 acetic acid:trifluoroethanol:DCM. Chromatography yielded the 
protected peptide 186 (Figure 36) ready for incorporation into a polymer. 
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7. Synthesis of the Catalytic Polymers. 
With the binding "receptor unit" in hand, we were now ready to synthesise the catalytic 
polymers. Polyallylamine hydrochloride is commercially available in two molecular 
weights- ~ 11 ,OOOkDa, and ~ 70,OOOkDa. For our reactions we decided to utilise the 
higher molecular weight polyallylamine. The molecular weight of the monomer in the 
hydrochloride salt is 93, so each high molecular weight polymer contains approximately 
752 amino groups. When calculating quantities and equivalents of reagents, the number 
of monomer equivalents in the polymer was always used. As discussed in section 5, any 
unreacted amino groups on the polyallylamine backbone were to be functionalised using 
Fmoc protected lysine. Since this meant that one third of all the amino groups on the 
polymers would contain lysine, a large quantity of the protected lysine starting material 
would be required, and although this is commercially available, it was more economical 
to synthesise it in house. 
7.0 Synthesis of Fmoc protected lysine. 
Traditionally, Fmoc protecting groups are introduced by reacting the amino acid with 
Fmoc-CI 183 under basic conditions l44. Under these conditions however, fonnation of a 
dipeptide by-product has been seen to occur (Scheme 54)146. The Fmoc-amino acid 
anion 187 fonned as the initial product is able to act as a nucleophile and attack the 
Fmoc-C1183 to fonn a mixed anhydride 188. The amino acid starting material can then 
either attack the carbonyl group of the O-Fmoc moiety to afford the desired product 
189, or the carbonyl of the amino acid group, to afford an Fmoc-dipeptide by-product 
190. 
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Scheme 54 
The use of succinimidyl 9-fluorenylmethyl carbonate (Fmoc-OSu) 191, which is readily 
prepared from Fmoc-CI 183 (Scheme 55), has been reported to avoid the formation of 
this by-product I46. This reagent seemed a better choice for the synthesis of protected 
lysine. Fmoc-OSu 191was prepared in a 90% yield using a literature procedure by 
reacting Fmoc-CI 183 with N-hydroxysuccinimide (NHS) 192 and triethylamine in 
dioxane. Addition of Fmoc-OSu 191 to a solution of lysine 193 in 90/0 aqueous sodium 
carbonate solution, afforded the Fmoc protected lysine. Purification by washing with 
water yielded pure 194 in 71 % yield (Scheme 55). 
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7.1 Synthesis of Test and Control Polymers. 
Results and Discussion 
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For the attachment of the receptor site and functional groups to the polymer backbone 
we had envisaged using the methodology described by Menger in his synthesis of 
artificial phosphatases (Scheme 56)95. Polyallylamine hydrochloride 196 was converted 
to the free base 134 by stirring with an ion-exchange resin. The free amine 134 was then 
reacted with a range of carboxylic acids and 1-[3-( dimethyl amino )propyl]-2-
ethylcarbodiimide hydrochloride (EDe) 196 in either dioxane or water to afford the 
functionalised polymer 197. 
127 
n 
195 
Amberlite ion-exchange 
.. 
resin 
"" 
/N-(CH2h-N=C=N-CH2CH3 
196 
+ 
Scheme 56 
Results and Discussion 
n 
134 
197 
The simplest polymer to be synthesised was a control containing only lysine and the 
polyallylamine backbone. It was logical therefore, to attempt the synthesis of this 
polymer first. Following Menger's approach, when 1.5 equivalents of 
FmocLys(Fmoc)OH 194 and EDC 196 were heated with polyallylamine 134 at 50°C 
for 2 days, no coupling between the polymer and amino acid was observed (Scheme 
57). The bulky aromatic Fmoc groups make 194 relatively non-polar, and consequently 
insoluble in water and dioxane. We therefore reasoned that a change of reaction solvent 
was necessary for the reaction to proceed. 
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Tanaka et al. have recently published work in which they use polylallylamine 
derivatives as stationary phases for electrokinetic chromatography147. This was of 
interest as they used a different method to convert the polyallylamine hydrochloride to 
the free base. They report that if polyallylamine hydrochloride 195 is stirred in 
methanol with 1 equivalent of potassium hydroxide overnight, the free base is formed. 
Removal of solvent followed by the polymer being redissolved in ethanol, precipitates 
the potassium chloride formed during the course of the reaction and leaves the free base 
134 ready to use in an organic solvent. They have then performed coupling reactions 
onto the polymer using a variety of different solvents. 
We decided to use this methodology for our reactions since the use of organic solvents 
was desirable. It was also decided to add NHS 192 to the reaction mixture as an 
additional activating agent148• Activation of the carboxylic acid is by attack of the acid 
on the carbodiimide moiety in 196. The hydroxyl group of NHS can then attack the 
intermediate 198 to form an active ester 199 which was hoped would be more 
susceptible to nucleophilic attack from the polyaUylamine than the product 198 formed 
from the reaction between benzoic acid and EDC (Scheme 58). 
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Initially this method was tested using a system comprised of polyallylamine 134 and 
benzoic acid 200 in ethanol (Scheme 59). A solution of polyallylamine 134 in ethanol 
was prepared as described above. Benzoic acid 200 was dissolved in ethanol, and 1.2 
equivalents of EDC 196, and 1.4 equivalents of NHS 192 were added, and the solution 
stirred for 4 hours. The reaction was monitored using TLC so that when no further 
reaction between the benzoic acid 200, EDC 196 and NHS 192 was observed, a solution 
of polyallylamine 134 in ethanol was added to the mixture. A white precipitate instantly 
formed, which was collected by filtration, to afford a white plastic-like gum. As the 
gum would not dissolve in any solvent, it was analysed using solid state NMR which 
showed that the product was 201 with the benzoic acid coupled to the polymer as we 
had hoped. 
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Although the test reaction was successful, a couple of changes had to be made to the 
reaction conditions before they could be applied to the reaction between polyallylamine 
134 and FmocLys(Fmoc)OH 194. Firstly, 194 proved to be insoluble in ethanol, and 
further investigations found solubility to be highest in chloroform. No previous 
syntheses of polyallylamine derivatives have reported the use of chloroform as a 
solvent. It was found however, that free polyallylamine could be completely solvated by 
chloroform, which was therefore used as the solvent for the reaction between the amino 
acid residue and activating agents. The free polyallylamine was still added to the 
reaction as an ethanolic solution. 
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Secondly, the use of chlorofonn as a solvent made EDC a poor choice of activating 
agent. EDC 196 was developed for use in coupling reactions in which the reaction 
proceeds in aqueous media l49 . For use in organic solvents such as chlorofonn, the polar 
nature of EDC makes it unsuitable, and the less polar N, N' -dicyclohexylcarbodiimide 
(DCC) 202 (Figure 37) is a more suitable choice of reagent, as not only is it completely 
soluble, it is also more economical 1 50. 
Q-N=C=N-Q 
196 202 
Figure 37 
A solution of polyallylamine free base 134 in ethanol was prepared as described above 
and added to a solution containing 1 equivalent of FmocLys(Fmoc)-OH 194, 1.2 
equivalents of DCC 202 and 1.4 equivalents of NHS 192 in chlorofonn (Scheme 60). 
After stirring for 3 hours, a white solid had precipitated out of solution. As with the 
polyallylamine derivative fonned from benzoic acid, the white solid proved to be 
insoluble in any solvent, and analysis was perfonned using solid state 13C NMR, and 
solid state IR. If the coupling had occurred, the NMR data should show two different 
types of carbonyl peaks relating to the amide bond where the amino acid is coupled to 
the polymer, and the carbamate linker of the Fmoc group. The NMR data indeed 
showed an amide peak at 174.5ppm, and a peak at 157.6ppm, which is characteristic of 
the carbonyl moiety in the Fmoc group. IR analysis showed the presence of two 
different carbonyl groups, at 1693 and 1651cm-1• The two analyses combined clearly 
indicated that the coupling between the amino acid residue and polyallylamine to fonn 
polymer 203 had proceeded cleanly and efficiently. 
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Deprotection of polymer 203 proved to be straightforward. The polymer was suspended 
in a solution of 20% piperidine in DMF, and sonicated for 3 hours. Filtration, and 
extensive washing with DMF and DCM, followed by drying afforded the deprotected 
polymer 204 as a white solid (Scheme 61). When the solid was added to acidic D20, a 
transparent gel formed, which could be analysed by solution phase NMR. IH NMR 
showed an aliphatic polymer, with no peaks in the aromatic region of the spectra, thus 
showing that the Fmoc groups had been cleanly removed. 
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7.2 Synthesis of the Functionalised Polymers. 
With the control polymer successfully synthesised it was time to apply the methodology 
to the more complex polymers containing more than one functional group. A general 
synthesis was designed as shown in Scheme 62. It was vital that both the receptor unit 
containing the Arg-Arg moiety 186, and the functional amino acid residues were 
incorporated into the polymers before the remaining free amino groups on the polymer 
backbone could be functionalised with lysine. Therefore they would be coupled first 
onto the polyallylamine backbone. Once TLC has showed this reaction to be complete, 
the lysine could then be coupled to the polymer. The Arg-Arg peptide 186 and amino 
acid "catalytic group" being coupled simultaneously should influence each other's 
position on the polymer backbone. 
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The activating reagent was agam altered, this time from DCC 202 to N,N'-
diisopropylcarbodiimide (DIC) 205. Ureas are formed as a by-product of the reaction 
when carbodiimides are utilised as activating agents. When DCC is used the urea 
formed is highly insoluble in organic solvents, and thus is hard to remove from the 
reaction product. DIC forms a soluble urea which can be removed by washing, and 
hence was the preferred reagent l51 . 
~--N===C===N--~ 
205 
Figure 38 
The first polymer synthesised in this manner was 206 (Figure 39), and contained only 
the Arg-Arg peptide and lysine. A solution containing 0.3 equivalents of 
FmocArg(Pbf)-Arg(Pbf)OH 186 and DIC 205 and NHS 192 in chloroform was stirred 
and monitored by TLC. A solution of polyallylamine free base 134 in ethanol was then 
added to the mixture. No white precipitate formed in this instance. The Pbf group stains 
a distinct pink colour with anisaldehyde. When TLC was run, a new spot which stained 
this distinct pink colour had appeared on the baseline, and failed to move even when the 
eluent was changed to 100% methanol. This suggested that a high molecular weight unit 
had been formed which contained the Pbf group. When TLC showed no further 
reaction, a solution containing 0.6 equivalents of FmocLys(Fmoc)OH 194, DIC 205 and 
NHS 192 in chloroform was added to the reaction, and the resulting mixture left to stir 
for 48 hours. 
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Disappointingly after this time, only a small amount of white precipitate had formed, 
which was collected by filtration. NMR analysis showed it to be a low molecular weight 
material. Attention therefore turned to the chloroform solution. TLC still indicated the 
presence of the coupled polymer product in the solution. Dilution of this solution with 
methanol resulted in the immediate precipitation of a white gum, which was collected 
by filtration and washed repeatedly with methanol. The solubility of the polymer in 
chloroform meant that the product could now be analysed using solution NMR. 
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7.3 Polymer Analysis using PFG NMR. 
When the solution IH NMR of the polymer was first run, only solvent peaks appeared to 
be present in the spectrum (see Figure 40 a). Upon closer inspection however, it was 
evident that there were other very broad peaks present which were masked by the 
sharper solvent peaks. NMR spectra of high molecular weight molecules appear as 
broad lines due to efficient relaxation 152. 
The masking of the broad polymer peaks by the sharper peaks of impurities could prove 
problematic. An initial glance at the spectrum would indicate that there is a high 
percentage of impurities present in the sample due to the high intensity of the sharp 
peaks. In fact, this is more likely to be a simple result of the much higher solubility of 
low molecular weight species. In order to view true spectra of our polymers, we needed 
an NMR technique that would effectively mask the peaks of the low molecular weight 
impurities. We decided to continue our use of PFG NMR techniques to achieve this. 
As described on page 95, translational diffusion rates in solution for high and low 
molecular weight species are significantly different. The intensity of a signal observed 
in PFG-NMR experiments is dependent on how far the molecule has diffused between 
the two pulses. Clearly, a low molecular weight species will have travelled further. 
Hence at high gradient strength (25Gcm-I), signals corresponding to low molecular 
weight species will be suppressed, and the signals of the polymer can be observed more 
clearly. This technique was used on all of the polymer samples. An example of the 
effectiveness of the method can be seen in Figure 40. 
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(b) 
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a) Polymer 206. NMR spectra no gradient applied. b) NMR spectra with 500/0 gradient. 
Figure 40 
139 
Results and Discussion 
7.4 Synthesis of Other Polymers. 
Further polymers were synthesised usmg the methodology described above. Initial 
attention was focused on the synthesis of polymers containing histidine residues as the 
catalytic group. Two polymers were successfully synthesised, one, 207 containing only 
histidine and lysine in a 1:2 ratio, and the other 208 containing lysine, histidine and the 
Arg-Arg receptor unit in 1: 1: 1 ratios, which was of course the first example of the 
ultimate objective of our modular strategy (Figure 41). 
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Polymers containing cysteine residues were the next target. However, when 0.3 
equivalents of FmocCys(Trt)OH 209, and 0.6 equivalents of FmocLys(Fmoc)OH 194 
were reacted with DIC 205 and NHS 192, and added to the polyallylamine solution, 
none of the desired polymeric product was observed by 1H NMR. Lysine had attached 
to the polymer as before, but none of the cysteine residue could be observed. The use of 
the trityl protecting group with cysteine has two problems. Firstly it is easily cleaved, 
and can fall off during the course of the reaction. In this instance the thiol group is now 
able to act as a nucleophile, and can attack the activated ester, resulting in the formation 
of thiol esters such as 210 (Scheme 63). Second, the steric bulk of the S-Trt group can 
prevent the polymer attacking the activated ester. Racemisation is also a problem in 
couplings involving cysteine residues 145. 
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Instead of the DICINHS combination, we decided to use a more reactive activating 
agent. HA TU 211, is an aminium based derivative which when used in the presence of a 
tertiary base, has been shown to give the most superior results for peptide coupling, as 
well as suppressing enantiomerization 153. The mechanism of activation to form the OAt 
ester 212 is shown in Scheme 64. 
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FmocCys(Trt)OH 209 was stirred with 1 equivalent ofHATU 211 and DIPEA in DCM 
and added to an ethanolic solution of polyallylamine 134. After stirring for 30 minutes, 
a solution of Fmoc(Lys)FmocOH 194 and HATU 211 in DCM was added to the 
reaction mixture, which was stirred for a further two days (Scheme 65). In this instance 
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a white precipitate formed, which was collected and washed, and shown by NMR 
analysis to be the correct product 213. 
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Unfortunately due to time limitations, we were unable to synthesise any more polymers. 
However, the use of HA TU as the activating reagent shows promise for hindered 
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systems. For the synthesis of polymers which do not pose problems of steric hindrance 
of racemisation, the DICINHS system would still be more appropriate in view of the 
expense of the HA TU reagent. 
7.5 Deprotection of Polymers. 
All the polymers were deprotected using the same method demonstrated for polymer 
208 in Scheme 66. The polymers contain both acid labile (Pbf, Trt) protecting groups, 
and base labile (Fmoc) protecting groups. It was desirable for the fully deprotected 
polymer to be in a neutral form, without any counter-ions present, so it was decided to 
cleave the acid labile groups first. This was achieved by sonication of the polymer with 
a mixture of 95:2.5:2.5 trifluoroacetic acid: triisopropylsilane (TIS):H20. The role of 
the TIS was two fold. First it is known to accelerate the cleavage of the arginine Pbf 
protecting grouplS4. Secondly, it acts as an effective quencher for the stable cation 
formed during cleavage of trityl protecting groups 155. Filtration, followed by extensive 
washing with water and DCM afforded the polymers free of acid labile protecting 
groups. 
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The base labile Fmoc groups were removed by sonication with a 20% piperidine in 
DMF solution. Filtration, followed by washing with water, and ether, and extensive 
drying afforded the fully deprotected polymers 215-218 which were now ready to be 
tested for catalytic activity. 
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8. Binding and Rate Studies of the Polymers. 
8.0 Diffusion Rate Measurements of the TSA in the Presence of 
Polymer. 
With the Arg-Arg peptide now incorporated into a polymer, it was important to see if 
the TSA still showed a strong affinity for the receptor unit now that the surrounding 
microenvironment had changed. As the role of the Arg-Arg was to stabilise and bind the 
transition state of the ester hydrolysis, the affinity of the polymer for the TSA is crucial, 
and if after incorporation into the polymer, the chosen receptor no longer showed any 
such affinity, then the catalytic capabilities of the polymer would be seriously called 
into question. 
The binding of the TSA 146 to polymer 218, containing Arg-Arg and lysine, was 
monitored by measuring the change in diffusion coefficient of the TSA upon 
complexation. The method used was as described in chapter 4. In this instance however, 
the difference in molecular weights between the polymer host (MW > 70,000), and TSA 
ligand (MW 419) is far greater than that between the TSA and the dipeptides used in the 
earlier studies, and it was expected that the change in diffusion coefficient observed 
upon binding should be much greater. 
Three solutions were prepared. One contained 8.Smg of polymer 218 in 1ml of D20, 
another was a 2mM solution of TSA 146 in D20. The third solution consisted of 8.Smg 
of polymer in 1 ml of a 2mM solution of TSA. All solutions were at pD7. The diffusion 
coefficients of polymer and TSA in all solutions were measured, and the results are 
shown in Table 8. 
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Sample D TSA x 10-10m2/s Dpolymer X 10-10 m2 Is 
8.5mg Polymer 218 
-
0.161 
2mM TSA 146 4.251 
-
2mM TSA 146 + 8.5mg 0.861 0.161 
Polymer 
Table 8 
As can be seen from Table 8, when the TSA was mixed with polymer 218, the observed 
diffusion coefficient of the TSA decreased by a value of 3.4 x 10-lOm2/s. This is a very 
significant change, and suggests very strong complexation between the TSA and 
polymer. It was a concern that the change might be a result of the increased viscosity of 
the solution caused by the presence of the polymer. In order to determine whether or not 
this was the case, the diffusion coefficient of the water (Dso1v) was measured. This has a 
known value of 2.3 x 10-9m2/s156,157, and should the change in diffusion coefficient be 
due to a change in viscosity of the solution, then the diffusion coefficient of water 
should also be altered. Fortunately, the measured value of Dsolv was the same as the 
literature value, and thus it can be assumed that the observed change in DTsA is due to 
complexation to the polymer. 
As discussed previously, the observed diffusion coefficient, Dobs, is actually a mole 
fraction weighted average of the diffusion coefficient of bound and free molecules 
(Equation 4). As the molecular weight of the polymer is now considerably larger than 
the ligand, the assumption can be made that the diffusion coefficient of the complex 
(DCOMP) is the same as that for the free polymer measured and shown in Table 8, and 
thus the percentage of bound TSA can be calculated from Equation 4. 
Equation 4 
Substituting the values shown in Table 8 into Equation 4, the mole fraction, and thus the 
percentage of bound TSA in the complex was calculated and found to be a very 
significant 820/0. Unfortunately, the exact molecular weight of the polymer is unknown. 
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and hence it is not possible to know the concentration of the polymer in solution, and 
thus measure an exact binding constant Ka using Equation 6. However, an approximate 
value can be obtained, since the molecular weight of the starting polymer is known to 
be -70,000. The concentration of the polymer solution is thus approximately O.lmM, 
and this value can be substituted into Equation 6 to give an approximate value of Ka. 
The concentration of free and bound TSA can be calculated using the mole fraction 
found above. 
K = [COMPLEX] 
a [TSA IPolymer] Equation 6 
Substituting the values into Equation 6 gIves a value for Ka of 45555LM- 1±20%. 
Although this figure is only an approximation, it indicates that the TSA has a strong 
affinity for the polymer. The results of these binding studies were encouraging, since if 
the polymer does indeed have a strong affinity for the TSA, then it should also bind the 
transition state in the ester hydrolysis, and hence have some catalytic affect on the 
reaction. 
8.1 Hydrolysis Reactions of the Ester Substrate. 
Before testing the polymers as catalysts for the hydrolysis of ester 145, the rate of the 
control reaction, i.e. in the absence of any polymer had to be measured. The reactions 
were monitored by analytical HPLC. The hydrolysis of ester 145 yields two products, 
acid 219 and alcohol 153 (Scheme 65). Using a reverse phase column, and a solvent 
gradient elution system of acetonitrile and water, ester 145 and acid product 219 
(Scheme 67) could be clearly separated with retention times of 18.01 and 11.9 minutes 
respectively, although phenethyl alcohol 153 could not be observed under these 
conditions. 
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A O.SmM solution of ester 145 in phosphate buffer pH7 was prepared, and stirred at 
room temperature. The reaction was monitored by HPLC after 10 minutes, and 
thereafter at thirty-minute intervals. After 24 hours, none of the peak corresponding to 
acid 219 was observed in the HPLC trace, and IH NMR of the sample confirmed that no 
reaction had occurred. The reaction was repeated, but on this occasion heated at SO°C 
for 24 hours. Again the HPLC trace showed only starting material. 
Four polymers were now tested for their abilities to catalyse the hydrolysis of ester 145. 
Since the control showed no reaction after 24 hours, any production of product during 
the same timescale could be seen as a significant rate increase. The four polymers used 
were the control polymer 204, containing lysine residues only, polymer 218, containing 
the Arg-Arg unit and lysine, polymer 217, with lysine and histidine residues, and the 
vital polymer 215, which contained all three units, Arg-Arg, lysine and histidine (Figure 
43). 
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The conditions used for each polymer catalysed reaction were the same. A O.5mM 
solution of 145 in phosphate buffer (pH7) was stirred with 15mg of polymer for 24 
hours at room temperature. The reaction was monitored as described above using 
HPLC. Both the formation of acid 219, and decrease in concentration of the starting 
material were monitored. In the presence of the control polymer 204, after 24 hours, no 
significant reaction had occurred. The results for the other three polymers are 
summarised in Figures 44 and 45, showing the decrease in concentration of the ester 
145 and the formation of the acid product 219 respectively. 
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Looking at Figures 44 and 45 it is evident that all three polymers had an effect on the 
hydrolysis of ester 145. Figure 44 shows that in all three cases, when the reaction was 
performed in the presence of the polymer, the concentration of ester 145 significantly 
decreased non-linearly with time. In the case of polymer 217, containing only lysine and 
histidine residues, the concentration of the starting material had halved after only 1 
hour. The results indicate that with all three polymers, binding of the substrate to the 
polymer is occurring. 
Figure 45 shows the concentration of acid 219 formed during the course of the reaction. 
Again, all three polymers showed formation of product, which in itself can be seen as a 
significant achievement, when bearing in mind that no product whatsoever was fonned 
in the control reaction. In order to compare the efficiency of the three polymers, the 
initial rate of reaction, kobs was measured. For polymers 217 and 218, the rate was 
relatively slow, and this value could be measured as the gradient of the slope in Figure 
45. For polymer 215 however, the rate was considerably faster, and the rate was 
measured by plotting a logarithmic graph of time against ([ AcidJx:J - [Acid]t). The half-
life tl/2 was read from the graph, and using Equation 12 the initial rate calculated. The 
rates for all three polymers are summarised in Table 9. 
k = 0.643 
obs t 
1/2 
Equation 12 
Polymer kobs 
Polymer 215 0.008 
Polymer 217 9 x 10-6 
Polymer 218 9 x 10-5 
Table 9 
As can be seen from Table 9, the relative rate constants give a reversal of the trends 
observed for the change in ester concentration observed in Figure 44. With an initial 
153 
Results and Di cu ion 
rate constant of 9 x 10-5, the reaction containing polymer 217, containing lysine and 
histidine only showed the slowest rate of formation of product. Polymer 218, containing 
the Arg-Arg receptor unit, showed a 10-fold rate acceleration over polymer 217. 
Polymer 215, containing both the receptor Arg-Arg unit, and histidine residues had the 
greatest effect on the rate of formation of product and showed a 900-fold rate 
acceleration over polymer 217. 
In order to obtain more information on how the reaction was proceeding, inhibition 
studies were carried out by performing the hydrolysis reactions in the presence of the 
TSA 146. Should the catalysis be occurring due to binding and stabilisation of the 
transition state of the reaction, then the TSA should act as an inhibitor, and the rate of 
reaction should be significantly reduced. Reactions were carried out by stirring a 
solution with 0.5mM concentrations of both ester 145, and TSA 146 in the presence of 
15mg of polymer, and the reaction monitored as before. Unfortunately due to time 
constraints and a lack of available polymer, the inhibition studies were only carried out 
on polymers 217 and 218. Figures 46 and 47 show the rate of formation of acid 219 for 
both polymers, in the presence and absence of TSA. 
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The initial rates of formation of product were measured in the same way as described 
above, and summarised in Table 10. For comparison, the rates calculated in the absence 
of TSA have also been included in the table. 
Polymer kobs in presence of kobs in absence of TSA 
TSA 
Polymer 217 9 x 10-) 9 x 10-0 
Polymer 218 4 x 10-5 9 X 10-) 
Table 10 
Table 10 shows that for the case of the polymer containing the Arg-Arg receptor unit, 
but no "catalytic groups", the rate decreased by half in the presence of the TSA. This 
suggests, that as intended, the polymer is acting by stabilising the transition state of the 
reaction. On the other hand, polymer 217, showed a 10-fold rate increase in the 
presence of the TSA. This result is interesting, and suggests a much more complex 
lnechanisln is involved in the catalysis. 
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Unfortunately, due to time constraints, no more kinetic studies could be performed, a 
would have been desirable, so it is difficult for us to make accurate statements about 
the actual mode of action of any of the polymers. Varying the concentrations of both 
ester and polymer would provide more information. However it is possible to make 
some deductions from the data collected. To aid in this discussion, it is interesting to 
study Figures 48 and 49, which show the "missing" concentration of ester in the 
reaction mixture in the absence and presence of TSA respectively. The "missing" 
concentration can be described as the initial concentration of ester minus the sum of 
the acid and ester concentrations at any given time. This data gives information on 
how much of the substrate is bound to the polymer. 
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Figure 48 indicates that Polymer 218 has a low, but fairly constant concentration of 
ester bound to the polymer at any given time. Polymer 217 containing histidine and 
lysine has a very high "missing" concentration. This is a good indication that a large 
proportion of ester is strongly bound to the polymer. Polymer 215, containing both 
binding and catalytic moieties shows a steadily increasing value of missing, or bound 
ester concentration. Figure 49 shows that in the presence of the TSA, the 
concentration shown in the graph varied little for Polymer 218, but in the case of 
polymer 217 is almost halved. 
Polymer 218 containing the Arg-Arg receptor unit but no catalytic groups how a 
distinct rate increase over the control reaction, and very little of the e ter sub trate i 
bound to the polymer at any given time. The inhibition tudies cau ed a 2-fold 
decr a e in reaction rate thus indicating that some aspect of the cataly i wa cau ed 
by binding of a tran ition tate. There i likely to be another factor in the cataly i b 
thi polym r howe r. Th guanidine group of the arginine re idue are protonated at 
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hydroxide ions. If the substrate is bound to the polymer then these hydroxide ions are 
able to hydrolyse the ester to give products. 
The mode of action of the other two polymers is likely to be far more complex. Polymer 
217 containing histidine and lysine residues apparently shows strong binding of the 
ester substrate, and a slow release of product. Approximately half of the initial 
concentration of ester is bound to the polymer at most times. When the TSA is added, 
the rate of release of product more than doubles. Several different theories can be 
proposed to explain the action of this polymer. Firstly, the substrate could bind very 
tightly to the polymer. However, this theory wouldn't explain the increase in reaction 
rate with the addition of TSA. Second, hydrolysis could be occurring at a binding site, 
but the product is binding very tightly to the polymer, either at a similar site, or at a 
different, second type of binding site. When the TSA is added, it may bind 
competitively with the product, and the rate of release of the acid is increased. Third, 
there could be some type of "acyl-enzyme" formed by a covalent reaction between the 
histidine or lysine on the polymer and the substrate. Hydrolysis of this intermediate 
would then become the rate limiting step. The binding of the TSA may change the 
binding, or conformation of binding sites and aid the hydrolysis of this complex. 
Without further studies however, it is impossible to accurately predict whether one of 
these, or another route is the actual mode of action. 
What is clear is that the combination of both receptor site, and histidine in polymer 215 
is required to form an efficient catalyst for the hydrolysis of ester 145. One strange 
feature of this polymer is that as the reaction proceeds, the concentration of the product 
becomes constant, whilst the "missing" ester concentration steadily increases. This 
could be due to the system reaching equilibrium, so that the concentration of the product 
will no longer increase, but ester is still able to bind to the polymer, until the point 
where the polymer binding sites are saturated. The actual role of the histidine molecule 
is however unclear. In the active site of enzymes, histidine has a number of roles but 
most commonly acts as a general acid/base. It is also possible however that the histidine 
may, under certain conditions act as a nucleophile to form an acyl-imidazole 
intermediate, which should break down to give products. With the data in hand it is 
impossible to make a prediction about how the histidine is acting in this case. 
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In spite of the fact that the detailed mechanisms of the catalysis are not yet known, these 
preliminary results show significant rate enhancements, and thereby provide proof of 
the initial concept. Clearly, the modular assembly of designed receptor sites in 
combination with selection of catalytic groups represents a novel strategy for the 
assembly of artificial enzymes in a manner which also allows us to explore the various 
contributing factors which are responsible for enzymic catalysis. 
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9. Conclusions and Future Outlook. 
9.0 Conclusions. 
This thesis has described the development of a novel, "semi-rational" strategy for the 
preparation of artificial enzymes. Many of the previous attempts at developing artificial 
enzymes had achieved success in terms of catalysis, but in many instances, knowledge 
of the active site formed was limited. The initial concept for our approach was inspired 
by this fact. We wished to develop an approach in which it was possible to know which 
factors were responsible for catalysis, and also to be able to change them in order to 
make the catalyst more efficient. The idea was based on designing a known receptor 
site, and incorporating this onto a polymer backbone. The group responsible for binding 
and stabilising the transition state of the reaction was thus known. A range of active 
catalytic groups could then be grafted onto the polymer, and then the best system 
selected based on its ability to catalyse a given reaction, in our case ester hydrolysis. 
The receptor molecule was chosen based on its ability to bind to a phosphonate TSA. 
The phosphonate contained three recognition points in the form of not only the 
phosphonic acid moiety, but also a carboxylic acid and amide linkage. A library of 
dipeptides were chosen as possible candidates since dipeptides possess appropriate 
functionality which could interact as required with the TSA. Binding interactions were 
studied using a combination of NMR and molecular modelling techniques. A novel 
method of studying small molecule-small molecule binding by measuring changes in 
diffusion coefficient by PFG-NMR, followed by molecular modelling to study the 
nature of the binding interactions identified the dipeptide Arg-Arg as a suitable receptor 
molecule to be incorporated into a polymer. 
A range of amino acid residues, senne, histidine and cysteine were chosen to be 
incorporated alongside the receptor into a polymer as potential catalytically active 
groups. The choice of amino acids was based on knowledge of residues that playa vital 
role in the active site of proteases. Polyallylamine was selected as the polymer backbone 
since not only did it contain functionality suitable for coupling to the receptor and 
catalytic groups, but also because it was highly soluble and flexible. A flexible polymer 
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should be able to move freely in solution, and has the potential to exhibit "induced fit" 
as seen in natural enzymes, i.e. a change in conformation to bind a substrate. 
Due to time limitations, only polymers containing the receptor and histidine could be 
prepared and tested for catalysis. A control reaction showed that the chosen ester did 
not hydrolyse under neutral conditions. A set of three polymers, one containing 
hisitidine, one containing the receptor, and one containing both were prepared and 
tested for catalysis of the hydrolysis of the chosen ester. In all three cases rate 
accelerations were observed. However, the polymer which contained both receptor and 
catalytic groups showed a 900-fold rate acceleration over the polymer containing just 
catalytic histidine residues, and a 90-fold rate acceleration over the polymer containing 
the receptor only. 
This result neatly demonstrated the success of our initial concept. A receptor had been 
designed and incorporated into a polymer, and shown to catalyse the chosen ester 
hydrolysis. In addition, a suitable catalytic group had also been found. However, the 
most efficient catalysis was observed using a polymer which contained both receptor 
and catalytic residues. By clearly separating the catalytic groups and receptor, it was 
possible to investigate individually the effect and importance of each on the rate of 
reaction. 
9.1 Future Outlook. 
Our initial work in this area has successfully proved our proposed concept. However 
there is still plenty of scope for further studies. 
With regard to the polymers already synthesised further kinetic studies should be 
performed which could give a greater understanding of the mechanism of catalysis. 
Firstly, studies varying the concentration of the substrate would enable us to calculate 
the maximum rate acceleration, and observe if the system follows Michaelis-Menton 
kinetics, operating by initial formation of a polymer-substrate complex. 
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Second, inhibition studies should be expanded upon. TSA inhibition studies should be 
performed on Polymer 215, in a similar manner to polymers 217 and 218. Also 
important is to study the effect of varying the concentration of the TSA on the rates of 
reaction. This information could provide an insight into the binding and mechanism of 
the polymers, especially polymer 217. 
Competition studies between the substrate that the system was designed for, and a 
simple ester, such as phenyl acetate, which contains no real "binding moieties" would 
also help in identifying the mode of binding. Clearly if the rate of hydrolysis of the 
substrate is increased relative to that of the competitive ester, then the binding of the 
substrate to the polymer, as predicted in Figure 28 is important. However, choice of 
ester here would be crucial, since the rate of hydrolysis of the substrate is exceedingly 
slow. The ester chosen would have to behave in a similar fashion. 
Synthesis of the same polymers usmg the lower molecular weight polyallylamine 
should be performed. All of the catalytic features of the higher molecular weight species 
could still be incorporated into the polymer, but there would be added benefits, such as 
the increased solubility in a variety of solvents. This would enable the polymer to 
behave as a homogeneous catalyst in solution. 
Synthesis of other polymers containing different "catalytic groups", and testing these as 
catalysts in the ester hydrolysis is also a priority. Due to the known role of serine and 
cysteine residues in natural enzymes, the use of these residues, both on their own, and in 
combination with histidine would be desirable. 
Finally, investigations into finding a better "binding unit" could be performed. The 
binding studies described within this thesis were limited to nine dipeptides. However, 
there are clearly a vast number of possible peptides available, and the chances that we 
found the optimum binder are minimal. A more efficient binding assay, that utilized 
techniques such as UV and fluorescence could be set up, for initial studies, and once 
possible binders identified, the NMR diffusion technique could be used to identify the 
best binder. 
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The complexities involved in biomimetic catalysis are difficult to mimic using either 
conventional design, or more modem selection approaches. We have successfully 
demonstrated that the application of a "step by step" approach which combines both 
design and selection elements can be used, not only to synthesise an efficient catalyst, 
but also to provide at every step along the way detailed information about relative 
importance of the groups contributing to the molecular environment of the active site. 
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Experimental 
1. General Experimental. 
IH NMR spectra were recorded at 300MHz on a Bruker AMX300 spectrometer, at 
400MHz on a Bruker AMX400 spectrometer, or at 500MHz on a Bruker A vance 500 
spectrometer. Chemical shifts (OH) are referenced to the residual solvent peak, except 
for spectra recorded in D20, in which case T.S.P was used as an internal standard. 
Chemical shifts are quoted in parts per million (ppm) using the following abbreviations: 
s, singlet; d, doublet; t, triplet; q, quartet; dd, double doublet; dt, doublet of triplets; m, 
multiplet; br, broad. The coupling constants (1) refer to vicinal 3 JHH couplings unless 
otherwise stated, and are recorded in Hertz and quoted to the nearest 0.5Hz. 
l3C NMR spectra were recorded at 75.4MHz on a Bruker AMX300 spectrometer, at 
100.6MHz on a Bruker AMX400 spectrometer, or at 125.7MHz on a Bruker Avance 
500 spectrometer. Chemical shifts (oc) are referenced to the residual solvent peak and 
are quoted to 0.1 ppm. Carbon spectra assignments are supported by DEPT editing. 
Solid state l3C NMR spectra were recorded at 75.4MHz on a Bruker MSL300 
spectrometer. 
31 p NMR were recorded at 121.4MHz on a Bruker AMX300 spectrometer. Chemical 
shifts (op) are referenced to 85% aq. H3P04, and are quoted to O.lppm. 
2D- NOESY NMR spectra were carried out on a Bruker Avance 500 spectrometer. PFG 
Diffusion Ordered SpectroscopY (DOSY) NMR experiments were carried out on a 
Bruker A vance 500 NMR spectrometer equipped with a Bruker GAB-type gradient 
accessory. 
Melting points were determined using a Reichart Hotstage or Electrothermal 9100 
instrument and are uncorrected. 
Infrared spectra were recorded on a Perkin-Elmer 1600 Fourier transform spectrometer, 
and were recorded either as thin films (NaCI), as KBr disks, or as CHCb solutions 
(NaCI). Absorption maxima are reported in wavenumbers (em-I) using the following 
abbreviations: w, weak; m, medium; s, strong; br, broad. Only selected absorbances are 
165 
Experimental 
reported. Polymer solid state IR were performed using a microscope IR at Imperial 
College, London. 
Mass spectra were recorded under either fast atom bombardment (F AB), or atmospheric 
pressure chemical ionisation (APCI) conditions by the ULIRS mass spectrometry 
service at the School of Pharmacy, University College London. Only molecular ions, or 
fragments from molecular ions are reported. High resolution mass spectra are accurate 
to ±lOppm. 
Microanalyses were performed In the University College London Chemistry 
Department. 
DMF was dried with MgS04, and then distilled from silica gel and stored over Linde 
Type 4A molecular sieves. Diisopropylethylamine (DIPEA) was distilled from, and 
stored over KOH. THF was freshly distilled from sodium-benzophenone under N 2. 
Benzene was distilled from sodium, and DCM was distilled from calcium hydride. 
Methanol was distilled using magnesium turnings and iodine. Triethylamine was 
distilled from P20 5 and stored over KOH. N-Methylmorpholine was distilled from 
calcium hydride and stored over Linde Type 4A molecular sieves. Tert-Butylamine was 
distilled neat immediately prior to use. 
With the exception of FmocLysine(Fmoc )OH which was synthesised in house, all 
protected amino acids, and dipeptides were purchased from BACHEM and used as 
bought. 
Analytical HPLC was carried out on a Shimadzu dual pump LC-I OAS with a Shimadzu 
SPD-6A UVNIS variable wavelength detector, and Shimadzu C-R6A chromatapac 
integrator, and a reverse phase CI8 column (4.6 by 250mm) from HiChrom. Solvents 
were HPLC grade and degassed prior to use. 
Analytical thin layer chromatography was performed on aluminium sheets pre-coated 
with Merck silica gel 60 F254, and visualised with ultraviolet light (254nm), plus either 
basic potassium permanganate, acidic vanillin, or acidic anisaldehyde solution. Flash 
chromatography was performed using BDH silica gel (40-60flm). 
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All glassware was oven dried and cooled under a flow of nitrogen. All reactions 
requiring dry solvents were carried out under an atmosphere of nitrogen. 
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2. Synthesis of Phosphonate Transition State Analogue and Ester 
Substrate 
For consistency when assigning NMR spectra, the following numbering system is used 
for assignment purposes only in the para-substituted benzene rings: 
3 5 
2 6 
1 
NH 
2.0 Synthesis of the Transition State Analogue (TSA). 
Synthesis of Benzyl Phosphonic Acid Dimethyl Ester (149)158. 
149 
A stirred solution of trimethyl phosphite (l95ml, 1.65mol) and benzyl bromide 
(27.82ml, 0.234mol) in benzene (lOOml) was heated at reflux for 19 hours. The solvent 
was removed in vacuo, and the excess trimethyl phosphite removed by distillation to 
yield a colourless oil. This was further purified by fractional distillation (l35-138°C, 
3.5mmHg) to afford benzyl phosphonic acid dimethyl ester 149 as a clear colourless oil 
(27g, 93%); Rr 0.36 (Si02; EtOAc); IH NMR (500MHz, CDCh) DH/ppm 3.13 (d, 
2JPH=21.5, ArCfuP), 3.63 (d, 3JpocH=11.0, 6H, 2 x OCH3), 7.21-7.36 (m, 5H, 5 x ArH): 
13e NMR (lOO.6MHz, CDCh) Dc/ppm 32.8 (d, Jcp=138.0, ArCH2P), 52.7 (2 x OCH3), 
126.9 (C(l)), 128.6 (C(3), C(5)), 129.6 (C(2), C(6)), 131.5 (l x quaternary, C(4)): V max 
(thin filmlcm- 1) 584(m), 700(m), 756(m), 832(s), 916(m), 1026(s, P-OMe), 1186(m), 
1250(s, P=O), 1406(m), 1466(m), 1496(m), 1603(m), 2844(m), 2891 (m), 2957(s). 
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2970(m), 3170(m), 3400(s), 3631(s); m/z (FAB) 201 (100%, [M+Ht); HRMS found 
201.0675, [M+Ht (C9H 140 3P) requires 201.0681. 
Synthesis of (4-Nitro-Benzyl)-Phosphonic Acid Dimethyl Ester (156)159. 
156 
Nitric acid (70% w/v, 24.lml) and sulphuric acid (98% w/v, 24.1ml) were mixed 
together with external cooling. When the temperature reached O°C, benzyl phosphonic 
acid dimethyl ester 149 (19.2g, 0.096mol) was added dropwise over 45mins. The 
mixture was stirred at O°C for 1 hour, after which time the reaction was quenched by 
addition to ice H20 (600ml). The product was extracted with toluene (4 x 150ml), the 
organic layers were combined, washed with aq. NaHC03 (sat., 2 x 100ml), aq. NaCI 
(sat., 1 x 100ml), and dried over Na2S04. The solvent was removed in vacuo to yield (4-
nitro-benzyl) .. phosphonic acid dimethyl ester 156 as a pale yellow solid (10.l3g, 79%); 
m.p. 68-70°C (lit. 75°C159); Rc 0.22 (Si02; EtOAc); IH NMR showed a 9: 1 ratio of 
para:ortho isomers; Data for para isomer only; IH NMR (500MHz, CDCb) bH/ppm 
3.19 (d, 2JpH=22.5, 2H, ArCfuP), 3.62 (d, 3JpocH=11.0, 6H, 2 x OClli) , 7.39 (dd, 
4JpH=2.5, J=8.5, 2H, C(3)H, C(5)H), 8.08 (d, J=8.5, 2H, C(2)H, C(6)H); l3e NMR 
(75.4MHz, CDCb) bclppm 33.3 (d, Jcp=138.0, ArCH2P), 53.4, 53.5 (2 x OCH3), 124.2 
(C(2), C(6», 131.0 (C(3), C(5», 139.8, 147.4 (2 x quaternary, C(1), C(4»; V max 
(CHCb/cm- 1) 549(m), 689(m), 740(m), 829(m), 864(s), 1032(s), 1053(s, P-OMe), 
1186(m), 1249(s, P=O), 1347(s, C-N02), 1403(w), 1452(w), 1487(w), 1515(s, C-N02), 
1599(m), 2454(w), 2853(w), 2851(m), 3000(s), 3414(m, br); m/z (FAB) 246 (100%, 
[M+Ht); HRMS found 246.0540, [M+Ht (C9H13N05P) requires 246.0531. 
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Synthesis of (4-Amino-Benzyl)-Phosphonic Acid Dimethyl Ester (150)160. 
150 
To a solution of (4-nitro-benzyl)-phosphonic acid dimethyl ester 156 (15g, 0.061mol) in 
MeOH (200ml) was added 10% Pd/C (1.5g, cat.). The mixture was placed in a Parrs 
hydrogenation equipment under a hydrogen pressure of 50 p.s.i. and shaken for 24 
hours. The catalyst was removed by filtration, and the solvent removed in vacuo. The 
residue was dissolved in aq. HCI (2M, 100ml), and any unreacted starting material 
extracted with toluene (2 x 90ml). The aqueous layer was adjusted to pH9 using 
NaHC03, and the product extracted into DCM (4 x 80ml). The organic layers were 
combined, washed with H20 (1 x 80ml), aq. NaCI (sat., 1 x 80ml), dried over Na2S04, 
and concentrated to ~20ml. On standing crystallisation occurred to afford pink crystals, 
which were collected by filtration to yield (4-amino-benzyl)-phosphonic acid dimethyl 
ester 150 (6.95g, 53%); m.p. 105-107°C (lit. 103°CI60); Rr 0.34 (Si02; EtOAc:MeOH; 
9:1); IH NMR (500MHz, CDCh) DH/ppm 3.00 (d, 2JPH=21.0, 2H, ArCfuP), 3.59 (d, 
3JpocH=l1.0, 6H, 2 x OCH3), 6.57 (d, J=8.0, 2H, C(2)H, C(6)H), 7.01 (dd, 4JPH=2.5, 
J=8.0, 2H, C(3)H, C(5)H); 13e NMR (75.4MHz, CDCh) Dc/ppm 32.7 (d, Jcp=136.0, 
ArCH2P), 53.7, 53.8 (2 x OCH3), 116.1, (C(2), C(6», 121.3 (1 x quaternary, C(4», 
131.3,131.4 (C(3), C(5», 146.4 (1 x quaternary, C(l»; Vrnax (CHCh/cm- l ) 563(m), 
661(m), 696(m), 815(m), 857(s), 1052(s, P-OMe), 1130(w), 1179(s), 1242(s), 1263(s, 
P=O), 1403(m), 1452(m), 1508(s, Ar), 1621(s, Ar), 2853(w), 2951(m), 3001(s), 
3386(m, -NH2), 3449(m, -NH2); m/z (FAB) 216 (70%, [M+H]l; HRMS found 
216.0776, [M+Ht (C9HI5N03P) requires 216.0790. 
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Synthesis of [4-(2,2,2-Trifluoroacetylamino)-Benzyl]-Phosphonic Acid Dimethyl 
Ester (151). 
151 
To a stirred solution of (4-amino-benzyl)-phosphonic acid dimethyl ester 150 (4.04g, 
0.019mol) in anhydrous THF (40ml) under N2 was added trifluoroacetic anhydride 
(2.71ml, 0.019mol) and N-methylmorpholine (2.11ml, 0.019mol). The solution was 
stirred at r.t. for 1.5 hours. The solvent was removed in vacuo, and the residue dissolved 
in EtOAc (lOOml). The solution was washed with aq. KHS04 (IN, 4 x 20ml), aq. 
NaHC03 (5%, 2 x 20ml), aq. NaCI (sat., 1 x 20ml), and dried over Na2S04. The solvent 
was concentrated in vacuo until precipitation occurred. The solid was collected by 
filtration to yield [4-(2,2,2-trifluoroacetylamino )-benzyl]-phosphonic acid dimethyl 
ester 151 as a white crystalline solid (4.69g, 80%); m.p. 130-132°C; Rr 0.47 (Si02; 
EtOAc:MeOH; 9:1); IH NMR (300MHz, CDCh) DH/ppm 3.16 (d, 2JPH=21.5, 2H, 
ArCfuP), 3.75 (d, 3JpocH=I1.0, 2H, 2 x OCH3), 7.13 (dd, 4JPH=2.5, J=8.5, 2H, C(3)H, 
C(5)H), 7.51 (d, J=8.5, 2H, C(2)H, C(6)H), 10.79 (s, IH, F3CC(O)NH); 13C NMR 
(75.4MHz, CDCh) Dc/ppm 32.4 (d, Jcp=139.5, ArCH2P), 53.4, 53.5 (2 x OCH3), 121.7 
(C(2), C(6», 128.2 (CF3C(O)NH), 130.6 (C(3), C(5», 135.8, 135.9 (2 x quaternary, 
C(I), C(4», 155.9 (CF3C(O)NH); 31p NMR (l21.4MHz, CDCh) Dp/ppm 30.1; Vrnax 
(CHCh/cm-1) 559(m), 725(m), 787(w), 822(m), 866(m), 902(m), 1099(s, C-F), 1062(s, 
P-OMe), 1157(s, C-F), 1195(s, C-F), 1259(s, P=O), 1287(m), 1421(m), 1516(m, 
C(O)NH), 1555(m), 1606(m), 1718(s, C=O), 2951(m), 3000(m), 3042(s), 3197(m), 
3253(m, C(O)NH), 3421(m, C(O)NH); m/z (FAB) 312 (100% , [M+Hr); HRMS found 
312.0620, [M+Hr (CIIH14F3N04P) requires 312.0613. 
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Synthesis of [4-(2,2,2-Trifluoroacetylamino )-Benzyl]-Phosphonic Acid tert-
Butylamine Salt Methyl Ester (158). 
158 
[4-(2,2,2-Trifluoroacetylamino )-benzyl]-phosphonic acid dimethyl ester 151 (3.08g, 
9.91mmol) was suspended in tert-butylamine (30ml) and the mixture refluxed for 7 
days. The reaction was concentrated in vacuo, and the residue dissolved in H20, and 
lypholised to yield [4-(2,2,2-trifluoroacetylamino )-benzyl]-phosphonic acid tert-
butylamine salt methyl ester 158 as a white solid (3.4g, 920/0); Rr 0.21 (Si02; 
CHCh:MeOH; 3:1); IH NMR (400MHz, D20) DH/ppm 1.12 (s, 9H, (CH3)3CNH3), 3.33 
(d, 2JpH=21.5, 2H, ArClliP), 4.67 (d, 3JpocH=I1.0, 3H, OCH3), 6.94 (d, J=7.5, 2H, 
C(3)H, C(5)H), 7.08 (d, J=7.5, 2H, C(2)H, C(6)H); l3e NMR (l00.6MHz, D20) 
Dc/ppm 27.9 «CH3)3CNH3), 33.8 (d, Jcp=130.0, ArCH2P), 52.3 (OCH3), 117.1, 117.5 (2 
x quaternary), 123.8, 123.9 (C(2), C(6», 130.9, 131.0 (C(3), C(5», 131.7, 141.9 (2 x 
quaternary); 31p NMR (l21.4MHz, D20) Dp/ppm 22.4. 
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Synthesis of [4-(2,2,2-Trifluoroacetylamino)-Benzyl]-Phosphonic Acid Methyl 
Ester (159). 
159 
tert-Butylamine salt 158 (3g, 8mmol) was dissolved in MeOH (50ml) and stirred with 
cation exchange resin Amberlite IR-120 (plus) for 4 hours. The resin was removed by 
filtration and the solvent removed in vacuo to afford [4-(2,2,2-trifluoroacetylamino)-
benzyl]-phosphonic acid methyl ester 159 as a cream coloured solid (1.75g, 68%); m.p. 
206-208°C; IH NMR (500MHz, CD30D) 8H/ppm 3.18 (d, 2JPH=21.5, 2H, ArCfuP), 
3.65 (d, 3JpocH=I1.0, 3H, OCH3), 7.33 (dd, 4JPH=2.5, J=8.5, 2H, C(3)H, C(5)H), 7.58 
(d, J 8.5, 2H, C(2)H, C(6)H); l3e NMR (75.4MHz, CD30D) 8c1ppm 33.9 (d, 
2JpH=139.5, ArCH2P), 53.3 (OCH3), 115.9, 119.8 (2 x quaternary), 122.6 (C(2), C(6», 
131.6 (C(3), C(5», 136.9 (1 x quaternary), 157.4 (CF3C(O)NH); Vrnax (KBr/cm-1) 
504(m), 556(m), 699(m), 835(s), 1046(m, P-OMe), 1162(s, C-F), 1244(m, P=O), 
1285(m), 1346(w), 1414(m), 1462(m), 1516(m), 1543(m), 1605(m), 1721(s, C=O), 
2858(w), 2913(w), 2960(m), 3083(m), 3137(m), 3206(m, C(O)NH), 3315(m, C(O)NH); 
m/z (FAB) 298 (80%, [Mt); 136 (100%) HRMS found 298.0443, [Mt 
(ClOHIIF3N04P) requires 298.0456. 
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Synthesis of [4-(2,2,2-Trifluoroacetylamino )-Benzyl]-Phosphonic Acid Chloride 
Methyl Ester (152). 
152 
Method 1. 
Phosphorus pentachloride (0.S6g, 2.6mmol) was added to a stirred solution of [4-(2,2,2-
trifluoroacetylamino)-benzyl]-phosphonic acid dimethyl ester 151 (O.Sg, 1.7mmol) in 
CHCh (Sml) under N2 and heated at 40°C for 16 hours. S02 gas was bubbled through 
the solution for 10 mins. to remove any excess phosphorus pentachloride. The solvent 
was removed in vacuo to afford [4-(2,2,2-trifluoroacetylamino )-benzyl]-phosphonic 
acid chloride methyl ester 152 as a brown solid (0.S02g, 98% crude). Analytical data as 
below. 
Method 2. 
[4-(2,2,2-Trifluoroacetylamino )-benzyl]-phosphonic acid methyl ester 159 (4g, 
0.013mol) was suspended in anhydrous DCM (SOml) under N2. Oxalyl chloride 
(1.76ml, 0.02mol) was added followed by the dropwise addition of DMF (Sl~l, 
0.7mmol). The reaction was stirred for 24 hours at r.t. After this time the solution had 
become homogeneous. The solvent was removed in vacuo, and the solid washed with 
toluene (1 x 20ml), to yield [4-(2,2,2-trifluoroacetylamino )-benzyl]-phosphonic acid 
chloride methyl ester 152 as a cream coloured solid (4.l2g, 99%); IH NMR (300MHz, 
CDCh) DH/ppm 3.S8 (dd, 2JPH=21.0, J 7.S, 2H, ArCfuP), 3.9S (d, 3 JpocH=13.S, 3H, 
OCH3), 7.28 (dd, 4JPH=3.0, J=8.0, 2H, C(3)H, C(S)H), 7.62 (d, J=8.0, 2H, C(2)H, 
C(6)H), 9.73 (s, IH, CF3C(O)NH); 13C NMR (7S.4MHz, CDCh) Dc/ppm 40.4 (d, 
Jcp=139.0, ArCH2P), S3.8 (OCH3), 114.4, 118.2 (2 x quaternary), 121.6 (C(3), C(S)), 
131.1 (C(2), C(6)), 136.3 (1 x quaternary), ISS.S (CF3C(O)NH); 31 p NMR (121.4MHz, 
CDCh) Dp/ppm 42.1; m/z (F AB) 31S, 317 (100%, [Mr). 
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Synthesis of [4-(2,2,2-Trifluoroacetylamino)-Benzyl]-Phosphonic Acid Methyl 
Ester Phenethyl Ester (154). 
154 
[4-(2,2,2-Trifluoroacetylamino )-benzyl]-phosphonic acid chloride methyl ester 152 
(4.lg, 0.013mol) was dissolved in anhydrous THF (60ml) and added dropwise to a 
stirred solution of 2-phenylethanol (1.55ml, 0.013mol) and triethylamine (3.6ml, 
0.026mol) in anhydrous THF (20ml) under N2• The solution was stirred for 24 hours at 
r.t. After this time triethylamine hydrochloride had formed as a white precipitate. The 
precipitate was removed by filtration, and the solvent evaporated. The residue was 
dissolved in EtOAc (60ml) and washed with aq. NaHC03 (5%, 2 x 30ml), aq. KHS04 
(50/0, 2 x 40ml), aq. NaCI (sat., 1 x 50ml), and dried over Na2S04. The solvent was 
removed in vacuo to afford a yellow oil that was purified by flash chromatography 
(Si02; EtOAc) to yield [4-(2,2,2 trifluoroacetylamino )-benzyl]-phosphonic acid methyl 
ester phenethyl ester 154 as a yellow solid (4.11g, 79%); m.p. 135-137°; Rr 0.34 (Si02; 
EtOAc); IH NMR (300MHz, CDCh) DH/ppm 2.96 (t, J=7.0, 2H, POCH2ClliAr), 3.10 
(d, 2JPH=21.5, 2H, ArClliP), 3.62 (d, 3JpocH=I1.0, 3H, OCH3), 4.14-4.27 (m, 2H, 
POClliCH2Ar), 7.14 (dd, 4JPH=2.5, J=8.0, 2H, C(3)H, C(5)H), 7.21 (d, J=7.0, 2H, 
ortho-ArH) , 7.30 (t, J=7.0, IH, para-ArH), 7.32 (t, J=7.0, 2H, meta-ArH), 7.55 (d, 
J=8.0, 2H, C(2)H, C(6)H); 13e NMR (75.4MHz, CDCh) Dc/ppm 32.7 (d, Jcp=138.5, 
ArCH2P), 37.3 (POCH2CH2Ar), 53.1 (OCH3), 67.3 (POCH2CH2Ar), 119.2 (l x 
quaternary, CF3C(O)NH), 121.7 (C(2), C(6)), 127.2 (para-ArC) 128.9, 129.3, (2 x 
ortha-ArC, 2 x meta-ArC), 130.6 (C(3), C(5)), 128.1, 136.2, 137.5 (3 x quaternary, 
ArC), 155.9 (CF3C(O)NH); Vmax (CHCh/cm-1) 557(m), 650(m), 721(s), 769(s), 
1018(m), 1061(m, P-OR), 1157(m, C-F), 1247(s, P=O), 1287(m), 1380(m), 1462(s), 
1515(m), 1551 (m), 1610(m), 1723(s, C=O), 3017(m), 3461 (s, C(O)NH), 3593(s, 
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C(O)NH); m/z (APcr+) 402 (100%, [M+H]l; HRMS found 402.1082, [M+Hr 
(CIsH20F3N04P) requires 402.1090. 
Synthesis of (4-Amino-Benzyl) Phosphonic Acid Methyl Ester Phenethyl Ester 
(160). 
160 
[4-(2,2,2-trifluoroacetylamino )-benzyl]-phosphonic acid methyl ester phenethyl ester 
154 (4g, 9.97mmol) was dissolved in anhydrous MeOH (50ml) and cooled to O°C. To 
the stirred solution was added sodium borohydride (3.77g, 97mmol) in portions. The 
solution was warmed to r.t., and stirred for 2 hours. The solvent was removed in vacuo, 
and the residue diluted with aq. NH40H (10%, 60ml). The aqueous phase was extracted 
with EtOAc (4 x 50ml). The combined organic extracts were dried over Na2S04, and the 
solvent removed in vacuo to yield the product 160 as a yellow gum (2.97g, 96%); Rr 
0.36 (Si02; EtOAc:MeOH; 9: 1); IH NMR (300MHz, CDCh) DH/ppm 2.81 (t, J=7.0, 
2H, POCH2CfuAr), 2.92 (d, 2JPH=21.0, 2H, ArCfuP), 3.47 (d, 3JpocH=11.0, 3H, 
OCH3), 4.01-4.14 (m, 2H, POCfuCH2Ar), 6.52 (d, J=8.0, 2H, C(2)H, C(6)H), 6.93 (dd, 
4JPH=2.5, J=8.0, C(3)H, C(5)H), 7.10 (d, J--7.0, 2H, ortho-ArH), 7.17 (t, IH, para-
ArH), 7.22 (t, J 7.0, 2H, meta-ArH); 13e NMR (75.4MHz, CDCh) Dc/ppm 3l.8 (d, 
Jcp=139.0, ArCH2P), 36.6 (POCH2CH2Ar), 52.3 (OCH3), 66.2 (POCH2CH2Ar), 115.7 
(C(2), C(6)), 120.7 (C(4)), 127.0 (para-ArC), 128.8, 129.5 (2 x ortho-ArC, 2 x meta-
ArC), 130.9 (C(3), C(5)), 137.0 (1 x quaternary, ArC), 145.2 (C(1)); 31 p NMR 
(121.4MHz, CDCh) Dp/ppm 29.3; Vmax (CHCh/cm- l ) 650(m), 729(m), 770(m), 771(m), 
1012(m), 1065(m, P-OR), 1095(m), 1271(s, P=O), 1382(m), 1459(m), 1517(w), 
1623(m), 3012(m), 3619(m, -NH2), 3665(m, -NH2); m/z (APCr+) 306 (1000/0, [M+Hr); 
HRMS found 306.1259, [M+Hr (C I6H21N03P) requires 306.1264. 
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Synthesis of [4-(4-Carboxy-l-0xobutyl)-Amino-Benzyl]-Phosphonic Acid Methyl 
Ester Phenethyl Ester (155). 
o o 
HO N 
H 
155 
Triethylamine (1.73ml, 12.4mmol) and glutaric anhydride (1.35g, 12mmol) were added 
to a stirred solution of (4-amino-benzyl) phosphonic acid methyl ester phenethyl ester 
160 (3g, 9.8mmol) in anhydrous DCM (50ml) under N2, and the reaction stirred at 
reflux for 12 hours. The solution was diluted with H20 (40ml) and adjusted to pH9 
using NaHC03. The layers were separated and the aqueous layer washed with DCM (2 
x 50ml). The pH of the aqueous solution was adjusted to 2 using aq. HCI (2M), and the 
product extracted with DCM (4 x 70ml). The organic layer was dried over Na2S04, and 
the solvent removed in vacua to afford 155 as a white gum (3.44g, 84%); IH NMR 
(300MHz, CDCh) DH/ppm 1.99 (m, 2H, H02CCH2CfuCH2C(O)NH), 2.38, 2.41 (2t, 
J=7.0, 4H, H02CCfuCH2CfuC(O)NH), 2.92 (t, J=7.0, 2H, POCH2CfuAr), 3.07 (d, 
2JPH=21.5, 2H, ArCfuP), 3.56 (d, 3JpocH=I1.0, 3H, OCIL), 4.18 (m, 2H, 
POCfuCH2Ar), 7.12 (d, J=8.0, 2H, C(3)H, C(5)H), 7.18 (d, J=7.0, 2H, artha-ArH), 
7.26 (t, J=7.0, IH, para-ArH), 7.31 (t, J=7.0, 2H, meta-ArH), 7.50 (d, J=8.0, 2H, 
C(2)H, C(6)H), 8.99 (s, IH, C(O)NH), 9.12 (s, br, C02H); l3C NMR (75.4MHz, 
CDCh) Dclppm 21.2 (H02CCH2CH2CH2C(O)NH), 31.7, 32.4 
(H02CCH2CH2CH2C(O)NH), 33.7 (POCH2CH2Ar), 36.9 (d, Jcp=139.0, ArCH2P), 53.3 
(OCH3), 67.4 (POCH2CH2Ar), 120.6 (C(2), C(6», 126.3, 126.4, 127.1, 128.9 (l x para-
ArC, 2 x artha-ArC, 2 x meta-ArC), 129.4 (C(3), C(5», 130.5, 137.5, 137.9 (3 x 
quaternary, ArC), 172.2 (C(O)NH), 176.8 (C02H); 31 p NMR (l21.4MHz, CDCh) 
Dp/ppm 29.5; Vmax (CHCh/cm- l ) 557(w), 650(m), 783(m), 908(m), 1018(m), 1060(m, P-
OR), 1139(w), 1178(w), 1251(s, P=O), 1307(w), 1380(m), 1412(m), 1457(m), 1517(s, 
C(O)NH), 1603(s), 1685(s, C=O), 1703(s, C=O), 2854(m, br, C02H), 2954(m, br, 
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C02H), 2995(m), 3156(m), 3307(m, C(O)NH), 3429(m, C(O)NH); mlz (APCI+) 420 
(80%, [M+Ht); HRMS found 420.1576, [M+Ht (C21H27N06P) requires 420.1543. 
Synthesis of [4-( 4-Carboxy-l-0xobutyl)-Amino-Benzyl]-Phosphonic Acid 
Phenethyl Ester (146). 
o 
HO 
o 
N 
H 
146 
A suspension of 155 (2.18g, 5mmol) in tert-butylamine (50ml) was heated at reflux for 
7 days. After this time, the excess tert-butylamine was removed in vacuo, and the 
residue dissolved in water and lypholised to yield a white solid. This was dissolved in 
MeOH (lOOmI) and stirred with cation exchange resin Amberlite IR-120 (plus) for 4 
hours. The resin was removed by filtration, and the solvent evaporated. The residue was 
suspended in aq. HCI (5N, 30ml) and stirred for 24 hours. The product was collected by 
filtration and dried in vacuo, to afford 146 as a white solid (1.42g, 67%); m.p. 139-
141°C; IH NMR (500MHz, D20) DH/ppm l.92 (m, 2H, H02CCH2CfuCH2C(O)NH), 
2.26 (t, J-7.5, 2H, H02CCH2CH2CfuC(O)NH), 2.42 (t, 1=7.5, 
H02CCfuCH2CH2C(O)NH), 2.85 (t, 1=6.5, 2H, POCH2CfuAr), 2.91 (d, 2JPH=20.5, 2H, 
ArCfuP), 4.10 (dt, 3JpOCH=6.5, J=6.5, 2H, POCfuCH2Ar), 7.14 (dd, 4JpOCH=3.0, 1=8.0, 
2H, C(3)H, C(5)H), 7.25 (d, J=7.0, 2H, ortho-ArH), 7.29 (t, J=7.5, IH,para-ArH), 7.36 
(t, J=7.5, 2H, meta-ArH), 7.45 (d, J=8.0, 2H, C(2)H, C(6)H); 13C NMR (75.4MHz, 
CD30D) Dc/ppm 22.5 (H02CCH2CH2CH2C(O)NH), 33.5 (H02CCH2CH2CH2C(O)NH), 
34.6 (H02CCH2CH2CH2C(O)NH), 35.3 (POCH2CH2Ar), 37.8 (d, 1cp=138.5, ArCH2P), 
67.8 (POCH2CH2Ar), 12l.6, 128.0, 129.3, 129.5, 129.9, 130.6 (9 x ArC), 13l.8, 139.1, 
139.4 (3 x quaternary, ArC), 174.1 (C(O)NH), 177.3 (C02H); 31p NMR (l21.4MHz, 
CD30D) Dp/ppm 27.2; Vmax (CHCh/cm-1) 494(m), 570(m), 615(m), 1009(m), 1092(s, P-
OR), 1217(s), 1259(s, P=O), 1312(w), 1410(m), 1516(m, C(O)NH), 1653(s, C=O), 
1698(s, C=O), 2886(m, br, C02 H), 2977(m, br, C02H), 3024(m), 3621 (m, C(O)NH), 
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3686(m, C(O)NH); m/z (FAB) 428 (76%, [M+Na]j, 406 (42%, [M+H]j; HRMS 
found 428.1239, [M+Nat (C2oH24N06PNa) requires 428.1225: Anal. Ca1cd. for 
C2oH24N06P: C, 59.25, H, 5.96, N, 3.46, P, 7.46%, Found: C, 59.53, H, 6.01, N. 3.56, P. 
8.01 %. 
2.1 Synthesis of the Ester Substrate. 
Synthesis of [4-(2,2,2-Trifluoro-Acetylamino)-Phenyl]-Acetic Acid (164)161. 
OH 
164 
4-Aminophenylacetic Acid 163 (lOg, 0.066mol) was dissolved in acetonitrile (90ml) 
and H20 (lOml) and cooled to O°C. Na2C03 (l3.87g, 0.132mol) was added, followed by 
the drop-wise addition of trifluoroacetic anhydride (28.03ml, 0.198mol). The reaction 
was allowed to warm to r.t., and then stirred vigorously for 1 hour. The acetonitrile was 
removed in vacuo, and the residue diluted with EtOAc (lOOml) and H20 (lOOml). The 
pH was adjusted to 2 using conc. HC!. The layers were separated, and the organic phase 
washed with aq. HCI (2M, 2 x 50ml), aq. NaCI (sat., 1 x 50ml), dried over Na2S04, and 
concentrated until a white precipitate appeared. The solid was collected by filtration to 
afford [4-(2,2,2-trifluoro-acetylamino )-phenyl]-acetic acid 164 as a white crystalline 
solid (9.4g, 58%); m.p. 183-185°C (lit. 175°CI61 ); 10 NMR (300MHz, CD30D) 
8H/ppm 3.60 (s, 2H, ArCfuC02H), 7.3 (d, J=8.5, 2H, C(3)H, C(5)H), 7.56 (d, J=8.5, 
2H, C(2)H, C(6)H); Be NMR (75.4MHz, CD30D) 8c1ppm 41.7 (ArCfuC02H), 116.0 
(l x quaternary, CF3C(O)NH), 122.6, 122.7 (C(2), C(6», 131.4, 131.5 (C(3), C(5», 
134.2, 136.9 (2 x quaternary, ArC), 157.4 (CF3C(O)NH), 175.8 (C02H); Vrnax (KBr/cm-
I) 671(m), 712(w), 794(w), 835(m), 1148(m, C-F), 1176(s, C-F), 1250(m), 1291(m), 
1346(m), 1421(s), 1543(s), 1598(m), 1700(s, C=O), 3290(s, C(O)NH); m/z (FAB) 258 
(l000/0, [M+Ht); HRMS found 248.0540, [M+Ht (CIOH9N03F3) requires 248.0535. 
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Synthesis of [4-(2,2,2-Trifluoro-Acetylamino)-Phenyl]-Acetyl Chloride (165)162, 
CI 
165 
To a stirred suspension of [4-(2,2,2-trifluoro-acetylamino )-phenyl]-acetic acid 164 (3g, 
0.012mol) in anhydrous DCM (80ml) under N2 was added oxalyl chloride (I.38ml, 
0.016mol) and DMF (40IlI, trace). The suspension was stirred for 3 hours, after which 
time it had become a homogenous solution. The solvent and excess reagents were 
removed in vacuo to afford [4-(2,2,2-trifluoro-acetylamino)-phenyl]-acetyl chloride 165 
as an off-white solid (3.15g, 99%); IH NMR (400MHz, CD3CN) 8H/ppm 4.28 (s, 2H, 
ArCfuCOCI), 7.33 (d, J-8.5, 2H, C(3)H, C(5)H), 7.62 (d, J=8.5, 2H, C(2)H, C(6)H); 
13C NMR (100.6MHz, CD3CN) 8c1ppm 52.7 (ArCH2COC1), 118.3 (C(2), C(6)), 122.3 
(1 x quaternary, CF3C(O)NH), 130.8 (1 x quaternary, C(4)), 13l.4 (C(3), C(5)), 136.7 
(1 x quaternary, C(1)), 157.3 (CF3C(O)NH), 173.5 (COCI); Vrnax (KBr/cm-1) 509(m), 
561(m), 599(s), 636(m), 710(s), 800(m), 1002(s), 1151(s), 1203(s), 1 247(m), 1285(m), 
1404(m), 1502(m), 1554(m, C(O)NH), 1614(m), 1704(s, C=O), 1793(s, C=O), 
3102(m), 3147(m, C(O)NH), 3214(m, C(O)NH), 3297(m, C(O)NH); m/z (FAB) 265, 
267 (30%, [Mt). 
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Synthesis of [4-(2,2,2-Trifluoro-Acetylamino)-Phenyl]-Acetic Acid Phenethyl Ester 
(166). 
o 
166 
A solution of [4-(2,2,2-trifluoro-acetylamino )-phenyl]-acetyl chloride 165 (513mg, 
1.93mmoI) in anhydrous THF (lOml) was added slowly to a stirred solution of 2-
phenylethanol (346JlI, 2.9mmoI) and triethylamine (807JlI, 5.8mmol) in anhydrous THF 
(20ml) under N2. The reaction was stirred for 12 hours. Concentration in vacuo, gave a 
white solid which was dissolved in EtOAc (lOOmI), then washed with aq. HCI (0.5M, 2 
x 50mI), aq. NaHC03 (sat., 2 x 50ml), aq. NaCI (sat., 1 x 50ml), and dried over Na2S04. 
The solvent was removed in vacuo to yield the crude product as an orange oil. 
Purification by flash chromatography (Si02; DCM) afforded 166 as a white solid 
(430mg, 63%); m.p. 96-98°C; Rr 0.37 (Si02; DCM); IH NMR (300MHz, CDCh) 
bH/ppm 2.81 (t, J=7.0, 2H, C02CH2CfuAr), 3.48 (s, 2H, ArCfuC02R), 4.20 (t, J=7.0, 
2H, C02CfuCH2Ar), 7.12 (d, J=8.5, 2H, C(3)H, C(5)H), 7.15-7.22 (m, 5H, 5 x ArH), 
7.37 (d, J=8.5, 2H, C(2)H, C(6)H), 8.09 (s, IH, CF3C(O)NH); 13e NMR (75.4MHz, 
CDCh) bclppm 35.4 (C02CH2CH2Ar), 41.2 (ArCH2C02R), 65.9 (C0 2CH2CH2Ar), 
120.9, 121.0 (C(2), C(6)), 124.5 (l x quaternary, CF3C(O)NH), 127.0 (para-ArC), 
128.8, 128.9, 129.3, 129.4 (2 x ortho ArC, 2 x meta ArC), 130.6, 130.7 (C(3), C(5)), 
132.5, 134.5, 137.9 (3 x quaternary, ArC) 157.4 (CF3C(O)NH), 171.7 (C02H); Vmax 
(CHCh/cm-J) 650(m), 708(s), 752(s), 767(m), 1098(m, C-OR), 1250(m, C-OR), 
1278(m), 1287(m), 1342(w), 1380(m), 1465(m), 1543(m), 1605(m), 1744(s, C=O), 
1792(s, C=O), 2900(m), 2959(m), 2978(m), 3149(m), 3422(m, C(O)NH), 3617(m, 
C(O)NH); m/z (FAB) 352 (40%, [M+Ht), 374 (70%, [M+Nat); HRMS found 
374.0969, [M+Nat (CJSHJ6F3N03Na) requires 374.0980. 
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Synthesis of 4-Amino-Phenyl Acetic Acid Phenethyl Ester (167). 
o 
167 
Sodium borohydride (564mg, 15mmol) was added to a stirred solution of 166 (2.62g, 
7.5mmol) in anhydrous MeOH (50ml), and the solution stirred at r.t. for 14 hours. The 
solvent was removed in vacuo, and the residue diluted with EtOAc (200ml), and aq. 
NH40H (10%, 200ml). The layers were separated and the aqueous layer washed with 
EtOAc (2 x 60ml). The organic layers were combined, and the product extracted into 
aq. HCI (2M, 3 x 75ml). The pH was adjusted to 9 using NaHC03, and the product 
extracted into EtOAc (3 x 75ml), dried over Na2S04, and the solvent removed in vacuo 
to afford a yellow oil. Purification by flash chromatography (Si02; DCM:EtOAc; 11: 1) 
afforded 167 as a yellow oil (0.75g, 400/0); Rr 0.4 (Si02; DCM:EtOAc; 11:1); IH NMR 
(300MHz, CDCb) OR/ppm 2.92 (t, J=7.0, 2H, C02CH2CfuAr), 3.49 (s, 2H, 
ArCfuC02R), 4.31 (t, J=7.0, 2H, C02CfuCH2Ar), 6.60, (d, J=8.5, 2H, C(2)H, C(6)H), 
7.03 (d, J:--8.5, 2H, C(3)H, C(5)H), 7.08 (1H, m,para-ArH), 7.18 (d, J=7.5, 2 x ortho-
ArH) , 7.28 (2H, m, 2 x meta-ArH); 13e NMR (75.4MHz, CDCb) Dc/ppm 34.7 
(C02CH2CH2Ar), 40.2 (ArCH2C02R), 64.9 (C02CH2CH2Ar), 114.9 (C(2), C(6)), 123.3 
(1 x quaternary, C(4)), 126.2 (para-ArC), 128.2, 128.7 ( 2 x ortho-ArC, 2 x meta-ArC), 
129.8, 129.9 (C(3), C(5)) 137.6 (1 x quaternary ArC), 145.4 (1 x quaternary, C(1)), 
171.8 (C02R); Vmax (thin film/em-i) 499(w), 519(w), 700(m), 749(m), 833(m), 
1003(m), 1150(s, C-OR), 1254(m, C-OR), 1435(w), 1453(w), 1517(m), 1626(m), 
1725(s, C=O), 2955(m), 3028(w), 3060(w), 3350(w), 3371(s, -NH2) , 3453(s, -NH2); 
m/z (APCI+) 256.0 (1000/0, [M+Ht). 
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Synthesis of Benzene Acetic Acid 4-[(4-Carboxy-l-0xobutyl)amino]-Phenethyl 
Ester (145, Ester Substrate). 
o o 
HO N 
H 
145 
o 
Glutaric anhydride (0.376g, 3.3mmol) was added to a stirred solution of triethylamine 
(483J.lI, 3.5mmol) and 4-amino-phenyl acetic acid phenethyl ester 167 (0.7g, 2.8mmol) 
in anhydrous DCM (25ml) under N2. The solution was heated at reflux for 16 hours. 
After cooling the solvent was removed in vacuo, and the residue dissolved in EtOAc 
(50ml). The solution was washed with aq. HCI (2M, 1 x 50ml), and aq. NaCI (sat., 1 x 
50ml), dried over Na2S04, and the solvent removed in vacuo to afford a beige solid as 
the crude product. The product was recrystallised from H20/CH3CN to yield 145 as a 
white solid (O.99g, 990/0); m.p. I05-107°C; Rr 0.15 (Si02; DCM:EtOAc; 11:1); IH 
NMR (400MHz, CDCh) DH/ppm 2.03 (m, 2H, H02CCH2CfuCH2C(O)NH), 2.43 (t 
J=7.5, 2H, H02CCH2CH2CfuC(O)NH), 2.47 (t, J=7.5, 2H, 
H02CCfuCH2CH2C(O)NH), 2.95 (t, J=7.0, 2H, C02CH2CfuAr) 3.59 (s, 2H, 
ArCfuC02R), 4.33 (t, J=7.0, 2H, C02CfuCH2Ar), 7.16 (d, J=8.5, C(2)H, C(6)H), 7.18 
(d, J=7.0, 2H, 2 x ortho-ArH), 7.25 (IH, m, para-ArH), 7.28 (2H, m, 2 x meta-ArH), 
7.46 (d, J--8.5, C(3)H, C(5)H), 8.00 (s, IH, C(O)NH); 13C NMR (lOO.6MHz, CDCh) 
Dclppm 20.5 (H02CCH2CH2CH2C(O)NH), 32.9 (H02CCH2CH2CH2C(O)NH), 34.9 
(C02CH2CH2Ar), 36.0 (H02CCH2CH2CH2C(O)NH), 40.7 (ArCH2C02R), 65.4 
(C02CH2CH2Ar), 120.1 (C(2), C(6)), 126.5 (para-ArC), 128.5, 128.9 (2 x ortho-ArC, 2 
x meta-ArC), 129.8 (C(3), C(5)), 130.6, 136.8, 137.5 (3 x quaternary, ArC), 171.1 
(C02R), 171.8 (gO)NH), 177.9 (C02H); Vrnax (nujol/cm-l) 794(w), 941(w), 1 I 66(m), 
1224(m), 1313(w), 1348(w), 1377(s), 1411(m), 1460(s, nujol), 1533(s, C(O)NH), 
1598(m), 1654(s, C=O), 1691(s, C=O), 1730(s, C=O), 2677(m, br, C02H), 2870(m, be 
C02H), 2852(s, nujol), 2923(s, nujol), 3319(m, C(O)NH); m/z (FAB) 392 (75%, 
[M+Nar), 370 (520/0, [M+Hr), 286 (50%), 255 (33%); HRMS found 370.1647. 
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[M+Hr (C21H2SNOs) requires 370.1654; Anal. Calcd. for C21H24NOs: C, 68.28; H. 
6.28, N 3.790/0, Found: C, 68.19; H, 6.22; N, 3.72%. 
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3. Binding Studies - Diffusion Measurements by NMR, and Molecular 
Modelling. 
3.0 Measurement of Diffusion Coefficients of Peptides and TSA (146) 
Using Pulsed Field Gradient (NMR) Techniques. 
The maximum field strength of the gradient accessory was determined to be 50Gcm- 1 
according to standard procedure163 • 
3mM solutions of each dipeptide (168-176, Chapter 2.4) in D20 were prepared. The pD 
was adjusted to 7 using NaOD and DCl. A 30mM solution of TSA 146 in D20 at pD7 
was prepared in the same way. Sample mixtures containing one peptide and the TSA 
146 were also made up so that the concentration of the peptide was 3mM, and TSA 
30mM, and the pD adjusted to 7 using the method above. 
Diffusion coefficients of the peptides and the TSA, both in the pure samples, and the 
mixtures were measured by PFG-NMR spectroscopy using the bipolar pulse pair 
longnitudinal encode-decode (BPP-LED) sequence 125. This pulse sequence contains a 
delay T e (11.2ms in our experiments) at the end of the experiment which avoids special 
artefacts arising from residual eddy currents. 
In these experiments, the attenuation of the NMR resonance depends on gradient areas 
as shown in Equation 2: 
Equation 2 
Where 10 is the intensity of the resonance in the NMR spectrum in the absence of 
gradient pulses, y is the gyromagnetic ratio, ~ is the diffusion delay time, g and 8 are the 
amplitude and duration of the bipolar gradient pulse pair, D is the diffusion coefficient, 
and 't is the delay between the bipolar gradient pulse pair. 
In each experiment, a data set of 32 separate BPP-LED spectra was acquired as a 
function of gradient amplitude which ranged from 5-95% (100% =50Gcm- 1). The 
spacing of the gradient amplitudes was incremented according to a "squared scale" such 
that spacing between the squared gradient is equal. The following variables were kept 
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constant: 8= 1.2ms, t=O 1 ms, ~=200ms. All of the diffusion measurements were 
performed at 298K. In all experiments, the HOD resonance was suppressed by 
application of a selective saturation pulse to improve the reliability of the measurement 
of a-proton intensities and to increase the value of the receiver gain which could be 
used in the acquisition of the FID. 
Data processing was performed on standard TJ/T2 software under XwinNMR which 
utilises a standard simplex algorithm to fit data to Equation 2. The results are shown in 
Results and Discussion. The error value for the experiments is < ±0.1 x 10- lOm2/s. 
As a control, we always checked the diffusion coefficient of H20 which should have a 
value of2.3 x 10-9 m2/s at 298KJ56,J57. In our experiments a value between 2.2 and 2.4 x 
1 0-9m2 Is was always observed, even when water suppression was performed on the 
residual water peak. 
3.1 Determination of the Binding Constant Ka for the complex between 
TSA 146 and Arginine-Arginine. 
11 Samples were prepared all with a ImM concentration of arginine-arginine 168, and 
with a TSA 146 concentration varying from 0-40mM. The diffusion coefficients of the 
TSA 146 and the peptide 168 were measured in all the samples using the method 
described above (3.0). The Associate 1.6 programme, which employs the non-linear 
least squares Levenberg-Marquardt method to fit parameters to equilibrium 
complexation models, was used to determine the binding constant Ka J29,130. The results 
are shown in Chapter 2.4 
3.2 Determination of Internuclear Distances in the TSA Using 2D-
NOESY Experiments. 
A 30mM solution of TSA 146 in D20 was prepared. The pD was adjusted to 7 using 
DCI and NaOD. 2D-NOESY experiments were carried out at 298K using 256 
experiments in F 1 Dimension, and mixing delays (tm) varying from 100-600ms. From 
these spectra integral volume intensities of all of the cross peaks were measured using 
standard XwinNMR routines. Based on the fact that the distance for ortho protons of a 
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phenyl group is normally 2.sA (rref), Equation S was used to calculate the internuclear 
distance (ris) between two nuclei a and b: 
I 
_ [intensity ab ]-6 
rab - rref. . 
mtenSIty ref Equation 8 
where intensityab is the cross peak intensity of the two spins to be measured at time t, 
intensitYref is the reference cross peak intensity, rref is the reference distance and rab is the 
unknown distance between nuclei a and b. The results are as shown in Chapter 2.4, 
Table 3. 
The accuracy of this method is reasonably reliable because it relies on the sixth root of 
NOE intensities, thus large errors in intensity measurements have a small effect on the 
derived internuclear seperation136. 
3.3 Molecular Modelling. 
Arginine-arginine 168 was built using the Biopolymer module of Sybyl with extended 
conformations. [4-( 4-Carboxy-l-oxobutyl)-amino-benzyl]-phosphonic acid phenethyl 
ester (TSA) 146 was sketched in Sybyl131 and converted into 3D using Concord. Both 
molecules were minimised using the Tripos force field with Gasteiger-Huckel charges 
and Powell minimiser to an RMS gradient of 0.005kcall A, Non-bonded cut-offs were 
applied at sA and a distance dependant dielectric of SO was used to crudely approximate 
the electrostatic screening due to solvation. Both molecules were then subjected to a 
conformational search using the Random search facility of Sybyl for 5000 iterations 
using the following parameters: Energy cut-off 500kcal/mol; Convergence threshold 
0.05; RMS threshold 0.75 A; Minimum hits 200. Each conformation was minimised for 
100 steps or to gradient less than 0.05 kcall A using the parameters described above. 
The geometrical constraints measured by NOESY NMR were applied to the database of 
conformations generated for the TSA. Four conformations fitted the constraints, and of 
these two were discarded due to distortions of one of the phenyl rings. The distance 
between the carboxylate and phosphonate groups on the remaining two conformers was 
measured and found to be 12-14 A. 
For the Arg-Arg 168 to complex as a bidentate ligand to the TSA 146 the distance 
between either the two guanidine groups, or one guanidine group and the tenninal 
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ammo group had to be similar to this distance. This constraint was applied to the 
database of conformations generated for Arg-Arg and gave ten conformations to dock 
against the TSA. 
All combinations of the above conformations of both molecules were fitted together 
using the DOCK command until the electrostatic interactions were maximised, and the 
steric energy minimised. The complex was then minimised using the parameters above. 
The energies of both the complex (Etotal), and the individual components were 
measured, and used to calculate the interaction energy of the complex (Ei) using 
Equation 9: 
Equation 9 
Where Epep is the energy of the peptide, and ETSA is the energy of the TSA. The results 
are shown in Chapter 2.4, Tables 4-6. 
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4. Synthesis of 'Tripeptide Binding Unit'. 
4.0 Synthesis of 6-(9H-Fluoren-9-ylmethoxycarbonylamino)-Hexanoic 
Acid (182). 
7 
HO 
o 
2 
182 
A stirred solution of 6-aminocaproic acid 179 (3g, 23mmol) in 10% aq. Na2C03 
solution (6.09g, S7mmol in 60ml H20) was cooled to O°C. To the cooled solution was 
added 9-fluorenylmethyl chloroformate (S.92g, 23mmol) in dioxane (30ml). The 
solution was stirred for 10 mins., after which time a white precipitate had formed, and 
then allowed to warm to r.t. and stirred for 4 hours. The mixture was diluted with H20 
(SOOml), and washed with Et20 (2 x 100mI). The aqueous layer was adjusted to pH 1 
using conc. HCI, and a white precipitate formed, which was extracted into EtOAc (3 x 
200mI). The organic layers were combined and dried over Na2S04, and the solvent 
removed in vacuo to yield the crude product as a white solid. Purification by flash 
chromatography (Si02; EtOAc) yielded 6-(9H -fluoren-9-ylmethoxycarbonylamino)-
hexanoic acid 182 as a white solid (6.98g, 86%); m.p. 118-120°C; Rr 0.S8 (Si02; 
EtOAc); IH NMR (SOOMHz, CDCh) DH/ppm 1.37 (m, 2H, H02CCH2CH2CfuCH2), 
LSI (m, 2H, H02CCH2CH2CH2Cfu), 1.67 (m, 2H, H02CCH2CfuCH2CH2), 2.34 (t, 
J=7.0, CfuC02H), 3.04 (br, s, minor rotamer, CfuNHC(O)), 3.17 (q, J=6.5, major 
rotamer, CfuNHC(O)), 4.19 (t, J=6.S, IH, C(9)H), 4.38 (d, J=6.S, major rotamer, 
C(9)HCfuOC(O)), 4.4S (br, s, minor rotamer, C(9)HCfuOC(O)), 4.77 (be s, lH, 
CH2NHC(O)), 7.29 (t, J=7.S, 2H, C(2)H, C(7)H), 7.38 (t, J=7.S, 2H, C(3)H, C(6)H), 
7.S7 (d, J=7.S, 2H, C(1)H, C(8)H), 7.70 (d, J=7.S, 2H, C(4)H, C(S)H); 13e NMR 
(12S.7MHz, CDCh) Dc/ppm 24.2, 26.1, 29.S (3 x CH2, H02CCH2CH2CH2CH2), 33.8 
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(CH2NHC(O)), 40.7 (H02CCH2CH2CH2CH2), 47.2 (C(9)H), 66.9 (C(9)HCH20C(O)). 
119.9, 125.0, 127.0, 127.6 (C(1), C(2), C(3), C(4), C(5), C(6), C(7), C(8)), 141.3 (C(1 '). 
C(8')), 143.9 (C(4'), C(5')), 156.4 (NHC(O)O), 179.0 (C02H); Vrnax (nujoVcm-1) 732(s). 
779(m),949(m), 1002(m), 1031(m), 1078(w), 1102(m), 1131(m), 1249(s), 1260(m). 
1296(m), 1343(m), 1372(m), 1454(s, nujol), 1525(s, C=O), 1684(s, C=O), 1707(s, 
C=O), 2660(m, C02H, str) , 2719(m, C02H, str), 2848(s, CH2, nujol), 2919(s, CH2, 
nujol), 3342(s, OC(O)NH); m/z (F AB) 376 (26%, [M+Nat), 354 (16%, [M+Ht). 179 
(100%); HRMS found 376.1525, [M+Nat (C2\H23N04Na) requires 376.1517; Anal. 
Calcd. for C2\H23N04 : C, 71.37; H, 6.56; N, 3.96%, Found: C, 71.39; H, 6.57; N, 
3.88%. 
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4.1 Synthesis of 6-(Fmoc-Arg(PbO-Arg(PbO)-Amino Hexanoic Acid 
(186). 
Fmoc-CA-OH + 2-Cl-Trt---<::> 
181 
DIPEA, DCM 
Fmoc-CA-O---<::> 
20% Piperidine/DMF 
FmocArg(Pbf)-OH, PyBOP, 
HOBt, DIPEA, DMF 
Fmoc-Arg(Pbf)-CA-o--e::::> 
200/0 Piperidine/DMF 
H2N -Arg(Pbf)-CA-O--C:::> 
FmocArg(Pbf)-OH, PyBOP, 
HOBt, DIPEA, DMF 
Fmoc-Arg(Pbf)-Arg(Pbf)-CA-o---C::> 
2:2:6 
AcOH:MeOH:DCM 
Fmoc-Arg(Pbf)-Arg(Pbf)-CA-OH 
c::> = 2-CITrityl Resin 
CA = -HN(CH2)sC02" 
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Coupling of 6-(9H-Fluoren-9-ylmethoxycarbonylamino)-Hexanoic Acid to 2-
Chlorotrityl Resin. 
DIPEA (1.81ml, 10Ammol) was added to a solution of 6-(9H-Fluoren-9-
ylmethoxycarbonylamino)-hexanoic acid 182 (0.9Ig, 2.6mmol) in anhydrous OCM 
(20ml) under N2, and the solution stirred for 10mins. The solution was added to 2-
chlorotrityl resin 181 (substitution 1.08mmol/g) under N2, and the mixture agitated by 
sonication at r.t. for 3 hours. After this time the resin was filtered, and washed with 
MeOH (3 x SOml), MeOH:DCM:DIPEA (2:17:1,3 x SOml), DCM (3 x 50ml), OMF (3 
x SOml) and DCM (3 x SOml), and dried under vacuum (2.91g). 
Test For Level of Fmoc Substitution. 
Two Samples of dry resin (0.S-2mg) were weighed into 10mm silica UV cells and 
dissolved in 20% Piperidine/DMF (3ml). The samples were agitated for 10mins. using a 
Pasteur pipette. The UV absorbance at 290nm for each sample was recorded, and the 
loading calculated using Equation 11: 
Loading (mmol/g) = (Abs/mass of sample) x 1.75 Equation 11 
The loading was found to be 0.88mmol/g. This value was used to calculate no. of mols. 
of reagents to be used in subsequent couplings. 
Fmoc Deprotection. 
The resin (2.9Ig) was suspended in 20% piperidinelDMF (2Sml), and sonicated at r.t. 
for 3 hours. The resin was filtered, and washed with DMF (S x 60ml), and OCM (5 x 
SOml), and dried under vacuum (1.902g). 
1 st Coupling of Fmoc-Arg(Pbt)-OH to Resin. 
Fmoc-Arg(Pbf)-OH (3.2Sg, Smmol), PyBOP (2.6Ig, 5mmol), and HOBt (677mg, 
Smmol) were dissolved in anhydrous OMF (40ml) under N2• DIPEA (1.75ml, 10mmol) 
was added, and the solution added immediately to the resin (1.9g, 1.67mmol). The 
suspension was agitated by sonication at r.t. for 4 hours. After this time the Kaiser test 
indicated complete reaction of the resin bound free amine. The resin was filtered, and 
washed with DMF (4 x 100ml), OCM (3 x 100mI), DMF (2 x 50ml), and OCM (2 x 
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100ml). The reSIn was dried under vacuum (2.734g). The test for level of Fmoc 
substitution was perfonned using the above method, and found to be 0.6mmol/g. 
Fmoc Deprotection. 
The resin (2.7g) was suspended in 20% piperidine/DMF (2Sml), and sonicated at r.t. for 
3 hours. The resin was filtered, and washed with DMF (4 x 7Sml), and DCM (4 x 
7Sml), and dried under vacuum (2.00g) 
2nd Coupling of Fmoc-Arg(Pbt)-OH to Resin. 
Fmoc-Arg(Pbf)-OH (1.74g, 2.7mmol), PyBOP (lAg, 2.7mmol), and HOBt (362mg, 
2.7mmol) were dissolved in anhydrous DMF (30ml) under N2. DIPEA (0.9Sml, 
SAmmol) was added and the solution added immediately to the resin (lg, 0.7mmol) 
under N2. The suspension was sonicated at r.t. for 4 hours. After this time the Kaiser test 
indicated complete reaction of the resin bound amine. The resin was filtered, and 
washed with DMF (4 x 7Sml), DCM (3 x 7Sml), DMF (2 x SOml), and DCM (2 x 
7Sml). The resin was dried under vacuum (lAg). The test for level of Fmoc substitution 
was perfonned using the above method, and found to be 0.3mmol/g. 
Cleavage of Peptide from Resin. 
The resin (lAg) was sonicated in a solution of AcOH:trifluoroethanol:DCM (2:2:6, 
20ml) for 3 hours. The resin was filtered, and washed with the above solution (1 x 
SOml), DCM (l x SOml), MeOH (l x 30ml), and DCM (l x SOml). The solution was 
diluted with hexane (2S0ml), and the solvent removed in vacuo to afford a cream 
coloured solid. Flash chromatography (Si02; EtOAc:MeOH; 8S: IS) yielded 186 as a 
cream solid (0.S8g). 
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Analytical data for 6- (Fmoc-Arg(Pbf)-Arg(Pbf)-)aminohexanoic acid 186 (Fmoc-
Arg(Pbf)Arg(Pbf)CA-OH). 
Numbering and lettering is for analytical purposes only. 
c o 
o ~ 
, a 
,S", 
o NH 
HN~ 
NH 
0--..... c 
o NH 2 ~ 
HO 
H 
N al 
H H b 
NyN,,- a ~ e 
IS", f 
NH 0 0 o 
186 
m.p. l35-137°C; Rr 0.55 (Si02; EtOAc: MeOH; 80:20); IH NMR (500MHz, CD30D) 
8H/ppm 1.36-1.56 (m, 14H, H02CCH2CfuCfuCfu, 2 x (CfuCfuCH2NH(=NH»), 1.41 
(s, 12H, 2 x(-CH2C(CH3)20-», 2.04, 2.05 (2s, 2 rotamers, 6H, 2 x (C(e)Cfu», 2.22 (t, 
J=7.0, 2H, H02CCfu), 2.49, 2.50 (2s, 2 rotamers, 6H, 2 x (C(f)CH3», 2.55, 2.56 (2s, 2 
rotamers, 6H, 2 x (C(b)CH3», 2.94 (d, J=4.5, 4H, 2 x (-CfuC(CH3hO-», 3.14 (m, 6H, 
CfuNHC(O), 2 x (CH2NH(=NH»), 4.05 (m, IH, C(u2)H), 4.18 (t, J=7.0, 2H, C(9)H), 
4.29 (dd, J=5.5, 9.0, IH, C(ul)H), 4.40 (d, J=7.0, 2H, C(9)HCfu), 7.26 (t, J=7.5, 2H, 
C(2)H, C(7)H), 7.34 (t, J=7.5, 2H, C(3)H, C(6)H), 7.60 (d, br, J=7.5, C(I)H, C(8)H), 
7.75 (d, J=7.5, 2H, C(4)H, C(5)H); l3C NMR (l25.7MHz, CD30D) 8c/ppm 12.5 (2 x 
C(e)CH3), 19.4, 19.6 (2 x C(b)CH3, 2 x C(f)CH3), 26.0, 27.5, 28.5, 29.9 
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(H02CCH2CH2CH2CH2. 2 x (CH2CH2CH2NH(=NH»), 36.1 (H02CCH2), 40.2, 41.4 
(CH2NHC(O), 2 x (CH2NH(=NH»), 47.4 (2 x(-CH2C(CH3)20-», 49.5 (C(9)), 54.3 
(C(a1», 56.3 (C(a2», 68.3 (C(9)HCH2), 87.6 (2 x(-CH2C(CH3hO-»), 118.4 (2 x C(e)), 
120.9 (C(4), C(5», 126.1 (C(1), C(8», 128.1 (C(2), C(7», 128.7 (C(3), C(6», 133.5 (2 x 
C(b), 2 x C(f), 134.4 (2 x C(a», 139.4 (C(4'), C(5'», 142.5 (C(1 '), C(8'»), 145.2 (2 x 
C(c», 158.1 (2 x C(d», 158.5, 159.8, (NHC(O)O, 2 x (NH(C=N»)), 173.6, 174.4, 174.6 
(C02H, 2 x (C(O)NH»); Vmax (nujol/cm-1) 640(w), 663(w), 721(m), 759(m), 783(m), 
806(m), 852(m), 968(w), 991(w), 1087(s), 1153(s, -S02-N), 1242(s), 1299(m), 1377(s, -
S02-N), 1458(s), 1539(s, C(O)NH), 1543(s, C(O)NH), 1620(s, C=O), 1675(s, C=O), 
1712(s, C=O), 2677(m, C02H), 2723(m, C02H), 2854(s, nujol) 2923(s, nujol), 3163(m, 
C(O)NH), 3317(s, C(O)NH), 3433(m, C(O)NH); m/z (FAB) 1193 (100%, [M+Nat), 
1170 (600/0, [M+Ht); HRMS found 1192.5187, [M+Nat (Cs9H79012N9S2Na) requires 
1192.5160. 
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5. Synthesis of Polymers. 
General: The polymer used was polyallylamine hydrochloride mw 70,000. The 
molecule weight of the monomer is 93, and number of mols. refers to the number of 
monomer equivalents in the polymer. 
For spectral editing purposes we have used PFG BPP-LED NMR when analysing 
polymers. This is based on the fact that translational diffusion rates in solution for high 
and low molecular weights are significantly different (x 1 00). Hence at high gradient 
strength (50%, 25Gcm- l ) signals corresponding to low molecular weight species will be 
suppressed, and thus the signals of the polymer observed more clearly. From 
experiments with varying gradient strengths we found that 15-20Gcm-1 was sufficient 
for suppression of peaks corresponding to species of molecular weight < 500amu. 
5.0 Synthesis of Fmoc Protected Lysine (194). 
Synthesis of 9-Fluorenylmethyl-Succinimidyl-Carbonate (Fmoc-OSu, 191)146. 
2 
3 
0 
o~ ___ N 
0 
0 
6 7 
191 
Triethylamine (2.65ml, 0.019mol) was added dropwise to a stirred solution of 9-
fluorenylmethyl chloroformate (5g, 0.019mol) and N-hydroxysuccinimide (2.45g, 
0.021 mol) in dioxane (40ml) at O°C. A white precipitate formed. The mixture was 
allowed to warm to r.t. and stirred for 1 hour. The white precipitate was removed by 
filtration, and the solvent removed in vacuo to yield a white solid. The solid was 
triturated with PE 30-40 (2 x 20ml) and dried under vacuum to yield 191 as a white 
solid (5.75g, 90%); m.p. 125-128°C (lit. 148-150°C I46); IH NMR (500MHz. 
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CDCh) 8H/ppm 2.81 (s, 4H, C(O)CfuCfuC(O)N), 4.33 (t, J=7.5, IH, C(9)H), 4.55 (d, 
J=7.5, 2H, C(9)HCfu), 7.33 (dd, J=7.5, 7.5, 2H, C(2)H, C(7)H), 7.42 (dd, J=7.5, 7.5 
2H, C(3)H, C(6)H), 7.61 (d, J=7.5, 2H, C(l)H, C(8)H), 7.76 (d, J=7.5, 2H, C(4)H, 
C(5)H); 13e NMR (75.4MHz, CDCh) 8c1ppm 25.7, 25.8 (C(O)CH2CH2C(O)N), 46.8 
(C(9)HCH2), 73.2 (C(9)HCH2), 120.1, 120.5 (C(4), C(5», 125.6 (C(l), C(8», 127.5, 
127.8 (C(2), C(7», 128.6, 129.2 (C(3), C(6», 141.7, 142.9 (C(l '), C(4'), C(5'), C(8'»), 
151.9 (OC(O)O), 169.1, 172.3 (2 x NC(O»; Vrnax (nujol/cm-l) 709(w), 731(m), 756(m), 
935(w), 950(m), 989(m), 1074(w), 1157(s), 1201(m), 1230(m), 1263(m), 1377(m), 
1461(s, nujol), 1714.6(s), 1737.7(s, C=O), 1784.0(s, C=O), 1814.9(m), 2339.5(m), 
2678.9(m), 2852.5(s, CH2, nujol), 2922.0 (s, CH2, nujol); m/z (FAB) 470 (100%), 379 
(360/0),337 (34%, [Mt); HRMS found 337.0950, [Mt (CI 9H1SOsN) requires 337.0938. 
Synthesis of 2,6-bis-(9-H-Fluoren-9-ylmethoxycarbonylamino )-Hexanoic Acid 
(FmocLys(Fmoc)OH, 194)164. 
7 
5 6 
194 
Lysine.HCI (1.35g, 7.4mmol) was dissolved in aq. Na2C03 solution (9%. 2.36g, 
22mmol in 26ml). The solution was cooled to O°C, and to it added Fmoc-OSu 191 (5g. 
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15mmol) in dioxane (30ml). The solution was allowed to wann to r.t. and stirred for 1 
hour. After this time a white precipitate had fonned. The mixture was diluted with H20 
(400ml), and washed with EhO (1 x 100ml), and EtOAc (1 x 100ml). The pH of the 
aqueous layer was adjusted to 1 using conc. HCI. A white precipitate fonned which was 
extracted into CHCh (3 x 150ml). The organic layers were combined, dried over 
Na2S04, and the solvent removed in vacuo to yield a cream oil, which upon cooling 
solidified. The solid was suspended in water, stirred for 10 hours, and filtered to yield 
194 as a white solid (4.03g, 71 %); m.p. 118°C; Rr 0.47 (Si02; EtOAc:MeOH; 8:2); 10 
NMR (CDCh, 500MHz) DR/ppm 1.23-1.72 (m, 6H, CfuCfuCfuCH(C02H)NH), 3.55 
(m, br, 2H, CfuNHC(O)), 4.15 (s, br, 2H, C(9)H), 4.33 (m, 4H, C(9)HCfu), 4.44 (ru, 
1H, C(a)H), 4.96 (s, br, 2H, 2 x NH), 7.24 (t, J=7.5, 4H, C(3)H, C(6)H), 7.33 (1, J=7.5, 
4H, C(2)H, C(7)H), 7.54 (d, J=7.5, 4H, C(1)H, C(8)H), 7.70 (d, J=7.5, 4H, C(4)H, 
C(5)H); 13e NMR (CDCh, 125.7MHz) Dc/ppm 22.2 (CH2CH2C(u)), 29.2 
(CH2CH2NHC(O)O), 31.7 (CH2C(a)), 40.4 (CH2NHC(O)O), 47.1 (2 x C(9)), 53.6 
(C(a)), 66.8 (2 x C(9)HCH2), 119.9 (C(4), C(5)), 124.8, 124.9 (C(1), C(8)), 126.5 (C(2), 
C(7)), 127.6 (C(3), C(6)), 141.2, 143.6 (C(1'), C(4'), C(5'), C(8')), 156.3, 156.7 (2 x 
OC(O)NH), 175.7 (C02H); Vrnax (nujol/cm-1) 732(m), 757(m), 1038(m), 1083(m), 
1103(m), 1148(m), 1234(m), 1264(s), 1339(m), 1374(m), 1454(s, nujol), 1535(s, 
OC(O)NH), 1655(m), 1690(s, C=O), 1725(s, C=O), 2675(m, C02H), 2725(m, C02H), 
2845(s, nujol), 2925(s, nujol), 3066(m, OC(O)NH), 3317(s, OC(O)NH); m/z (FAB) 613 
(1000/0, [M+Nat), 591 (42%, [M+Ht); HRMS found 591.2510, [M+Ht (C36H3SN206) 
requires 591.2495. 
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5.1 Synthesis of Polymer containing Benzoic Acid (201). 
KOH, MeOH 
n n 
EDC, NHS 
OH EtOH 
n 
HN 
201 
Polyallylamine hydrochloride (200mg, 2. 14mmol) was stirred with potassium 
hydroxide (1 OOmg, 2.2mmol) in MeOH (30ml) for 15 hours. The solvent was removed 
in vacuo, and the residue taken up in EtOH (30ml). A white solid (KC1) did not 
dissolve. The solution was filtered, and concentrated to a volume of 10ml in vacuo, to 
yield a solution of free polyallylamine 134 in EtOH. 
Benzoic Acid (643mg, 5.3mmol), N-hydroxysuccinimide (848mg, 7.4mmol) and EDC 
(1.2g, 6.3mmol) were dissolved in EtOH (60ml) and stirred at r.t. for 4 hours. The 
polyallylamine solution was added to the reaction. A white precipitate formed instantly. 
The solution was filtered, and the precipitate collected to yield the required polymer 201 
as a white gum (956mg); 13e NMR (75.4MHz, solid state) 14.5, 18.6,26.7, 33.5 (CH~, 
CH from polyallylamine), 57.8, 118.7-129.1 (ArC), 177.6 (C(O)NH). 
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5.2 Synthesis of Polymer 204 Containing Lysine. 
Reaction of Polyallylamine with FmocLys(Fmoc)-OH to Afford 203. 
14 
HN )=0 
o 
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6 
Polyallylamine hydrochloride (1 OOmg, 1.07mmol) was stirred with potassium 
hydroxide (50mg, 1.lmmol) in MeOH (20ml) for 15 hours. The solvent was removed in 
vacuo, and the residue dissolved in EtOH (20ml). The solution was filtered to remove 
any undissolved KCI which had formed, and concentrated to 10mi in vacuo, to yield a 
solution of free polyallylamine in EtOH. 
FmocLys(Fmoc)-OH 194 (874mg, 1.6mmol), DCC (396mg, 1.9mmol) and N-
hydroxysuccinimide (258mg, 2.2mmol) were dissolved in CHCh (50ml) and stirred at 
r.t. for 3 hours. The solution of polyallylamine was added to this solution, and the 
reaction stirred for a further 3 hours, after which time a white precipitate had formed. 
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The solid was collected by filtration, and dried under vacuum to yield the desired 
polymer 203 as a white insoluble solid (1.023g); 13e NMR (75.4MHz, solid state) 
Dc/ppm 24.7 (C(11», 27.7 (C(14», 33.3 (C(10), C(12», 36.2 (C(16», 40.9 (C(15», 42.1 
(C(13», 46.6 (C(9», 53.8, 55.8 (CHC(O)NH), 61.9, 63. L 67.7 (C(9)HCH2), 120.6 
(C(1), C(8», 126.8, (C(2), C(3), C(4), C(5), C(6), C(7», 141.9 (C(1 '), C(4'), C(5'), 
C(8'», 157.4 (NHC(O)O), 173.7 (RC(O)NH); Vrnax (nujol/cm-1) 736(m), 756(m), 
871(w), 937(w), 1033(m), 1087(m), 1103(w), 1141(m), 1242(s), 1377(s), 1461(s, 
nujol), 1539(s, NHC(O», 1651(s, C=O), 1693(s, C=O), 2854(s, nujol), 2923(s, nujol), 
3294(s, br). 
Removal of Base Labile (Fmoc) Protecting Groups to Afford Polymer 204. 
204 
Polymer 203 (583mg) was suspended in a solution of 20% piperidine/DMF (25ml) and 
stirred for 2 hours. The mixture was filtered, and the solid dried under vacuum, to afford 
the desired polymer 204 as a white solid (85mg); 1H NMR (500MHz, D20) bH/ppm 
0.82, 1.31 (CfuCH(CH2)CH2NHC(O), Cfu(CH2hNH2), 1.54 (CfuCH2NH2), 1.80 
(CfuCH(C(O)NH)NH2), 2.89, 3.05 (CH2CH(CH2)CH2NHC(O), CH2NH2, 
CfuNHC(O», 3.95 (CHC(O)NH); 13e NMR (125.7MHz, D20) Dc/ppm 19.5 
(CH 2CH(CH2)CH2NHC(O», 23.3 (CH2(CH2)2NH2), 28.1 (CH2CH(CH 2)CH2NHC(O», 
32.4, 35.6 (CH2CH(C(O)NH)NH2, CH2CH2NH2), 40.8 (CH2NH2), 53.5, 54.9 
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(CHC(O)NH, CH2NHC(O)), 171.2 (CHC(O)NH); Vmax (solid state/cm- i ) 736(w), 
818(m), 1088(m), 1243(w), 1310(m), 1369(m), 1452(s), 1562.41(s, C(O)NH), 1642(s, 
C=O), 2854(m), 2932(m, C(O)NH), 3274(m, C(O)NH). 
5.3 Synthesis of Polymer 217 Containing Lysine and Histidine. 
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Reaction of Polyallylamine with FmocLys(Fmoc)-OH, and FmocHis(Trt)-OH to 
Afford 207. 
Polyallylamine hydrochloride (200mg, 2mmol) was stirred with potassium hydroxide 
(96mg, 2mmol) in MeOH (I5ml) for 13 hours. The solvent was removed in vaCllO, and 
202 
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the residue dissolved in EtOH (20ml). The solution was filtered, and concentrated to a 
volume of Sml under reduced pressure, to yield a solution of free polyallylamine in 
EtOH. 
FmocHis(Trt)-OH (S33mg, 0.86mmol), FmocLys(Fmoc)-OH (761mg, 1.3mmol). DIC 
(376j.l1, 2.4mmol) and N-hydroxysuccinimide (322mg, 2.8mmol) were dissolved in 
CHCl3 (lOOml) and stirred for 3 hours, until no further reaction was observed by TLC 
(Si02; EtOAc:MeOH; 9: 1). The solution of free polyallylamine in EtOH was then added 
to the reaction, and the resulting solution left to stir for 24 hours. After this time a white 
precipitate had formed which was removed by filtration. The solution was concentrated 
to 30ml, and diluted with MeOH (1 OOml). A cream precipitate formed, which was 
collected by filtration, and washed with DCM: MeOH (2:1, 2 x 40ml), and dried under 
vacuum to yield the desired polymer 207 (97Smg); IH NMR (SOOMHz, CDCh - See 
Appendix 1 for spectrum) DH/ppm 1.0-l.9 (br, Cfu of poly allylamine and amino acids), 
2.80, 3.20 (br, CH of polyallylamine, CfuN of amino acids), 3.80-4.40 (br, aH of 
amino acids), 6.80-7.90 (br, H of Fmoc and Trityl groups); Vrnax (solid state/cm- I) 
670(m), 720(m), 749(w), 892(w), 1047(w), 1088(m), 1158(w), 1 186(w), 1243(m), 
1319(m), 1403(m), 1437(m), IS71(s, C(O)NH), 162S(s, C=O), 1667(s, C=O), 2851(m), 
2928(m), 3324(m). 
Deprotection of Acid Labile (Trt) Protecting Groups to Afford 220. 
Polymer 207 (97Smg) was suspended in a solution of TFA:triisopropylsilane:H20 
(9S:2.S:2.S, 30ml) and sonicated for 4 hours. The mixture was filtered, and the solid 
washed with H20 (2 x 30ml), Et20 (2 x 30ml), H20 (l x 30ml) and dried under vacuum 
to yield the desired polymer 220 (S3l.Smg); IH NMR (SOOMHz, CDCh - See 
Appendix 1 for spectrum) DH/ppm l.OS-l.61 (br, Cfu of poly allylamine/lysine). 2.7-3.5 
(br, Cfu of histidine, CH of poly allylamine, CfuNH- of lysine), 3.7-4.19 (br, aH of 
peptides), 6.S0 (br, CH=CR2), 7.09-7.78 (br, FmocH). 
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Removal of Base Labile (Fmoc) Protecting Groups to Afford Polymer 217. 
n-m 
217 
Polymer 220 (531mg) was suspended in 20% piperidine/DMF (25ml) and sonicated for 
4 hours. After this time the mixture was filtered. The solid was washed with H20 (1 x 
40ml), DMF (2 x 30ml), H20 (1 x 20ml), DCM (1 x 30ml), and dried in vacuo to yield 
the desired polymer 217 (93mg). IH NMR (500MHz, D20 - See Appendix 1 for 
spectrum) oH/ppm l.14, 1.40, l.65, l.85 (br, Clli of lysine/polyallyamine), 2.41, 2.93, 
3.27 (CH of polyallyalmine, ClliNH2 of lysine, Clli of histidine), 4.38, 4.76 (aH of 
peptides), 7.68, 8.67 (CH=N, CH=CR2, histidine ring). 
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5.4 Synthesis of Polymer 218 Containing Lysine and Arginine-
Arginine. 
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Reaction of Polyallylamine with FmocArg(Pbt)Arg(Pbt)CA-OH and 
FmocLys(Fmoc)-OH to Afford 206. 
Polyallylamine hydrochloride (IS0mg, l.4mmol) was stirred with potassium hydroxide 
(lOOmg, 2mmol) in MeOH (SOml) for 14 hours. The solvent was removed in vacuo, and 
the residue dissolved in EtOH (SOml). The solution was filtered to remove any KCl 
formed, and the solution concentrated to 10ml, yielding a solution of free 
polyallylamine in EtOH. 
FmocArg(Pbf)Arg(Pbf)CA-OH (622mg, O.Smmol), DIC (303~1, 1.9mmol) and N-
hydroxysuccinimide (260mg, 2.2mmol) were dissolved in CHCb (SOml) and stirred at 
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r.t. for 3 hours, until TLC (Si02; EtOAc:MeOH; 9: 1) showed no further reaction. The 
ethanolic solution of poly allylamine was then added, and the mixture stirred at r.t. 
At the same time, FmocLys(Fmoc)-OH (623mg, Immol), DIC (1981l1, 1.3mmol) and N-
hydroxysuccinimide (170mg, 1.5mmol) were dissolved in CHCh (50ml) and stirred for 
2 hours. This solution was then added to the reaction containing polyallylamine. The 
reaction was stirred for 48 hours. After this time a white precipitate had appeared which 
was removed by filtration. The solution was concentrated in vacuo to 20ml, and diluted 
with MeOH (lOOml). A white gum formed, which was collected by filtration, and 
washed with CHCh (30ml), and MeOH (50ml). The gum was dried under to vacuum to 
yield the desired polymer 206 (564mg); IH NMR (500MHz, CD30D - see appendix 1 
for spectrum) 8H/ppm 1.16-1.41 (br, Cfu from polyallylamine/ amino acids), 2.04 (be 
ArCH3 ofPbfgroup), 2.57, 3.23, 3.87-4.39 (br, aH of pep tides), 7.32-7.77 (br, FmocH). 
Cleavage of Acid Labile (Pbl) Protecting Groups to Afford 221. 
Polymer 206 (560mg) was suspended in a solution of TFA:triisopropylsilane:H20 
(95:2.5:2.5, 40ml) and sonicated at r.t. for 4 hours. The mixture was filtered, and 
washed with H20 (l x 50ml), TFA (1 x 30ml), Et20 (1 x 30ml), CHCl3 (1 x 40ml) and 
H20 (1 x 50ml), and dried under vacuum to yield the desired polymer 221 as a yellow 
gum (249mg); IH NMR (500MHz, CD30D- see appendix 1 for spectrum) 8H/ppm 1.19-
2.20 (br, Cfu of polyallylamine/amino acids), 2.46, 3.17, 4.13-4.35 (br, aH of 
peptides), 7.27-7.71 (br, FmocH); Vmax (solid state/cm-I) 749(s), 758(m), 1137(m), 
1202(m), 1246(m), 1449(w), 1508(m), 1524(m), 1541(s), 1653(s, C=O), 1685(s, C=O), 
2941(m), 3237(m, C(O)NH), 3343(m, C(O)NH). 
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Cleavage of Base Labile (Fmoc) Protecting Groups to Afford Polymer 218 
o-m m 
HN HN 
o o 
NH 
NH 
o 
218 
Polymer 221 (240mg) was suspended in a solution of 20% piperidine/DMF (40ml) and 
sonicated for 5 hours. The mixture was filtered and the polymer product was removed 
from the filter paper by sonicating in H20 (30ml) for 5 hours. The solvent was removed 
in vacuo, to yield the fully deprotected polymer 218 as a yellow-brown solid (79.8mg); 
IH NMR (500MHz, D20- see appendix 1 for spectrum) oH/ppm 1.15-1.96 (br, Clli of 
polyallylamine/amino acids) 2.14, 2.26, 2.47, 2.86-3.60 (br, CH of polyallylamine, 
CfuNH of amino acids) 3.93- 4.16 (br, aH of amino acids). 
207 
E\"pc 1-/111 L' II r u I 
5.5 Synthesis of Polymer 215 Containing Lysine, Histidine and 
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Reaction of Polyallylamine with FmocArg(Pbt)Arg(PbOCA~OH, FmocLys(Fmoc)-
OH and FmocHis(Trt)-OH to Afford 208. 
Polyallylamine hydrochloride (121mg, 1.3mmol) was stirred in MeOH (20ml) with 
potassium hydroxide (50mg, 1.5mmol) for 16 hours. The solvent was removed in 
vacuo, and the residue dissolved in EtOH (20ml). The solution was filtered to remove 
any KCI formed during the reaction, and concentrated to 10ml to yield a solution of free 
polyallylamine. 
FmocArg(Pbf)Arg(Pbf)CA-OH (450mg, O.38mmol), FmocHis(Trt)-OH (235mg, 
O.38mmol), DCC (188mg, O.91mmol) and N-hydroxysuccinimide (l22mg, 1.06mmol) 
were dissolved in CHCh (50ml) and stirred for 3 hours until TLC (Si02; EtOAc:MeOH: 
9: 1) showed no further reaction. The solution of polyallylamine was added, and the 
resultant solution stirred for 2 hours. 
Experimental 
At the same time, FmocLys(Fmoc)-OH (383mg, 0.65mmol), DCC (l61mg, 0.78mmol) 
and N-hydroxysuccinimide (105mg, 0.91mmol) were dissolved in CHCh (40ml) and 
stirred. After 2 hours, this solution was added to the reaction containing polyallylamine. 
The resulting solution was stirred for 24 hours. After this time the solution was diluted 
with MeOH (100ml). A precipitate formed which was collected by filtration, and dried 
under vacuum to afford the desired polymer 208 as a yellow gel (333mg): 1" NMR 
(500MHz, CDCh - see appendix 1 for spectrum) oH/ppm 0.91-1.80 (be Clli of 
polyallylamine and amino acids), 2.04 (br, ArCH3 of Pbf), 2.50, 3.09 (be CH of 
polyallylamine, CfuN of amino acids), 3.81-4.25 (br, aH of amino acids), 7.21-7.77 
(br, H of Fmoc and Trityl groups); V max (solid state/cm- I ) 732(m), 810(w), 1023(m), 
1090(s), 1149(w), 1257(m), 1301(m), 1386(m), 1555(m), 1656(s, C=O), 2935(m), 
3246(m, C(O)NH), 3312(m, C(O)NH). 
Cleavage of Acid Labile (Pbf, Trt) Protecting Groups to Afford 214. 
Polymer 208 (300mg) was suspended in a solution of TFA:triisopropylsilane:H20 
(95:2.5:2.5, 15ml) and sonicated at r.t. for 3 hours. The mixture was filtered, and 
washed with H20 (2 x 40ml), TFA (1 x 50ml), and H20 (1 x 50ml), and dried under 
vacuum to yield the desired polymer 214 as a yellow solid (227mg); 1" NMR 
(500MHz, CD30D - see appendix 1 for spectrum) oH/ppm l.21-1.90 (br, CH2 of 
polyallylamine/ amino acids), 2.47, 2.93, 3.20 (CH of poly allylamine, ClliNH of amino 
acids), 3.8-4.58 (br, aH of amino acids), 7.26-7.71 (br, FmocH); Vmax (solid state/cm-I) 
652(w), 725(s), 799(m), 823(w), 907(m), 1135(s), 1199(s), 1448(w), 1549(m), 1670(s, 
C=O), 2917(m), 3089(m, br, C(O)NH). 
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Cleavage of Base Labile (Fmoc) Protecting Groups to Afford Polymer 215. 
m 
HN 
NH 
NH 
215 
Polymer 214 (220mg) was suspended in a 20% piperidine/DMF solution (40ml) and 
sonicated at r.t. for 3 hours. The mixture was filtered and washed with DMF (3 x 40ml), 
H20 (2 x 40ml) and DCM (2 x 40ml). The solid was dried under vacuum to yield the 
fully deprotected polymer 215 as an orange solid (84mg); IH NMR (SOOMHz, CD30D 
- see appendix 1 for spectrum) 8H/ppm 0.9-2.1 (br, Cfu of polyallylamine and amino 
acids), 2.2-3.5 (br, CH of polyallylamine, Cfu of histidine, CH2NH of lysine/arginine), 
3.8-4.3 (br, aH of amino acids), 7.32 (br, CH=N, CH=CR2 of histidine); Ymax (solid 
state/cm- I ) 673(s), 727(m), 7SS(m), 1070(s), 1995(s), 11SI (m), 1214(m), 1232( m), 
1384(m), 1447(m), lS61(s, br), 1644(s, C=O), 2929(m), 2942(m), 3189(m, C(O)NH), 
3299(m, C(O)NH), 3367(m, C(O)NH). 
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Reaction of Polyallylamine with FmocCys(Trt)-OH and FmocLys(Fmoc)-OH to 
Afford 213. 
Polyallylamine hydrochloride (200mg, 2mmol) was stirred with potassium hydroxide 
(lOOmg, 2mmol) in MeOH (SOml) for 14 hours. The solvent was removed in vacuo, and 
the residue dissolved in EtOH (SOml). The solution was filtered to remove any KCI 
fonned, and the solution concentrated to 10ml, yielding a solution of free 
polyallylamine in EtOH. 
FmocCys(Trt)-OH (470mg, 0.8mmol), HATU (304mg, 0.8mmol) and DIPEA (279ul, 
1.6mmol) were dissolved in DCM (SOml) and stirred at r.t. for 30 mins, until TLC 
(Si02; EtOAc:MeOH; 9: 1) showed no further reaction. The ethanolic solution of 
polyallylamine was then added, and the mixture stirred at r.t. 
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At the same time, FmocLys(Fmoc)-OH (708mg, 1.2mmol), HATU (456mg, 1.2mmol) 
and DIPEA (418ul, 2.4mmol) were dissolved in DCM (50ml) and stirred for 30 mins. 
This solution was then added to the reaction containing polyallylamine. The reaction 
was stirred for 48 hours. Methanol (lOOml) was added to the solution and a \\'hite 
precipitate formed. The solid was collected by filtration, and washed with DCM 
(30ml), and MeOH (50ml). The solid was dried under to vacuum to yield the desired 
polymer 213 (658mg); IH NMR (500MHz, CDCh - see appendix 1 for spectrum) 
oH/ppm 1.20-2.00 (br, Cfu of polyallylamine and amino acids), 2.60-3.20 (br, CH of 
polyallylamine, CfuN of amino acids), 4.70-4.40 (br, aH of amino acids), 6.50-7.70 
(br, H of Fmoc and Trityl groups); Vrnax (solid state/cm- I ) 732(m), 810(w), 1023(m), 
1090(s), 1149(w), 1257(m), 1301(m), 1386(m), 1555(m), 1656(s, C=O), 2935(m), 
3246(m, C(O)NH), 3312(m, C(O)NH). 
Cleavage of Acid Labile (Trt) Protecting Groups to Afford 222. 
Polymer 213 (640mg) was suspended in a solution of TFA:triisopropylsilane:H20 
(95:2.5:2.5, 15ml) and sonicated at r.t. for 5 hours. The mixture was filtered, and 
washed with H20 (2 x 40ml), TFA (l x 50ml), and H20 (2 x 50ml), and dried under 
vacuum to yield the desired polymer 222 as an off-white solid (572mg); IH NMR 
(500MHz, CD30D - see appendix 1 for spectrum) oH/ppm 1.0-1.9 (be Cfu of 
polyallylamine/ amino acids), 2.6-3.6 (CH of polyallylamine, CfuNH of amino acids), 
3.7-4.4 (br, aH of amino acids), 6.50-7.80 (br, FmocH). 
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Cleavage of Base Labile (Fmoc) Protecting Groups to Afford 216. 
216 
Polymer 222 (560mg) was suspended in a 20%) piperidine/DMF solution (40ml) and 
sonicated at r.t. for 3 hours. The mixture was filtered and washed with DMF (3 x 40ml), 
H20 (2 x 40ml) and DCM (2 x 40ml). The solid was dried under vacuum to yield the 
fully deprotected polymer 216 as a cream coloured solid (93mg); 10 NMR (500MHz, 
D20 - see appendix 1 for spectra) bH/ppm 0.8-1.9 (br, Clli of polyallylamine and amino 
acids), 2.3-2.4 (br, CH of polyallylamine, Clli of cysteine, ClliNH of lysine), 3.7-4.4 
(br, aH of amino acids). 
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6. Binding and Reactions of Polymers. 
6.0 Binding Studies of Polymer 218 using PFG-NMR. 
Measurement of the Diffusion Coefficient of Polymer 218. 
Polymer 218 (8.5mg) was dissolved in D20 (lml) using sonication to ensure complete 
dissolution. The pD was adjusted to 7 using DCI and NaOD. The diffusion coefficient 
of the polymer in solution was measured by PFG-NMR using the BPP-LED pulse 
sequence l25 . A series of 32 BPP-LED spectra were acquired with gradient strength 
varying on a "squared" scale from 5-95% (lOO%=50Gcm- 1). The parameters used were: 
o=6ms, T=Olms, L\=200ms. The data was processed as described in section 3. The 
results are shown in Chapter 2.8. 
Measurement of the Diffusion Coefficient of the TSA 146 in a 2mM solution. 
A 2mM solution of TSA 146 in D20 was prepared, and the pD adjusted to 7 using DCI 
and NaOD. The diffusion coefficient was measured using the method and parameters 
described in section 3. The results are shown in Chapter 2.8 
Measurement of the Diffusion Coefficient of the TSA 146 in the presence of 
Polymer 218. 
TSA 146 (O.8mg) was added to the sample used to measure the diffusion coefficient of 
polymer 218, so that the concentration of TSA 146 in the solution was 2mM. The 
diffusion coefficient of the TSA 146 was then measured using the same method as 
described above. The parameters used were: o=3.2ms, T=O.l ms, L\=200ms. The data 
was processed as described in section 3. The results are shown in Chapter 2.8 
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6.1 Synthesis of Acid Product 219 (for use as a standard in HPLC). 
Synthesis of 4-[(4-Carboxy-l-Oxobutyl)amino] Benzene Acetic Acid (219) 
o o 
HO N 
H 
219 
3 
OH 
2 
1 
6 
4-Aminophenylacetic acid (lg, 6.6mmol) was suspended in 50ml DCM. Glutaric 
anhydride (0.91g, 7.9mmol) and triethylamine (2.05ml, 14.5mmol) were added and the 
mixture heated to reflux. After 12 hours a yellow solution had formed. The solution was 
cooled, and diluted with H20 (1 OOml). The organic layer was separated. The pH of the 
aqueous layer was adjusted to 1 using aq. HCI (2M), and extracted with EtOAc (2 x 
100ml). The organic layer was dried over Na2S04, and the solvent removed in vacuo to 
yield 219 as a cream solid (1.65g, 95%); m.p. 168-169°C; IH NMR (300MHz, 0 20) 
DH/ppm 1.92 (m, 2H, CH2CfuCH2), 2.30 (t, J=7.5, 2H, CfuC(O)NH), 2.42 (t, J=7.5, 
2H, CH2CfuC02H), 3.51 (s, 2H, ArCfuC02H), 7.27 (d, J=8.0, 2H, C(3)H, C(5)H), 
7.36 (d, J=8.0, 2H, C(2)H, C(6)H); I3C NMR (D20, 75.4MHz) Dc/ppm 22.7 
(CH2CH2CH2), 36.4 (CH2C(0)NH), 37.1 (CH2CH2C02H), 44.3 (ArCH2C02H), 122.7 
(C(3)H, C(5)H), 130.1 (C(2)H, C(6)H), 134.9 (C( 4)H), 135.4 (C(1 )H), 175.6 
(CH2C(0)NH), 181.3, 183.0 (2 x C02H); Yrnax (nujol/cm-1) 653(w), 721(w), 798(m), 
895(w, br), 1182(w), 1247(m), 1306(m), 1377(s), 1397(m), 1456(s), 1462(s), 1537(s), 
1599(m), 1633(m), 1660(s, C(O)NH), 1699(s, C=O), 1728(s, C=O), 2627(m, br), 
2852(s), 2922(s, O-H st), 3300(s, C(O)NH); m/z (FAB) 288 (74%, [M+Nar), 266 
(80%, [M+Ht), 248 (65%, [M+Hr-H20), 220 (43%, [M-C02Hr); HRMS found 
266.1033, M+H (C 13H1 6NOs) requires 266.1028; Anal. Calcd. For C\3H1SNOs: C. 
58.86; H, 5.70; N, 5.28%, Found: C, 58.73; H, 5.71: N, 5.25%. 
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6.2 Calibration of HPLC by the External Standard Method165• 
The compounds used as standards were all synthesised as described earlier (section 2.0, 
2.1). HPLC conditions were: Reverse phase C18 column (4.6 x 250mm), sample 
injection volume of 2J.lI, elution of CH3CN (+5%H20, 0.I%TFA)/H20 (0.1% TFA), 
solvent gradient 5-95% CH3CN over 20mins, flow rate Iml/min, UV detection at 
254nM. 
6.2.1 Calibration of Ester Starting Material. 
A 5mM solution of the ester substrate 145 (46.1mg in 25ml) in aq. phosphate buffer 
pH7 was prepared. From this stock solution, 5 solutions of differing concentrations (see 
Table 11) were prepared, and analysed by HPLC. The area of the peak at retention time 
18.01 mins. was measured. 
Concentration Of Ester Area of Ester Peak 
ImM 606353 
O.8mM 506804 
O.6mM 367242 
O.4mM 240582 
0.2mM 127880 
Table 11 
A plot of the area of the peak against the concentration was made, and linear regression 
analysis performed (Equation 13): 
y = 615796x Equation 13 
where y is the area of the ester, and x is the concentration. 
6.2.2 Calibration of Acid Product. 
A 5mM solution of the acid product 219 (33.1mg in 25ml) in aq. phosphate buffer pH7 
was prepared. From this stock solution, 5 solutions of differing concentrations (see 
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Table 12) were prepared, and analysed by HPLC. The area of the peak at retention time 
11.9 mins. was measured. 
Concentration of Acid Area of Acid Peak 
ImM 556559 
0.8mM 437926 
0.6mM 331037 
O.4mM 216663 
0.2mM 111659 
Table 12 
A plot of the area of the peak against the concentration was made, and linear regression 
analysis performed (Equation 14): 
y = 551939x Equation 14 
where y is the area of the acid, and x is the concentration. 
6.2.3 Calibration of TSA 146. 
A 5mM solution of the TSA 146 (50.0mg in 25ml) in aq. phosphate buffer pH7 was 
prepared. From this stock solution, 4 solutions of differing concentrations (see Table 
13) were prepared, and analysed by HPLC. The area of the peak at retention time 13.9 
mins. was measured. 
Concentration Of TSA Area of TSA Peak 
ImM 587627 
0.8mM 479769 
O.4mM 237143 
0.2mM 122796 
Table 13 
A plot of the area of the peak against the concentration was made, and linear regression 
analysis performed (Equation 15): 
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y = 592858x Equation 15 
where y is the area of the TSA, and x is the concentration. 
6.3 Hydrolysis of Ester 145 with Polymers. 
Control Reaction. 
Iml of a 0.5mM solution of ester 145 in aq. phosphate buffer pH7 was stirred at r.t. and 
pressure, and the change in concentration of ester 145, and formation of acid product 
219 were monitored by HPLC at time t=O, t=10mins, and then every 30mins for 7 
hours, and then after 24 hours. The results are described in Chapter 2.8 
General Procedure. 
1ml of a 0.5mM solution of ester 145 in aq. phosphate buffer pH7 was added to 15mg 
of polymer (1 of 204, 215, 217 or 218). The mixture was stirred at r.t. and pressure, 
and the change in concentration of ester 145, and formation of acid product 219 were 
monitored by HPLC at time t=O, t= 1 Omins, and then every 30mins for 7 hours, and then 
after 24 hours. The results are described in Chapter 2.8. 
6.4 Inhibition Experiments Using TSA 146. 
General Procedure. 
1ml of a solution of concentration 0.5mM ester 145 and 0.5mM TSA 146 in aq. 
phosphate buffer pH7 was added to 15mg of polymer (1 of 204, 215, 217 or 218). The 
mixture was stirred at r. t. and pressure, and and the change in concentration of ester 
145, TSA 146, and formation of acid product 219 were monitored by HPLC at time t=O, 
t= 1 Omins, and then every 30mins for 7 hours, and then after 24 hours. The results are 
described in Chapter 2.8. 
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Appendix 1. NMR Spectra of Polymers. 
a) Polymers Containing Lysine and Histidine. 
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b) Polymers containing Lysine and Arg-Arg. 
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c) Polymers Containing Lysine, Histidine and Arg-Arg. 
226 
Appendix 
e Q., 
Q., 
Q 
227 
.ipPCllcil.\ 
e 
Q. 
Q. 
o 
d) Polymers Containing Lysine and Cysteine. 
Appendix 
e 
c.. 
c.. 
o 
229 
AppendLt 
E 
Q. 
Q. 
= 
230 
Appendix 
II) 
2)\ 
References. 
References 
References: 
1. Fischer, E., Ber. Dtsch. Chern. Ges., 1894,27,2985. 
2. Fersht, A. R., 'Enzyme Structure and Mechanism, 2nd Ed'., Freeman New York, 
1985. 
3. Pauling, L., Nature, 1948, 161, 707. 
4. Rowan, S. J.; Sanders, 1. K. M., Curro Opin. Chern. Bioi., 1997, 1, 438. 
5. Blow, D. M., Ace. Chern. Res., 1976,9, 146. 
6. Blow, D. M.; Birktoft, J. 1.; Hartley, B. S., Nature, 1969, 221, 337. 
7. Blow, D. M.; Sigler, P. B.; Matthew, B. W.; Henderson, R., J. Mol. Bioi., 1968, 35. 
143. 
8. Mader, M. A.; Bartlett, P. A., Chern. Rev., 1997, 97, 1281. 
9. Eriksson, A. E.; Baase, W. A.; Wozniak, J. A.; Matthew, B. W., Nature, 1992, 355, 
371. 
10. Davis, A. M.; Teague, S. J., Angew. Chern. Int. Ed. Engl., 1996,35, 707. 
11. Williams, D. H.; Searle, M. S.; Mackay, J. P.; Gerhard, Y.; Maplestone, R. A., Proc. 
Natl. Acad. Sci. USA, 1993, 90, 1172. 
12. Fersht, A. R.; Shi, J.-P.; Knill-Jones, J.; Lowe, D. M.; Wilkinson, A. 1.; Blow, D. 
M.; Brick, P.; Carter, P.; Waye, M. M. Y.; Winter, G., Nature, 1985,314,235. 
13. Hansch, C., Ace. Chern. Res., 1993,26, 147. 
14. Hansch, C.; Hoekman, D.; Gao, H., Chern. Rev., 1996,96, 1045. 
15. Tong, L.; Pov, S.; Mui, S.; Lamarre, D.; Yockim, C.; Beaulieu, P.; Anderson, P. C., 
Structure, 1995,3,33. 
16. Kirby, A., Angew. Chern. Int. Ed. Engl., 1996,35,707. 
17. Komiyana, M.; Inoue, S., Bull. Chern. Soc. Jpn., 1980, 52, 334. 
18. Komiyana, M.; Hirai, H., Chern. Lett., 1980, 1251. 
19. Desper, J. M.; Breslow, R., J. Arn. Chern. Soc., 1994, 116, 12081. 
20. Breslow, R.; Nesnas, N., Tetrahedron Lett., 1999, 40, 3335. 
21. Tastan, P.; Akkaya, E. V., J. Mol. Ca ta I. A: Chern., 2000, 157, 261. 
22. Yu, 1.; Zhao, Y.; Hofferman, M. J.; Yenton, D. L., Bioorg. Med. Chern. Lett., 1999. 
9, 2705. 
23. Mattei, P.; Diederich, F., Angew. Chern. Int. Ed. Engl., 1996,35, 1341. 
24. Haring, D.; Distefano, M. D., Bioconjugate Chern., 2001. 12,385. 
233 
References 
25. Breslow, R.; Dong, S. D., Chern. Rev., 1998,98, 1997. 
26. Breslow, R.; Zhang, B., J Am. Chern. Soc., 1992, 114, 5882. 
27. Clyde-Watson, Z.; Vidal-Ferron, A.; Twyman, L. 1.; Walker, C. 1.: McCallien, \\'. 
J.; Fanni, S.; Bampos, N.; Wylie, R. S.; Sanders, 1. K. M., New. J Chern., 1998, 493. 
28. Marty, M.; Clyde-Watson, Z.; Twyman, L. J.; Nakash, M.; Sanders, J. K. M .. 1. 
Chern. Soc. Chern. Cornrnun., 1998, 2265. 
29. Sanders, 1. K. M., Pure Appl. Chern., 2000, 72, 2265. 
30. Laschat, S., Angew. Chern. Int. Ed. Engl., 1996, 35, 289. 
3l. Kang, J.; Santamaria, 1.; Hilmersson, G.; Rebek Jr., J., J Arn. Chern. Soc., 1998, 
120, 7389. 
32. Meissner, R. S.; Rebek Jr., J.; de Mendoza, J., Science, 1995,270, 1485. 
33. Kang, J.; Rebek Jr., 1., Nature, 1997, 385, 50. 
34. Kang, J.; Hilmerson, G.; Santamaria, J.; Rebek Jr., J., J Arn. Chern. Soc., 1998, 1 ](), 
3650. 
35. Tam-Chang, S.-W.; Jimenez, L.; Diederich, F., Helv. Chirn. Acta., 1993, 76,2616. 
36. Mattei, P.; Diederich, F., Helv. Chirn. Acta., 1997,80, 1555. 
37. Habicher, T.; Diederich, F.; Gramlich, B., Helv. Chirn. Acta., 1999,82, 1066. 
38. Klotz, K. I.; Royer, G. P.; Scarpa, I. S., Proc. Natl. Acad. Sci. USA., 1971, 68, 263. 
39. Jang, B-B.; Lee, K.-P.; Min, D.-H.; Suh, 1., J Arn. Chern. Soc., 1998, 120, 12008. 
40. Suh, J.; Moon, S.-J., Inorg. Chern., 2001, 40, 4890. 
4l. Jeung, C.-S.; Kim, C. H.; Min, K.; Suh, S.-W.; Suh, J., Bioorg. Med. Chern. Lett., 
2001, 11, 240l. 
42. Moon, S.-1.; Jeon, 1. W.; Kim, H.; Suh, M. P.; Suh, J., J Arn. Chern. Soc., 2000, 
122,7742. 
43. Suckling, C. J.; Zhu, L. M., Bioorg. Med. Chern. Lett., 1993, 3, 531. 
44. Haring, D.; Schuler, E.; Adam, W.; Saha-Moller, C. R.; Schreier, P., 1. Org. Chem., 
1999, 64, 832. 
45. Goldberg, 1. M.; Kirsch, 1. F., Biochemistry, 1996,35, 5280. 
46. Pauling, L., Chern. Eng. New., 1946,24, 1375. 
47. Jencks, W. P., 'Catalysis in Chemistry and Enzymology', McGraw-HilL New York, 
1969. 
48. Raso, V.; Stollar, B. D., Biochemistry, 1975, 14, 591. 
49. Kohler, G.; Milstein, C., Nature, 1975, 256, 495. 
50. Tramontano, A.; Janda, K. D.; Lerner, R. A., Science, 1986, 234, 1566. 
234 
Re(ereJlll'l 
51. Pollack., S. J.; Jacobs, 1. W.; Schultz, P. G., Science, 1986, 234, 1570. 
52. Benkovic, S. J.; Adams, 1. A.; Bordes Jr., C. L.; Janda, K. D.: Lerner. R. A .. 
Science, 1991, 252, 680. 
53. Hsieh, L. C.; Yonkovich, S.; Kochersperger, L.; Schultz, P. G., Science, 1993,260. 
337. 
54. Hilvert, D.; Hill, K. W.; Nared, K. D.; Auditor, M. T. M., 1. Arn. Chem. Soc .. 1989. 
111, 9261. 
55. Gouverneur, V. E.; Houk, K. N.; de Pascual-Theresa, B.; Beno. B.: Janda, K. D.: 
Lerner, R. A., Science, 1993,262, 204. 
56. Gruber, K.; Zhour, B.; Houk, K. N.; Lerner, R. A.: Shevlin, C. G.: Wilson, 1. A., 
Biochemistry, 1999, 38, 7062. 
57. Hsieh, L. C.; Schultz, P. G.; Stephans, J. C., 1. Arn. Chern. Soc., 1994, 116, 2167. 
58. Fujii, I.; Fukuyama, S.; Iwabuchi, Y.; Tanimura, R., Nat. Biotechnol., 1998, 16, 463. 
59. Driggers, E. M.; Cho, H. S.; Lui, C. W.; Katzka, C. P.; Braisted, A. C.; Ulrich, H. 
D.; Wenner, D. E.; Schultz, P. G., 1. Arn. Chern. Soc., 1998, 120, 1995. 
60. Li, T.; Janda, K. D.; Lerner, R. A., Nature, 1996, 379, 326. 
61. Wirsching, P.; Ashley, 1. A.; Lo, C.-H.; Janda, K. D.: Lerner, R. A., Science, 1995, 
270, 1775. 
62. Hasserodt, J., Synlett, 1999,2007. 
63. Janda, K. D.; Weinhouse, M. I.; Schloeder, D. M.; Lerner, R. A.; Benkovic, S. 1.,1. 
Am. Chern. Soc., 1990, 112, 1274. 
64. Ersoy, 0.; Fleck, R.; Sinskey, A.; Masamune, S., 1. Arn. Chern. Soc., 1996, 118, 
13077. 
65. Zhong, G.; Lerner, R. A.; Barbas III, C. F., Angew. Chern. Int. Ed. Engl., 1999, 38, 
3738. 
66. Wagner, 1.; Lerner, R. A.; Barbas III, C. F., Science, 1997,270, 1797. 
67. Zhong, G.; Shabat, D.; List, B.; Anderson, J.; Sinha, S. C.; Lerner, R. A.: Barbas III. 
C. F., Angew. Chern. Int. Ed. Engl., 1998, 110,2609. 
68. Abe. I.; Rohmer, M.; Prestwich, G. D., Chern. Rev., 1993, 93, 2189. 
69. Paschall, C. M.; Hasserodt, 1.; Jones, T.; Lerner, R. A.: Janda, K. D.; Christianson, 
D. W., Angew. Chern. Int. Ed. Engl., 1999, 38, 1743. 
70. Hasserodt, 1.; Janda, K. D.; Lerner, R. A .. Bioorg. Med. Chern .. 2000, 8, 995. 
71. Wulff, G., Angew. Chern. Int. Ed. Engl., 1995, 34, 1812. 
72. Vulfson, E.; Alexander, C.; Whitcombe, M., Chem. Brit .. 1997,23. 
References 
73. Wulff, G.; Gross, T.; Schonfeld, R., Angew. Chern. Int. Ed. Engl., 1997, 36, 1962. 
74. Matsui, 1.; Nicholls, 1. A.; Korube, I.; Mosbach, K., J. Org. Chern., 1996,61,5414. 
75. Liu, X.-C.; Mosbach, K., Macrornol. Rapid Cornrnun., 1997, 18,609. 
76. Strikovsky, A. G.; Kasper, D.; Grun, M.; Green, B. S.: Hradil, 1.: \Vulff, G .. J. .-1m. 
Chern. Soc., 2000, 122, 6295. 
77. Sellergren, B.; Karmalkar, R. N.; Shea, K. 1., J. Org. Chern., 2000, 65,4009. 
78. Polbom, K.; Severin, K., J. Chern. Soc. Chern. Cornrnun., 1999, 2481. 
79. Polbom, K.; Severin, K., Chern. Eur. J., 2000, 6,4604. 
80. Suh, 1.; Hah, S. S., J. Arn. Chern. Soc., 2000, 122, 3901. 
8l. Oh, S.; Chang, W.; Suh, 1., Bioorg. Med. Chern. Lett., 2001,11, 1469. 
82. Klibanov, A. M., Trends. Biochern. Sci., 1989, 14, 141. 
83. Klibanov, A. M., Nature, 1995,374, 536. 
84. Braco, L.; Dabulis, K.; Klibanov, A. M., Proc. Nat!. Acad. Sci. USA., 1990,87,274. 
85. Slade, C. 1.; Vulfson, E. N., Biotech. Bioeng., 1998, 57, 212. 
86. Peipker, F.; Fischer, L., Bioorg, Med. Chern., 1999, 7, 2231. 
87. Huc, 1.; Lehn, 1.-M., Proc. Nat!. Acad. Sci. USA., 1997,94,2106. 
88. Eliseev, A. V.; Nelen, M. I., Chern. Eur. J., 1998, 4, 825. 
89. Furlan, R. L. E.; Cousins, G. R. L.; Sanders, 1. K. M., J. Chern. Soc. Chem. 
Cornrnun., 2000, 176l. 
90. Huc, I.; Krische, M. 1.; Funeriu, D. P.; Lehn, 1.-M., Eur. J. Inorg. Chem., 1999, 
1415. 
9l. Polyakv, V. A.; Nelen, M. I.; Nazapack-Kandlousy, N; Ryabov, A. D.; Eliseev, A. 
V., J. Phys. Org. Chern., 1999, 12, 357. 
92. Cousins, G. R. L.; Poulsen, S.-A.; Sanders, 1. K. M., J. Chern. Soc. Chem. Commull., 
1999, 1575. 
93. Karan, C.; Miller, B. L., J. Arn. Chern. Soc., 2001, 123, 7455. 
94. Goral, V.; Nelen, M. I.; Eliseev, A. V.: Lehn, 1.-M., Proc. Natl. Acad. Sci. USA., 
2001,98, 1347. 
95. Menger, F. M.; Eliseev, A. V.; Migulin, B. A., J. Org. Chern., 1995, 60, 6666. 
96. Menger, F. M.; West, C. A.; Ding, 1., J. Chern. Soc. Chern. Cornmun., 1997,663. 
97. Menger, F. M.; Ding, 1.; Barragan, V., J. Org. Chern., 1998, 63, 7578. 
98. Berkessel, A.; Herault, D. A., Angew. Chern. Int. Ed. Engl., 1999, 38, 102. 
99. landeleit, B.; Schaefer, D. 1.; Powers, T. S.: Turner, H. W.: Weinberg, \\'. H., 
Angew. Chern. Int. Ed. Engl., 1999, 38, 2494. 
236 
References 
100. Bein. T., Angew. Chern. Int. Ed. Engl., 1999,38,323. 
101. Reetz, M. T., Angew. Chern. Int. Ed. Engl., 2001, 40, 284. 
102. Sutherland, J. D., Curro Opin. Chern. Bioi., 2000, 4, 263. 
103. Hart, E. A.; Hua, L.; Darr, L. B.; Wilson, W. K.; Pang, 1.: Matsuda, S. P. T .. J. Am. 
Chern. Soc., 1999, 121, 9887. 
104. Oue, S.; Okamoto, A. Y. T.; Kagamiyama, H., 1. Biol. Chern., 1999,274.2344. 
105. Reetz, M. T.; Zonta, A.; Shimossek, K.; Liebeton, K.; Jaeger. K.-E., Angew. Chem. 
Int. Ed. Engl., 1997, 36, 2831. 
106. Clayden, J.; Greeves, N.; Warren, S.; Wothers, P., 'Organic Chemistry'. Oxford 
University Press, 2001. 
107. Wolfenden, R., Annu. Rev. Biophys. Bioeng., 1976,5,271. 
108. Lugoukin; Arbuzov, Doklady Akad. Nauk. SSSR., 1948,59, 1309. 
109. Kagan, G.; Birkenmayer, R. D.; Strube, R. E., 1. Am. Chern. Soc., 1959,81,3026. 
110. Smith, M. B., 'Organic Synthesis', McGraw Hill, New York, 1994. 
111. Moree, W. J.; van der Morel, G. A.; van Boom, 1. H.; Liskamp, R. M. 1., 
Tetrahedron, 1993,49, 11055. 
112. Balthazar, T. M.; Flores, R. A., 1. Org. Chern., 1980, 45, 529. 
113. Malachowski, W. P.; Coward, J. P., 1. Org. Chern., 1994,45,7616. 
114. Malachowski, W. P.; Coward, J. P., 1. Org. Chern., 1994, 45, 7625. 
115. Janda, K. D.; Benkovic, S. J.; Lerner, R. A., Science, 1989,244,437. 
116. Campbell, D. A., 1. Org. Chern., 1992,57,6331. 
117. March, J., 'Advanced Organic Chemistry: Reaction, Mechanisms and Structure., 
Wiley, New York, 1992. 
118. Nicholls, 1.,1. Molecular Recognition, 1998, 11, 79. 
119. Eliseev, A. E., Current Opinion in Drug Discovery and Development, 1998, 1, 
106. 
120. Roberts, G. C. K., Drug Discovery Today, 2000, 5, 230. 
121. Dowden, J.; Edwards, P. D.; Flack, S. S.; Kilburn, J. D., Chern. Eur. 1., 1999, 5, 
79. 
122. Orfi, L.; Lin, M.; Larive, C. K., Anal. Chern., 1998, 70, 1339. 
123. Frish, L.; Sansone, F.; Casnati, A.; Ungaro, R.; Cohen, Y., 1. Org. Chem .. 2000. 
65,5026. 
124. Gounarides, J. S.; Chen, A.; Shapiro, M. 1.,1. Chromatogr. B., 1999, 725,70. 
125. Wu, D.; Chen, A.; Johnson, C. S., 1. Magn. Reson. A., 1995, 115, 260. 
237 
References 
126. Stejskal, E. 0.; Tanner, J. E., J. Chem. Phys., 1965, 42, 288. 
127. Data obtained using ISOST AR, accessed from the Chemical Database Service at 
Daresbury, see ref 137. 
128. Fielding, L., Tetrahedron, 2000, 56, 6151. 
129. Carcanague, D. R.; Diederich, F., Angew. Chem. Int. Ed. Engl., 1990, ]9. 769. 
130. Peterson, B. R.; Wallimann, P.; Carcanague, D. R.; Diederich, F .. Tetrahedron, 
1995,51,401. 
131. Sybyl 6.6.2 Tripos Inc., 1699 South Hanley Road., St. Louis, Missouri, 63144, 
USA. 
132. Grail, B. M.; Payne, J. W., J. Pept. Sci., 2000,6, 186. 
133. Cohen, N. C., 'Guidebook on Molecular Modelling in Drug Design', Academic 
Press, 1996. 
134. Goodman, J. M., 'Chemical Applications of Molecular Modelling', Royal Society 
of Chemistry, Cambridge, 1998. 
135. Ghose, R. S.; Jaeger, E. P.; Kowalazyk, P. J.; Peter, M. L.; Treasurywala, A. M., 1. 
Comput. Chem., 1993, 14, 1050. 
136. Neuhaus D.; Williams, M. P., 'The Nuclear Overhauser Effect in Structural and 
Conformational Analysis 2nd Ed.', Wiley-VCH, 2000. 
137. Isostar is accessed from the Chemical Database Service at Daresbury. 
Fletcher, D. A.; McMeaking, R. F.; Parkin, D. J., Chem. In! Comput. Sci., 1996, 36, 
746. 
138. Bruno, 1. J.; Cole, J. C.; Lommerse, J. P. M.; Rowland, R. S.; Taylor, R.; Verdonk, 
M. L., J. Comput. Aided Mol Des., 1997, 11,525. 
139. Allen, F. M.; Kennard, 0., Chemical Design Automation New., 1993, 8, 31. 
140. Fersht, A. R., 'Structure and Mechanism in Protein Science: A Guide to Enzyme 
Catalysis and Protein Folding', W. H. Freeman, New York, 1999. 
141. Carpino, L. A.; Shroff, H.; Triolo, S. A.; Mansour, E.-S. M. E.: Wenschuh, H.: 
Albericio, F., Tetrahedron Lett., 1993, 34, 7829. 
142. Wang, S.-S., J. Am. Chem. Soc., 1973, 95, 1328. 
143. Barlos, K.; Chatzi, 0.; Gatos, D.; Stavropoulos, G., Int. J. Peptide. Protein. Res., 
1991, 37, 513. 
144. Carpino, L. A.; Han, G. Y., J. Org. Chem., 1972,37,3404. 
145. Chan, W. C.; White, P. D., 'Fmoc Solid Phase Peptide Synthesis: A Practical 
Approach', Oxford University Press, 2000. 
References 
146. Lapatsanis, L.; Milias, G.; Froussios, K.; Kolovos, M., Synthesis, 1983,671. 
147. Tanaka, N.; Nakagawa, K.; Iwasaki, H.; Hosoya, K.; Kimata, K.: Araki. T.: 
Patterson Jr., D. G., J. Ch rom atogr. A., 1997,781, 139. 
148. Sehgal, D.; Vijay, 1. K., Anal. Biochem., 1994,218,87. 
149. Sheehan, J. C.; Ledis, S. L., J. Am. Chem. Soc., 1973, 95, 875. 
150. Pennington, R. M.; Fisher, R. R., J. BioI. Chem., 1981,256,8963. 
151. Angell, Y. M.; Garcia-Echevema, C.; Rich, D. H., Tetrahedron Lett., 1994, 3-/, 
5981. 
152. Williams, D. H.; Fleming, 1., 'Spectroscopic Methods in Organic Chemistry, 5th 
Ed.', McGraw Hill, UK, 1995. 
153. Carpino, L. A., J. Am. Chem. Soc., 1993, 115,4397. 
154. White, P., NovaBioChem Innovations, 2/93. 
155. Pearson, D.; Blanchette, M.; Baker, M. L.; Guidon, C. A., Tetrahedron Lett., 1989, 
30,2739. 
156. Weingartner, Z. Phys. Chem. (Neue Folge), 1982, 129. 
157. Holz, M.; Weingartner, J. Magn. Reson., 1991,92, 115. 
158. Thuong, N. T., Bull. Soc. Chim. Fr., 1965, 1925. 
159. Scherer, H., Chem. Ber., 1972, 105,3357. 
160. Rewcastle, G. W.; Baguley, B. C.; Cain, B. F.; J. Med. Chem., 1982,25, 1231. 
161. Janda, K. D.; Ashley, 1. A.; Jones, T. M.: McLeod, D. A.; Schloeder, D. M.: 
Weinhouse, M. 1.; Lerner, R. A.; Gibbs R. A.; Benkovic, P. A.; Hilhorst, R.; Benkovic, 
S. J., J. Am. Chem. Soc., 1991, 112,291. 
162. Tramontano, A.; Ammann, A. A.; Lerner, R. A., J. Am. Chem. Soc., 1988, 110, 
2282. 
163. Berger, S.; Braun, S.; Kalinowski, H.-O., '150 and More Basic NMR 
Experiments', Wiley-VCH, 1998. 
164. Fujii, N.; Futaki, S.; Funakoshi, S.; Akajii, K.; Morimoto, H.; Chern. Pharrn. Bull., 
1988, 36, 328l. 
165. Lindsay, S., 'High Performance Liquid Chromatography: Analytical Chemistry by 
Open Learning', Wiley, New York, 1992. 
166. Allen, F. H.; Kennard, 0., Chemical Design Automation News, 1993,8,31. 
